a.1.1.1;Truncated hemoglobin
a.1.1.4;Nerve tissue mini-hemoglobin (neural globin)
a.1.1.2;Globins
a.1.1.3;Phycocyanin-like phycobilisome proteins
a.1.2.1;Fumarate reductase/Succinate dehydogenase iron-sulfur protein, C-terminal domain
a.1.2.2;Dihydropyrimidine dehydrogenase, N-terminal domain
a.2.1.1;GreA transcript cleavage protein, N-terminal domain
a.2.2.1;Ribosomal protein L29 (L29p)
a.2.3.1;Chaperone J-domain
a.2.5.1;Prefoldin
a.2.6.1;HR1 repeat
a.2.7.1;Seryl-tRNA synthetase (SerRS)
a.2.7.2;Phenylalanyl-tRNA synthetase (PheRS)
a.2.7.3;Valyl-tRNA synthetase (ValRS) C-terminal domain
a.2.7.4;Methicillin resistance protein FemA probable tRNA-binding arm
a.2.8.1;Eukaryotic DNA topoisomerase I, dispensable insert domain
a.2.9.1;C-terminal UvrC-binding domain of UvrB
a.2.10.1;Epsilon subunit of F1F0-ATP synthase C-terminal domain
a.2.11.1;Fe,Mn superoxide dismutase (SOD), N-terminal domain
a.2.12.1;Sporulation inhibitor Sda
a.2.13.1;Transcriptional repressor TraM
a.2.14.1;DnaK suppressor protein DksA, alpha-hairpin domain
a.2.15.1;ISY1 N-terminal domain-like
a.2.16.1;Siah interacting protein N terminal domain-like
a.2.17.1;VPS23 C-terminal domain
a.2.17.2;VPS28 N-terminal domain
a.2.17.3;VPS37 C-terminal domain-like
a.2.18.1;SPy1572-like
a.2.19.1;Rabenosyn-5 Rab-binding domain-like
a.2.20.1;MxiH-like
a.2.21.1;YznC-like
a.139.1.1;Type I dockerin domain
a.140.1.1;LEM domain
a.140.2.1;SAP domain
a.140.3.1;Rho termination factor, N-terminal domain
a.140.3.2;YqbF C-terminal domain-like
a.140.4.1;Recombination endonuclease VII, C-terminal and dimerization domains
a.140.5.1;DNA-binding domain of EIN3-like
a.140.6.1;PRP4-like
a.271.1.1;SOCS box-like
a.143.1.1;RNA polymerase omega subunit
a.143.1.2;RPB6
a.212.1.1;KRAB domain (Kruppel-associated box)
a.3.1.1;monodomain cytochrome c
a.3.1.2;N-terminal (heme c) domain of cytochrome cd1-nitrite reductase
a.3.1.6;Quinoprotein alcohol dehydrogenase, C-terminal domain
a.3.1.3;Cytochrome bc1 domain
a.3.1.4;Two-domain cytochrome c
a.3.1.8;Di-heme cytochrome c SoxA
a.3.1.5;Di-heme cytochrome c peroxidase
a.3.1.7;Quinohemoprotein amine dehydrogenase A chain, domains 1 and 2
a.4.1.1;Homeodomain
a.4.1.2;Recombinase DNA-binding domain
a.4.1.3;Myb/SANT domain
a.4.1.13;SLIDE domain
a.4.1.11;GARP response regulators
a.4.1.4;DNA-binding domain of telomeric protein
a.4.1.5;Paired domain
a.4.1.6;DNA-binding domain of rap1
a.4.1.7;Centromere-binding
a.4.1.12;FIS-like
a.4.1.8;AraC type transcriptional activator
a.4.1.9;Tetracyclin repressor-like, N-terminal domain
a.4.1.14;Middle operon regulator, Mor
a.4.1.15;Psq domain
a.4.1.16;Alr1493-like
a.4.1.17;Nanomeric phage protein-like
a.4.1.18;SWIRM domain
a.4.1.19;Cgl2762-like
a.4.1.20;RpiR-like
a.4.2.1;Methylated DNA-protein cysteine methyltransferase, C-terminal domain
a.4.3.1;ARID domain
a.4.5.1;Biotin repressor-like
a.4.5.2;LexA repressor, N-terminal DNA-binding domain
a.4.5.3;Arginine repressor (ArgR), N-terminal DNA-binding domain
a.4.5.38;Transcriptional repressor Rex, N-terminal domain
a.4.5.4;CAP C-terminal domain-like
a.4.5.32;Lrp/AsnC-like transcriptional regulator N-terminal domain
a.4.5.5;ArsR-like transcriptional regulators
a.4.5.33;Transcriptional regulator IclR, N-terminal domain
a.4.5.28;MarR-like transcriptional regulators
a.4.5.36;DNA-binding protein Mj223
a.4.5.39;Penicillinase repressor
a.4.5.6;GntR-like transcriptional regulators
a.4.5.40;N-terminal domain of Bacillus PurR
a.4.5.7;Replication terminator protein (RTP)
a.4.5.37;LysR-like transcriptional regulators
a.4.5.8;N-terminal domain of molybdate-dependent transcriptional regulator ModE
a.4.5.9;Transcription factor MotA, activation domain
a.4.5.41;Transcription factor E/IIe-alpha, N-terminal domain
a.4.5.42;FUR-like
a.4.5.10;Replication initiation protein
a.4.5.11;Helicase DNA-binding domain
a.4.5.43;RecQ helicase DNA-binding domain-like
a.4.5.34;SCF ubiquitin ligase complex WHB domain
a.4.5.35;C-terminal fragment of elongation factor SelB
a.4.5.12;Restriction endonuclease FokI, N-terminal (recognition) domain
a.4.5.27;TnsA endonuclease, C-terminal domain
a.4.5.29;Plant O-methyltransferase, N-terminal domain
a.4.5.13;Linker histone H1/H5
a.4.5.14;Forkhead DNA-binding domain
a.4.5.15;DNA-binding domain from rap30
a.4.5.30;C-terminal domain of the rap74 subunit of TFIIF
a.4.5.16;C-terminal domain of RPA32
a.4.5.31;DEP domain
a.4.5.17;Cell cycle transcription factor e2f-dp
a.4.5.18;The central core domain of TFIIE beta
a.4.5.19;Z-DNA binding domain
a.4.5.20;P4 origin-binding domain-like
a.4.5.21;ets domain
a.4.5.22;Heat-shock transcription factor
a.4.5.23;Interferon regulatory factor
a.4.5.44;39 kda initiator binding protein, IBP39, N-terminal domain
a.4.5.24;Iron-dependent repressor protein
a.4.5.45;Dissimilatory sulfite reductase DsvD
a.4.5.46;La domain
a.4.5.25;Methionine aminopeptidase, insert domain
a.4.5.47;PCI domain (PINT motif)
a.4.5.48;F93-like
a.4.5.49;Archaeal DNA-binding protein
a.4.5.50;TrmB-like
a.4.5.51;Heat-inducible transcription repressor HrcA, N-terminal domain
a.4.5.52;DNA replication factor Cdt1
a.4.5.53;Eukaryotic translation initiation factor 3 subunit 12, eIF3k, C-terminal domain
a.4.5.54;Vacuolar sorting protein domain
a.4.5.55;Transcriptional regulator Rrf2
a.4.5.56;Rio2 serine protein kinase N-terminal domain
a.4.5.57;Rad21/Rec8-like
a.4.5.58;Hypothetical protein PH1932
a.4.5.59;An Obfc1 domain
a.4.5.60;ScpB/YpuH-like
a.4.5.61;PadR-like
a.4.5.62;Hypothetical protein YhgG
a.4.5.63;ROK associated domain
a.4.5.64;PF1790-like
a.4.5.65;MukF N-terminal domain-like
a.4.5.66;CodY HTH domain
a.4.5.67;FtsK C-terminal domain-like
a.4.5.68;Nudix-associated domain
a.4.5.69;HxlR-like
a.4.5.70;Marine metagenome family WH1
a.4.5.71;ReutB4095-like
a.4.5.72;PH0730 N-terminal domain-like
a.4.5.73;FaeA-like
a.4.5.74;STY4665 C-terminal domain-like
a.4.5.75;PSPTO2686-like
a.4.5.76;RHA1 ro06458-like
a.4.5.77;YjcQ-like
a.4.5.78;F112-like
a.4.5.79;MerB N-terminal domain-like
a.4.5.80;CED-4 C-terminal domain-like
a.4.5.81;ELL N2 domain-like
a.4.5.82;PF0610-like
a.4.5.83;Rv2827c N-terminal domain-like
a.4.5.84;Rps19E-like
a.4.5.85;RPO3F domain-like
a.4.6.1;PhoB-like
a.4.6.2;GerE-like (LuxR/UhpA family of transcriptional regulators)
a.4.6.3;Spo0A
a.4.12.1;Trp repressor, TrpR
a.4.12.2;Chromosomal replication initiation factor DnaA C-terminal domain IV
a.4.12.3;SPO1678-like
a.4.7.1;Ribosomal protein L11, C-terminal domain
a.4.8.1;Ribosomal protein S18
a.4.9.1;Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domain 3
a.4.10.1;N-terminal Zn binding domain of HIV integrase
a.4.11.1;RNA polymerase subunit RPB10
a.4.13.1;Sigma3 domain
a.4.13.2;Sigma4 domain
a.4.13.3;YlxM/p13-like
a.4.14.1;KorB DNA-binding domain-like
a.4.15.1;Rps17e-like
a.159.2.1;FF domain
a.159.1.1;Protein serine/threonine phosphatase 2C, C-terminal domain
a.159.3.1;B-form DNA mimic Ocr
a.159.4.1;DEK C-terminal domain
a.159.5.1;IscX-like
a.5.1.1;DNA helicase RuvA subunit, C-terminal domain
a.5.2.1;UBA domain
a.5.2.2;TS-N domain
a.5.2.3;TAP-C domain-like
a.5.2.4;CUE domain
a.5.7.1;DmpG/LeuA communication domain-like
a.5.7.2;Conserved carboxylase domain
a.5.3.1;CRAL/TRIO N-terminal domain
a.5.4.1;Elongation factor TFIIS domain 2
a.5.6.1;Double-stranded DNA-binding domain
a.5.8.1;Hypothetical protein AF0491, middle domain
a.5.9.1;HBS1-like domain
a.5.10.1;FGAM synthase PurL, linker domain
a.156.1.1;Ribosomal protein S13
a.156.1.2;Middle domain of MutM-like DNA repair proteins
a.156.1.3;Topoisomerase VI-B subunit middle domain
a.6.1.1;Domains B1 and B5 of PheRS-beta, PheT
a.6.1.2;DNA repair factor XPA DNA- and RPA-binding domain, C-terminal subdomain
a.6.1.4;Dachshund-homology domain
a.6.1.3;DNA-binding N-terminal domain of transcription activators
a.6.1.5;Terminase gpNU1 subunit domain
a.6.1.7;Excisionase-like
a.6.1.6;N-terminal subdomain of bacterial translation initiation factor IF2
a.7.1.1;Spectrin repeat
a.7.2.1;Enzyme IIa from lactose specific PTS, IIa-lac
a.7.3.1;Succinate dehydrogenase/fumarate reductase flavoprotein C-terminal domain
a.7.4.1;Smac/diablo
a.7.7.1;BAG domain
a.7.8.1;GAT domain
a.7.8.2;Phosphoinositide-binding clathrin adaptor, domain 2
a.7.5.1;Tubulin chaperone cofactor A
a.7.6.1;Ribosomal protein S20
a.7.10.1;Glycogen synthesis protein GlgS
a.7.11.1;Alpha-hemoglobin stabilizing protein AHSP
a.7.12.1;PhoU-like
a.7.13.1;XseB-like
a.7.14.1;MIT domain
a.7.15.1;PPK N-terminal domain-like
a.7.16.1;MIT domain
a.7.17.1;Efb C-domain-like
a.8.1.1;Immunoglobulin-binding protein A modules
a.8.1.2;GA module, an albumin-binding domain
a.8.2.1;Plasmid maintenance system epsilon/zeta, antidote epsilon subunit
a.8.3.2;4-alpha-glucanotransferase, domain 2
a.8.3.1;alpha-mannosidase, domain 2
a.8.3.3;AmyC C-terminal domain-like
a.8.5.1;Phosphoprotein XD domain
a.8.6.1;Staphylocoagulase
a.8.4.1;Heat shock protein 70kD (HSP70), C-terminal subdomain
a.8.7.1;Typo IV secretion system protein TraC
a.8.8.1;Avirulence protein AvrPto
a.8.9.1;Coronavirus NSP7-like
a.8.10.1;Vng1086c-like
a.8.11.1;AF1782-like
a.9.1.1;Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex
a.239.1.1;ChaB-like
a.10.1.1;Protozoan pheromone proteins
a.10.2.1;Hypothetical membrane protein Ta0354, soluble domain
a.11.1.1;Acyl-CoA binding protein
a.11.2.1;Second domain of FERM
a.272.1.1;YqgQ-like
a.12.1.1;Kix domain of CBP (creb binding protein)
a.13.1.1;RAP domain
a.14.1.1;VHP, Villin headpiece domain
a.240.1.1;BSD domain
a.15.1.1;TAF(II)230 TBP-binding fragment
a.16.1.1;N-terminal, RNA-binding domain of nonstructural protein NS1
a.16.1.2;Ribosomal protein S15
a.16.1.3;a tRNA synthase domain
a.141.1.1;Frizzled cysteine-rich domain
a.18.1.1;T4 endonuclease V
a.19.1.1;Fertilization protein
a.20.1.1;Peptidoglycan binding domain, PGBD
a.20.1.2;MMP N-terminal domain
a.21.1.1;HMG-box
a.22.1.1;Nucleosome core histones
a.22.1.2;Archaeal histone
a.22.1.3;TBP-associated factors, TAFs
a.22.1.4;Bacterial histone-fold protein
a.23.1.1;HSC20 (HSCB), C-terminal oligomerisation domain
a.23.2.1;Diol dehydratase, gamma subunit
a.23.3.1;Methane monooxygenase hydrolase, gamma subunit
a.23.4.1;Mitochondrial import receptor subunit Tom20
a.23.5.1;Hemolysin expression modulating protein HHA
a.23.6.1;EF2458-like
a.23.7.1;YvfG-like
a.161.1.1;beta-catenin-interacting protein ICAT
a.237.1.1;DNA polymerase III theta subunit-like
a.24.1.1;Apolipoprotein
a.24.2.1;Aspartate receptor, ligand-binding domain
a.24.3.1;Cytochrome b562
a.24.3.2;Cytochrome c'-like
a.24.4.1;Hemerythrin-like
a.24.5.1;TMV-like viral coat proteins
a.24.7.1;FKBP12-rapamycin-binding domain of FKBP-rapamycin-associated protein (FRAP)
a.24.8.1;Proteasome activator
a.24.9.1;alpha-catenin/vinculin
a.24.9.2;VBS domain
a.24.14.1;FAT domain of focal adhesion kinase
a.24.18.1;Oxygen-evolving enhancer protein 3,
a.24.10.1;Aerobic respiration control sensor protein, ArcB
a.24.10.2;Phosphorelay protein-like
a.24.10.3;Chemotaxis protein CheA P1 domain
a.24.10.4;Sensor-like histidine kinase YojN, C-terminal domain
a.24.10.5;Phosphorelay protein luxU
a.24.10.6;SphA-like
a.24.11.1;Bacterial GAP domain
a.24.12.1;Outer surface protein C (OspC)
a.24.19.1;Flagellar export chaperone FliS
a.24.13.1;Domain of the SRP/SRP receptor G-proteins
a.24.15.1;FAD-dependent thiol oxidase
a.24.17.1;Group V grass pollen allergen
a.24.16.2;Family 1 bi-partite nucleotidyltransferase subunit
a.24.16.3;HEPN domain
a.24.16.1;Kanamycin nucleotidyltransferase (KNTase), C-terminal domain
a.24.16.4;Glutamine synthase adenylyltransferase GlnE, domain 2
a.24.21.1;RecG, N-terminal domain
a.24.20.1;Colicin D immunity protein
a.24.22.1;Nickel-containing superoxide dismutase, NiSOD
a.24.23.1;Mannose-6-phosphate receptor binding protein 1 (Tip47), C-terminal domain
a.24.24.1;Domain from hypothetical 2610208m17rik protein
a.24.25.1;TrmE connector domain
a.24.26.1;YppE-like
a.24.27.1;MW0975(SA0943)-like
a.24.28.1;VPS28 C-terminal domain-like
a.24.29.1;TM1646-like
a.142.1.1;PTS-regulatory domain, PRD
a.25.1.1;Ferritin
a.25.1.2;Ribonucleotide reductase-like
a.25.1.3;Manganese catalase (T-catalase)
a.25.1.4;YciF-like
a.25.1.5;half-ferritin
a.25.1.6;PMT1231-like
a.25.1.7;MiaE-like
a.25.1.8;AMB4284-like
a.25.1.9;Rv2844-like
a.25.2.2;Cobalamin adenosyltransferase
a.25.2.1;Hypothetical protein Ta1238
a.25.3.1;ESAT-6 like
a.25.4.1;PE
a.25.4.2;PPE
a.25.5.1;HP0062-like
a.25.6.1;SO2669-like
a.26.1.1;Long-chain cytokines
a.26.1.2;Short-chain cytokines
a.26.1.3;Interferons/interleukin-10 (IL-10)
a.27.1.1;Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases
a.28.1.1;Acyl-carrier protein (ACP)
a.28.1.2;Peptidyl carrier domain
a.28.1.3;apo-D-alanyl carrier protein
a.28.2.1;Colicin E immunity proteins
a.28.3.1;Retrovirus capsid protein C-terminal domain
a.28.3.2;SCAN domain
a.29.2.1;Bromodomain
a.29.5.1;alpha-ketoacid dehydrogenase kinase, N-terminal domain
a.29.3.1;Medium chain acyl-CoA dehydrogenase-like, C-terminal domain
a.29.3.2;acyl-CoA oxidase C-terminal domains
a.29.6.1;Plant invertase/pectin methylesterase inhibitor
a.29.7.1;Mob1/phocein
a.29.8.1;Carnobacteriocin B2 immunity protein
a.29.8.2;EntA-Im
a.29.9.1;LemA-like
a.29.10.1;MAST3 pre-PK domain-like
a.29.11.1;PA2201 N-terminal domain-like
a.29.12.1;Nqo1C-terminal domain-like
a.29.13.1;Bacillus cereus metalloprotein-like
a.29.14.1;Ta0600-like
a.29.15.1;DsbB-like
a.29.16.1;IVS-encoded protein-like
a.29.17.1;YqcC-like
a.30.1.1;ROP protein
a.30.2.1;Homodimeric domain of signal transducing histidine kinase
a.30.3.1;Nonstructural protein ns2, Nep, M1-binding domain
a.30.4.1;Dimerisation domain of CENP-B
a.30.5.1;Hypothetical protein D-63
a.30.6.1;HP1531-like
a.30.7.1;BAS1536-like
a.30.8.1;FHV B2 protein-like
a.31.1.1;Dimerization-anchoring domain of cAMP-dependent PK regulatory subunit
a.273.1.1;Hairy Orange domain
a.178.1.1;Soluble domain of poliovirus core protein 3a
a.32.1.1;Transcription factor IIA (TFIIA), alpha-helical domain
a.33.1.1;Ectatomin subunits
a.34.1.1;SinR repressor dimerisation domain-like
a.34.2.1;Dimerization cofactor of HNF-1 alpha
a.34.3.1;Docking domain A of the erythromycin polyketide synthase (DEBS)
a.34.4.1;Adapter protein APS, dimerisation domain
a.35.1.1;POU-specific domain
a.35.1.2;Phage repressors
a.35.1.3;SinR domain-like
a.35.1.4;Cyanase N-terminal domain
a.35.1.5;GalR/LacI-like bacterial regulator
a.35.1.6;YdiL-like
a.35.1.7;CUT domain
a.35.1.8;Probable transcriptional regulator VC1968, N-terminal domain
a.35.1.9;Bacteriophage CII protein
a.35.1.10;NE0471 C-terminal domain-like
a.35.1.11;PrgX N-terminal domain-like
a.35.1.12;EDF1-like
a.35.1.13;NE1354
a.36.1.1;Signal peptide-binding domain
a.37.1.1;A DNA-binding domain in eukaryotic transcription factors
a.38.1.1;HLH, helix-loop-helix DNA-binding domain
a.38.2.1;Docking domain B of the erythromycin polyketide synthase (DEBS)
a.274.1.1;HAMP domain
a.39.1.1;Calbindin D9K
a.39.1.2;S100 proteins
a.39.1.10;Polcalcin
a.39.1.3;Osteonectin
a.39.1.4;Parvalbumin
a.39.1.5;Calmodulin-like
a.39.1.6;Eps15 homology domain (EH domain)
a.39.1.9;Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
a.39.1.8;Penta-EF-hand proteins
a.39.1.7;EF-hand modules in multidomain proteins
a.39.1.11;p25-alpha
a.39.2.1;Insect pheromone/odorant-binding proteins
a.39.4.1;Hypothetical protein MTH865
a.39.3.1;Cloroperoxidase
a.40.1.1;Calponin-homology domain, CH-domain
a.40.2.1;X-Prolyl dipeptidyl aminopeptidase PepX, N-terminal domain
a.40.3.1;Hook domain
a.41.1.1;Domain of poly(ADP-ribose) polymerase
a.42.1.1;SWIB/MDM2 domain
a.162.1.1;Pre-protein crosslinking domain of SecA
a.43.1.1;Arc/Mnt-like phage repressors
a.43.1.3;CopG-like
a.43.1.4;Omega transcriptional repressor
a.43.1.5;Met repressor, MetJ (MetR)
a.43.1.6;NE0241-like
a.43.1.7;SeqA N-terminal domain-like
a.43.1.8;Trafficking protein A-like
a.43.1.9;VCA0319-like
a.43.1.10;VirC2-like
a.43.1.11;PutA pre-N-terminal region-like
a.43.1.12;MJ0366-like
a.45.1.1;Glutathione S-transferase (GST), C-terminal domain
a.45.1.2;Arc1p N-terminal domain-like
a.46.1.1;Methionine synthase domain
a.46.2.1;Nucleoside phosphorylase/phosphoribosyltransferase N-terminal domain
a.46.3.1;TM0693-like
a.186.1.1;Circadian clock protein KaiA, C-terminal domain
a.186.1.2;Phosphoserine phosphatase RsbU, N-terminal domain
a.47.1.1;STAT
a.47.2.1;t-snare proteins
a.47.3.1;Cag-Z
a.47.4.1;CAPPD, an extracellular domain of amyloid beta A4 protein
a.47.5.1;FlgN-like
a.47.6.1;MukF C-terminal domain-like
a.48.1.1;N-terminal domain of cbl (N-cbl)
a.48.2.1;Transferrin receptor-like dimerisation domain
a.48.3.1;Conserved domain common to transcription factors TFIIS, elongin A, CRSP70
a.48.4.1;HIV integrase-binding domain
a.48.5.1;PG0775 C-terminal domain-like
a.179.1.1;Replisome organizer (g39p helicase loader/inhibitor protein)
a.229.1.1;Hypothetical protein YqbG
a.275.1.1;DnaD domain
a.49.1.1;C-terminal domain of B transposition protein
a.187.1.1;HAND domain of the nucleosome remodeling ATPase ISWI
a.180.1.1;N-terminal, cytoplasmic domain of anti-sigmaE factor RseA
a.50.1.1;Anaphylotoxins (complement system)
a.51.1.1;Cytochrome c oxidase subunit h
a.163.1.1;Crustacean CHH/MIH/GIH neurohormone
a.164.1.1;C-terminal domain of DFF45/ICAD (DFF-C domain)
a.276.1.1;BH2638-like
a.52.1.1;Plant lipid-transfer and hydrophobic proteins
a.52.1.2;Proteinase/alpha-amylase inhibitors
a.52.1.3;Seed storage protein, 2S albumin
a.53.1.1;p53 tetramerization domain
a.147.1.1;Bcr-Abl oncoprotein oligomerization domain
a.54.1.1;Domain of early E2A DNA-binding protein, ADDBP
a.55.1.1;Prokaryotic DNA-bending protein
a.55.1.2;DNA-binding domain (fragment?) of the TraM protein
a.241.1.1;TraM-like
a.56.1.1;CO dehydrogenase ISP C-domain like
a.57.1.1;Protein HNS-dependent expression A; HdeA
a.144.1.1;PABC (PABP) domain
a.144.2.1;Ribosomal protein L20
a.58.1.1;Chemotaxis receptor methyltransferase CheR, N-terminal domain
a.242.1.1;Dcp2 box A domain
a.243.1.1;TyeA-like
a.243.1.2;YopR Core
a.243.1.3;LcrE-like
a.230.1.1;YugE-like
a.188.1.1;PWI domain
a.59.1.1;PAH2 domain
a.165.1.1;Myosin phosphatase inhibitor 17kDa protein, CPI-17
a.189.1.1;XPC-binding domain
a.213.1.1;YfiT-like putative metal-dependent hydrolases
a.213.1.2;DinB-like
a.213.1.3;Sden0562-like
a.213.1.4;Maleylpyruvate isomerase-like
a.231.1.1;EspA-like
a.231.1.2;EspA chaperone CesA
a.214.1.1;NblA-like
a.244.1.1;EF2947-like
a.245.1.1;EB1 dimerisation domain-like
a.60.1.1;Pointed domain
a.60.1.2;SAM (sterile alpha motif) domain
a.60.1.3;Variant SAM domain
a.60.2.1;DNA helicase RuvA subunit, middle domain
a.60.2.3;Excinuclease UvrC C-terminal domain
a.60.2.2;NAD+-dependent DNA ligase, domain 3
a.60.2.4;Topoisomerase V repeat domain
a.60.2.5;Hef domain-like
a.60.2.6;Tex HhH-containing domain-like
a.60.2.7;ComEA-like
a.60.3.1;C-terminal domain of RNA polymerase alpha subunit
a.60.4.1;DNA repair protein Rad51, N-terminal domain
a.60.4.2;NusA extra C-terminal domains
a.60.4.3;Hypothetical protein AF1548, C-terminal domain
a.60.5.1;Barrier-to-autointegration factor, BAF
a.60.6.1;DNA polymerase beta, N-terminal domain-like
a.60.12.1;DNA polymerase beta-like, second domain
a.60.12.2;PsbU-like
a.60.7.1;5' to 3' exonuclease, C-terminal subdomain
a.60.8.1;HRDC domain from helicases
a.60.8.2;RNA polymerase II subunit RBP4 (RpoF)
a.60.8.3;RNase D C-terminal domains
a.60.8.4;EXOSC10 HRDC domain-like
a.60.9.1;lambda integrase-like, N-terminal domain
a.60.10.1;Enzyme I of the PEP:sugar phosphotransferase system HPr-binding (sub)domain
a.60.11.1;Hypothetical protein YjbJ
a.60.13.1;Putative methyltransferase TM0872, insert domain
a.60.14.1;eIF2alpha middle domain-like
a.60.15.1;YozE-like
a.60.16.1;GspK insert domain-like
a.61.1.1;Immunodeficiency virus matrix proteins
a.61.1.2;HTLV-II matrix protein
a.61.1.3;Mason-Pfizer monkey virus matrix protein
a.61.1.4;GAG polyprotein M-domain
a.61.1.5;EIAV matrix antigen
a.61.1.6;MMLV matrix protein-like
a.190.1.1;Flavivirus capsid protein C
a.62.1.1;Hepatitis B viral capsid (hbcag)
a.63.1.1;Apolipophorin-III
a.191.1.1;Methenyltetrahydrofolate cyclohydrolase-like
a.215.1.1;A middle domain of Talin 1
a.216.1.1;I/LWEQ domain
a.232.1.1;RNA-binding protein She2p
a.246.1.1;Hyaluronidase post-catalytic domain-like
a.246.2.1;TTHA0068-like
a.246.3.1;FLJ32549 domain-like
a.247.1.1;YoaC-like
a.64.1.3;Saposin B
a.64.1.1;NKL-like
a.64.1.4;Ameobapore A
a.64.1.2;Swaposin
a.64.2.1;Bacteriocin AS-48
a.65.1.1;Annexin
a.277.1.1;TAFH domain-like
a.66.1.1;Transducin (alpha subunit), insertion domain
a.68.1.1;Wiscott-Aldrich syndrome protein, WASP, C-terminal domain
a.69.1.1;C-terminal domain of alpha and beta subunits of F1 ATP synthase
a.69.2.1;Ypt/Rab-GAP domain of gyp1p
a.69.3.1;1-deoxy-D-xylulose-5-phosphate reductoisomerase, C-terminal domain
a.69.4.1;BH3980-like
a.70.1.1;N-terminal domain of the delta subunit of the F1F0-ATP synthase
a.70.2.1;Cas Cmr5-like
a.71.1.1;ERP29 C domain-like
a.71.2.1;Helical domain of Sec23/24
a.72.1.1;Functional domain of the splicing factor Prp18
a.73.1.1;Retrovirus capsid protein, N-terminal core domain
a.278.1.1;PSF1 N-terminal domain-like
a.278.1.2;PSF2 C-terminal domain-like
a.278.1.3;PSF3 C-terminal domain-like
a.278.1.4;SLD5 N-terminal domain-like
a.279.1.1;Jann4075-like
a.74.1.1;Cyclin
a.74.1.2;Transcription factor IIB (TFIIB), core domain
a.74.1.3;Retinoblastoma tumor suppressor domains
a.148.1.1;Arp2/3 complex 21 kDa subunit ARPC3
a.149.1.1;RNase III catalytic domain-like
a.149.1.2;PF0609-like
a.75.1.1;Ribosomal protein S7
a.80.1.1;DNA polymerase III clamp loader subunits, C-terminal domain
a.80.1.2;MgsA/YrvN C-terminal domain-like
a.160.1.1;Poly(A) polymerase, PAP, middle domain
a.160.1.2;2'-5'-oligoadenylate synthetase 1, OAS1, second domain
a.160.1.3;Archaeal tRNA CCA-adding enzyme substrate-binding domain
a.160.1.4;RNA editing terminal uridyl transferase 2, RET2, domain 2
a.160.1.5;AadK C-terminal domain-like
a.150.1.1;Anti-sigma factor AsiA
a.181.1.1;Antibiotic binding domain of TipA-like multidrug resistance regulators
a.217.1.1;Surp module (SWAP domain)
a.218.1.1;YgfY-like
a.219.1.1;Hypothetical protein YhaI
a.220.1.1;Hypothetical protein At3g22680
a.248.1.1;SP0561-like
a.280.1.1;RbcX-like
a.281.1.1;YmcA-like
a.281.1.2;YheA-like
a.282.1.1;RPA2825-like
a.283.1.1;Emsy N terminal (ENT) domain-like
a.249.1.1;YfmB-like
a.192.1.1;N-terminal domain of adenylylcyclase associated protein, CAP
a.250.1.1;IpaD-like
a.76.1.1;Iron-dependent repressor protein, dimerization domain
a.151.1.1;Glutamyl tRNA-reductase dimerization domain
a.193.1.1;GRIP domain
a.238.1.1;BAR domain
a.238.1.2;Arfaptin, Rac-binding fragment
a.238.1.3;IMD domain
a.238.1.4;FCH domain
a.194.1.1;L27 domain
a.221.1.1;Lissencephaly-1 protein (Lis-1, PAF-AH alpha) N-terminal domain
a.251.1.1;Phage replication organizer domain
a.284.1.1;YejL-like
a.252.1.1;CSE2-like
a.252.1.2;MED7 hinge region
a.77.1.2;DEATH domain, DD
a.77.1.4;DEATH effector domain, DED
a.77.1.3;Caspase recruitment domain, CARD
a.77.1.5;Pyrin domain, PYD
a.78.1.1;GntR ligand-binding domain-like
a.253.1.1;AF0941-like
a.79.1.1;Antitermination factor NusB
a.79.1.2;Hypothetical protein MG027
a.79.1.3;RmsB N-terminal domain-like
a.195.1.1;YutG-like
a.81.1.1;N-terminal domain of DnaB helicase
a.196.1.1;Invasion protein A (SipA) , C-terminal actin binding domain
a.285.1.1;MtlR-like
a.83.1.1;Guanido kinase N-terminal domain
a.84.1.1;Scaffolding protein gpD of bacteriophage procapsid
a.85.1.1;Hemocyanin, N-terminal domain
a.286.1.1;Sama2622-like
a.86.1.1;Hemocyanin middle domain
a.86.1.2;Catechol oxidase
a.87.1.1;DBL homology domain (DH-domain)
a.88.1.1;LigA subunit of an aromatic-ring-opening dioxygenase LigAB
a.166.1.1;RuBisCo LSMT C-terminal, substrate-binding domain
a.89.1.1;Methyl-coenzyme M reductase alpha and beta chain C-terminal domain
a.198.1.1;YcfC-like
a.254.1.1;PA2201 C-terminal domain-like
a.255.1.1;Rv1873-like
a.256.1.1;RUN domain
a.257.1.1;SipA N-terminal domain-like
a.90.1.1;Transcription factor STAT-4 N-domain
a.287.1.1;COG3793-like
a.287.1.2;PG1108-like
a.91.1.1;Regulator of G-protein signaling, RGS
a.168.1.1;SopE-like GEF domain
a.154.1.1;Variable surface antigen VlsE
a.199.1.1;YgfB-like
a.200.1.1;Hypothetical protein MTH393
a.258.1.1;PG0816-like
a.288.1.1;UraD-like
a.289.1.1;Sec63 N-terminal domain
a.289.1.2;Achaeal helicase C-terminal domain
a.92.1.1;Carbamoyl phosphate synthetase, large subunit connection domain
a.93.1.1;CCP-like
a.93.1.3;Catalase-peroxidase KatG
a.93.1.2;Myeloperoxidase-like
a.94.1.1;Ribosomal protein L19 (L19e)
a.290.1.1;PSPTO4464-like
a.182.1.1;GatB/YqeY domain
a.182.1.2;GatB/GatE C-terminal domain-like
a.233.1.1;YfbU-like
a.291.1.1;MG296-like
a.234.1.1;Hypothetical protein MPN330
a.211.1.1;HD domain
a.211.1.2;PDEase
a.211.1.3;modified HD domain
a.211.1.4;MioX-like
a.211.1.5;Ppx associated domain
a.202.1.1;Superantigen MAM
a.95.1.1;Influenza virus matrix protein M1
a.96.1.1;Endonuclease III
a.96.1.2;Mismatch glycosylase
a.96.1.4;3-Methyladenine DNA glycosylase I (Tag)
a.96.1.5;3-Methyladenine DNA glycosylase III (MagIII)
a.96.1.3;DNA repair glycosylase, 2 C-terminal domains
a.96.1.6;AgoG-like
a.97.1.1;C-terminal domain of glutamyl-tRNA synthetase (GluRS)
a.97.1.2;C-terminal domain of class I lysyl-tRNA synthetase
a.203.1.1;Putative anticodon-binding domain of alanyl-tRNA synthetase (AlaRS)
a.98.1.1;R1 subunit of ribonucleotide reductase, N-terminal domain
a.169.1.1;BEACH domain
a.99.1.1;Cryptochrome/photolyase FAD-binding domain
a.100.1.1;Hydroxyisobutyrate and 6-phosphogluconate dehydrogenase domain
a.100.1.9;Mannitol 2-dehydrogenase
a.100.1.2;Acetohydroxy acid isomeroreductase (ketol-acid reductoisomerase, KARI)
a.100.1.3;HCDH C-domain-like
a.100.1.8;Conserved hypothetical protein MTH1747
a.100.1.4;UDP-glucose/GDP-mannose dehydrogenase dimerisation domain
a.100.1.5;N-(1-D-carboxylethyl)-L-norvaline dehydrogenase
a.100.1.6;Glycerol-3-phosphate dehydrogenase
a.100.1.7;Ketopantoate reductase PanE
a.100.1.10;ProC C-terminal domain-like
a.100.1.11;HMD dimerization domain-like
a.100.1.12;TyrA dimerization domain-like
a.101.1.1;Uteroglobin-like
a.102.1.1;Glucoamylase
a.102.1.2;Cellulases catalytic domain
a.102.1.3;N-acylglucosamine (NAG) epimerase
a.102.1.4;Glycosyltransferase family 36 C-terminal domain
a.102.1.5;Bacterial glucoamylase C-terminal domain-like
a.102.1.6;Hypothetical protein YteR
a.102.1.7;Glycosyl Hydrolase Family 88
a.102.1.8;CPF0428-like
a.102.1.9;Trehalase-like
a.102.2.1;Class I alpha-1;2-mannosidase, catalytic domain
a.102.3.1;Alginate lyase A1-III
a.102.3.2;Hyaluronate lyase-like catalytic, N-terminal domain
a.102.5.1;Family 10 polysaccharide lyase
a.102.4.1;Terpenoid cyclase N-terminal domain
a.102.4.2;Terpene synthases
a.102.4.3;Protein prenyltransferases
a.102.4.4;Complement components
a.102.6.1;LanC-like
a.103.1.1;Citrate synthase
a.104.1.1;Cytochrome P450
a.145.1.1;Flagellar transcriptional activator FlhD
a.292.1.1;HP0242-like
a.293.1.1;SMc04008-like
a.108.1.1;Ribosomal protein L7/12, oligomerisation (N-terminal) domain
a.109.1.1;Class II MHC-associated invariant chain ectoplasmic trimerization domain
a.110.1.1;Aldehyde ferredoxin oxidoreductase, C-terminal domains
a.111.1.1;Type 2 phosphatidic acid phosphatase, PAP2
a.111.1.2;Haloperoxidase (bromoperoxidase)
a.111.1.3;Chloroperoxidase
a.170.1.1;BRCA2 helical domain
a.171.1.1;BRCA2 tower domain
a.155.1.1;H-NS histone-like proteins
a.177.1.1;Sigma2 domain of RNA polymerase sigma factors
a.113.1.1;DNA repair protein MutS, domain III
a.172.1.1;Helical scaffold and wing domains of SecA
a.204.1.2;MazG-like
a.204.1.3;AF0060-like
a.204.1.1;Type II deoxyuridine triphosphatase
a.204.1.4;HisE-like (PRA-PH)
a.205.1.1;Hsp90 co-chaperone CDC37
a.183.1.1;Nop domain
a.259.1.1;YidB-like
a.114.1.1;Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain
a.115.1.1;Orbivirus capsid
a.115.1.3;Phytoreovirus capsid
a.115.1.2;vp6, the major capsid protein of group A rotavirus
a.206.1.1;P40 nucleoprotein
a.260.1.1;Rhabdovirus nucleocapsid protein
a.116.1.1;BCR-homology GTPase activation domain (BH-domain)
a.116.1.2;p120GAP domain-like
a.117.1.1;Ras GEF
a.146.1.1;Telomeric repeat binding factor (TRF) dimerisation domain
a.173.1.1;Poly A polymerase C-terminal region-like
a.118.1.1;Armadillo repeat
a.118.1.10;Clathrin adaptor core protein
a.118.1.2;HEAT repeat
a.118.1.14;MIF4G domain-like
a.118.1.13;PHAT domain
a.118.1.15;Mo25 protein
a.118.1.7;Leukotriene A4 hydrolase C-terminal domain
a.118.1.3;Clathrin heavy chain proximal leg segment
a.118.1.4;Clathrin heavy-chain linker domain
a.118.1.5;Leucine-rich repeat variant
a.118.1.6;Phoshoinositide 3-kinase (PI3K) helical domain
a.118.1.8;Pumilio repeat
a.118.1.9;Regulatory subunit H of the V-type ATPase
a.118.1.16;PBS lyase HEAT-like repeat
a.118.1.17;BC3264-like
a.118.1.18;Eukaryotic translation initiation factor 3 subunit 12, eIF3k, N-terminal domain
a.118.1.19;Exportin HEAT-like repeat
a.118.1.20;B56-like
a.118.1.21;HspBP1 domain
a.118.1.22;GUN4-associated domain
a.118.1.23;Diap1 N-terninal region-like
a.118.1.24;Plakophilin 1 helical region
a.118.1.25;RPA1889-like
a.118.22.1;IP3 receptor type 1 binding core, domain 2
a.118.21.1;Chemosensory protein Csp2
a.118.3.1;Sec7 domain
a.118.4.1;Lipovitellin-phosvitin complex, superhelical domain
a.118.5.1;Bacterial muramidases
a.118.15.1;Aconitase B, N-terminal domain
a.118.18.1;HCP-like
a.118.6.1;Protein prenylyltransferase
a.118.7.1;14-3-3 protein
a.118.8.1;Tetratricopeptide repeat (TPR)
a.118.8.2;Transcription factor MalT domain III
a.118.8.3;BTAD-like
a.118.8.4;PrgX C-terminal domain-like
a.118.8.5;Atu0120-like
a.118.8.6;SusD-like
a.118.8.7;HAT/Suf repeat
a.118.8.8;CT2138-like
a.118.9.1;ENTH domain
a.118.9.2;VHS domain
a.118.9.3;Phosphoinositide-binding clathrin adaptor, N-terminal domain
a.118.9.4;RPR domain (SMART 00582 )
a.118.16.1;Translin
a.118.12.1;Ran-GTPase activating protein 1 (RanGAP1), C-terminal domain
a.118.13.1;Arp2/3 complex 16 kDa subunit ARPC5
a.118.14.1;FliG
a.118.17.1;Cullin repeat
a.118.17.2;Exocyst complex component
a.118.19.1;C-terminal domain of Ku80
a.118.20.1;Hypothetical protein ST1625
a.118.11.1;Cytochrome c oxidase subunit E
a.118.23.1;USP8 N-terminal domain-like
a.118.24.1;Pseudo ankyrin repeat
a.118.25.1;TROVE domain-like
a.118.26.1;MgtE N-terminal domain-like
a.261.1.1;GUN4-like
a.119.1.1;Plant lipoxigenases
a.119.1.2;Animal lipoxigenases
a.120.1.1;gene 59 helicase assembly protein
a.121.1.1;Tetracyclin repressor-like, C-terminal domain
a.157.1.1;Skp1 dimerisation domain-like
a.158.1.1;F-box domain
a.123.1.1;Nuclear receptor ligand-binding domain
a.124.1.1;Phospholipase C
a.124.1.2;P1 nuclease
a.235.1.1;ATP-dependent DNA ligase DNA-binding domain
a.236.1.1;DNA primase DnaG, C-terminal domain
a.262.1.1;PriB N-terminal domain-like
a.222.1.1;VPS9 domain
a.223.1.1;TF C-terminus
a.223.1.2;Porin chaperone SurA, peptide-binding domain
a.263.1.1;DNA terminal protein
a.224.1.1;Glycolipid transfer protein, GLTP
a.225.1.1;Hypothetical protein MG354
a.264.1.1;Duffy binding domain
a.265.1.1;Fic-like
a.226.1.1;Her-1
a.227.1.1;ERO1-like
a.126.1.1;Serum albumin-like
a.127.1.1;L-aspartase/fumarase
a.127.1.2;HAL/PAL-like
a.207.1.1;Formin homology 2 domain (FH2 domain)
a.128.1.1;Isoprenyl diphosphate synthases
a.128.1.2;Squalene synthase
a.128.1.3;Terpenoid cyclase C-terminal domain
a.128.1.4;Aristolochene/pentalenene synthase
a.128.1.5;Trichodiene synthase
a.129.1.1;GroEL chaperone, ATPase domain
a.129.1.2;Group II chaperonin (CCT, TRIC), ATPase domain
a.184.1.1;TorD-like
a.130.1.1;Dimeric chorismate mutase
a.130.1.2;Allosteric chorismate mutase
a.130.1.3;monomeric chorismate mutase
a.130.1.4;Secreted chorismate mutase-like
a.131.1.1;Peridinin-chlorophyll protein
a.132.1.1;Eukaryotic type heme oxygenase
a.132.1.2;Heme oxygenase HemO (PigA)
a.132.1.3;TENA/THI-4
a.132.1.4;PqqC-like
a.266.1.1;Bacterial tryptophan 2,3-dioxygenase
a.266.1.2;Indoleamine 2,3-dioxygenase-like
a.152.1.2;CMD-like
a.152.1.1;AhpD
a.152.1.3;Atu0492-like
a.152.1.4;TTHA0727-like
a.174.1.1;Double Clp-N motif
a.175.1.1;Orange carotenoid protein, N-terminal domain
a.208.1.1;DhaL-like
a.209.1.1;ADP-ribosylglycohydrolase
a.267.1.1;Topoisomerase V catalytic domain-like
a.268.1.1;PTPA-like
a.294.1.1;Tex N-terminal region-like
a.295.1.1;AGR C 984p-like
a.296.1.1;PMT central region-like
a.269.1.1;FtsH protease domain-like
a.185.1.1;Gametocyte protein Pfg27
a.176.1.1;N-terminal domain of bifunctional PutA protein
a.17.1.1;p8-MTCP1
a.17.1.2;COX17-like
a.133.1.2;Vertebrate phospholipase A2
a.133.1.1;Insect phospholipase A2
a.133.1.3;Prokaryotic phospholipase A2
a.134.1.1;Fungal elicitin
a.135.1.1;Tetraspanin
a.228.1.1;GDNF receptor-like
a.136.1.1;FinO-like
a.153.1.1;Nuclear receptor coactivator interlocking domain
a.270.1.1;Hermes dimerisation domain
a.210.1.1;Eukaryotic initiation factor 4f subunit eIF4g, eIF4e-binding domain
a.137.1.1;Ribosomal protein L39e
a.137.2.1;Methanol dehydrogenase subunit
a.137.3.1;Transducin (heterotrimeric G protein), gamma chain
a.137.4.1;Fe-only hydrogenase smaller subunit
a.137.5.1;Moesin tail domain
a.137.7.1;Proteinase A inhibitor IA3
a.137.8.1;Epsilon subunit of mitochondrial F1F0-ATP synthase
a.137.9.1;Quinohemoprotein amine dehydrogenase C chain
a.137.10.1;Stathmin
a.137.11.1;Anti-sigma factor FlgM
a.137.12.1;Glu-tRNAGln amidotransferase C subunit
a.137.13.1;RelB-like
a.137.14.1;Lag-3 N-terminal region
a.137.15.1;Lipase chaperone LifO-like
a.138.1.1;Cytochrome c3-like
a.138.1.2;Photosynthetic reaction centre (cytochrome subunit)
a.138.1.3;Di-heme elbow motif
b.1.1.1;V set domains (antibody variable domain-like)
b.1.1.2;C1 set domains (antibody constant domain-like)
b.1.1.3;C2 set domains
b.1.1.4;I set domains
b.1.18.1;NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain
b.1.18.2;E-set domains of sugar-utilizing enzymes
b.1.18.18;Other IPT/TIG domains
b.1.18.3;Arthropod hemocyanin, C-terminal domain
b.1.18.4;Class II viral fusion proteins C-terminal domain
b.1.18.5;Cytomegalovirus protein US2
b.1.18.6;Molybdenum-containing oxidoreductases-like dimerisation domain
b.1.18.7;ML domain
b.1.18.8;RhoGDI-like
b.1.18.16;Cytoplasmic domain of inward rectifier potassium channel
b.1.18.9;Transglutaminase N-terminal domain
b.1.18.10;Filamin repeat (rod domain)
b.1.18.11;Arrestin/Vps26-like
b.1.18.12;Gingipain R (RgpB), C-terminal domain
b.1.18.17;Copper resistance protein C (CopC, PcoC)
b.1.18.13;Cellulosomal scaffoldin protein CipC, module x2.1
b.1.18.14;Quinohemoprotein amine dehydrogenase A chain, domains 4 and 5
b.1.18.15;Internalin Ig-like domain
b.1.18.19;SoxZ-like
b.1.18.20;Enterochelin esterase N-terminal domain-like
b.1.18.21;AMPK-beta glycogen binding domain-like
b.1.18.22;Sec63 C-terminal domain-like
b.1.18.23;SVA-like
b.1.2.1;Fibronectin type III
b.1.3.1;PKD domain
b.1.4.1;beta-Galactosidase/glucuronidase domain
b.1.5.1;Transglutaminase, two C-terminal domains
b.1.6.1;Cadherin
b.1.6.2;Dystroglycan, N-terminal domain
b.1.7.1;Actinoxanthin-like
b.1.8.1;Cu,Zn superoxide dismutase-like
b.1.9.1;Cytochrome domain of cellobiose dehydrogenase
b.1.9.2;Family 9 carbohydrate-binding module, CBD9
b.1.9.3;Glucodextranase, domain C
b.1.16.1;Lamin A/C globular tail domain
b.1.10.1;Alpha-adaptin ear subdomain-like
b.1.10.2;gamma-adaptin C-terminal appendage domain-like
b.1.10.3;Coatomer appendage domain
b.1.15.1;Integrin domains
b.1.11.1;Pilus chaperone
b.1.11.2;MSP-like
b.1.12.1;Purple acid phosphatase, N-terminal domain
b.1.21.1;Fungal immunomodulatory protein, FIP
b.1.13.1;Superoxide reductase-like
b.1.17.1;Thiol:disulfide interchange protein DsbD, N-terminal domain (DsbD-alpha)
b.1.14.1;Invasin/intimin cell-adhesion fragments
b.1.19.1;Antigen MPT63/MPB63 (immunoprotective extracellular protein)
b.1.20.1;Tp47 lipoprotein, middle and C-terminal domains
b.1.22.1;ASF1-like
b.1.23.1;ApaG-like
b.1.24.1;Accessory protein X4 (ORF8, ORF7a)
b.1.25.1;LEA14-like
b.1.26.1;ICP-like
b.1.27.1;CalX-beta domain
b.1.28.1;NEAT domain
b.2.1.1;Diphtheria toxin, C-terminal domain
b.2.2.1;Cellulose-binding domain family II
b.2.2.2;Cellulose-binding domain family III
b.2.2.3;Bacterial chitobiase, n-terminal domain
b.2.3.1;Collagen-binding domain of adhesin
b.2.3.4;Fibrinogen-binding domain
b.2.3.2;Pilus subunits
b.2.3.3;PapG adhesin receptor-binding domain
b.2.3.5;F17c-type adhesin
b.2.3.6;Dr-family adhesin
b.2.4.1;Alpha-macroglobulin receptor domain
b.2.5.2;p53 DNA-binding domain-like
b.2.5.3;Rel/Dorsal transcription factors, DNA-binding domain
b.2.5.4;T-box
b.2.5.5;STAT DNA-binding domain
b.2.5.6;RUNT domain
b.2.5.7;DNA-binding domain from NDT80
b.2.5.8;DNA-binding protein LAG-1 (CSL)
b.2.6.1;Cytochrome f, large domain
b.2.8.1;beta-sandwich domain of Sec23/24
b.2.7.1;Second domain of Mu2 adaptin subunit (ap50) of ap2 adaptor
b.2.9.1;Peptidylarginine deiminase Pad4, middle domain
b.2.10.1;DR1885-like metal-binding protein
b.3.1.2;Rhamnogalacturonase B, RhgB, middle domain
b.3.1.1;Starch-binding domain
b.3.1.3;PUD-like
b.3.2.1;Carboxypeptidase regulatory domain
b.3.2.2;Pre-dockerin domain
b.3.3.1;VHL
b.3.4.1;Transthyretin (synonym: prealbumin)
b.3.5.1;Cna protein B-type domain
b.3.6.1;Aromatic compound dioxygenase
b.3.7.1;Hypothetical protein PA1324
b.4.1.1;HSP40/DnaJ peptide-binding domain
b.105.1.1;PBP5 C-terminal domain-like
b.105.1.2;Pencillin binding protein 4 (PbpD), C-terminal domain
b.5.1.1;alpha-Amylase inhibitor tendamistat
b.112.1.1;C-terminal domain of mollusc hemocyanin
b.154.1.1;Agglutinin HPA-like
b.155.1.1;Ribosomal protein L21p
b.6.1.1;Plastocyanin/azurin-like
b.6.1.4;Nitrosocyanin
b.6.1.2;Periplasmic domain of cytochrome c oxidase subunit II
b.6.1.3;Multidomain cupredoxins
b.6.1.5;Ephrin ectodomain
b.6.1.6;Peptidylarginine deiminase Pad4, N-terminal domain
b.6.1.7;SO1698-like
b.6.2.1;Major surface antigen p30, SAG1
b.146.1.1;Ctag/Cox11
b.156.1.1;Atu1913-like
b.7.1.1;PLC-like (P variant)
b.7.1.2;Synaptotagmin-like (S variant)
b.7.2.1;Periplasmic chaperone C-domain
b.7.3.1;PHL pollen allergen
b.7.4.1;Rab geranylgeranyltransferase alpha-subunit, insert domain
b.7.5.1;Smr-associated domain
b.8.1.1;MATH domain
b.8.1.2;SIAH, seven in absentia homolog
b.9.1.1;Neurophysin II
b.114.1.1;N-utilization substance G protein NusG, insert domain
b.121.3.1;Nucleoplasmin-like core domain
b.121.4.1;Picornaviridae-like VP (VP1, VP2, VP3 and VP4)
b.121.4.2;Comoviridae-like VP
b.121.4.3;Caliciviridae-like VP
b.121.4.4;Nodaviridae-like VP
b.121.4.8;Tetraviridae-like VP
b.121.4.5;Bromoviridae-like VP
b.121.4.6;Tymoviridae-like VP
b.121.4.7;Tombusviridae-like VP
b.121.4.9;Birnaviridae-like VP
b.121.5.1;Microviridae-like VP
b.121.5.2;Parvoviridae-like VP
b.121.5.3;Densovirinae-like VP
b.121.6.1;Papovaviridae-like VP
b.121.2.1;Coat protein p3
b.121.2.3;Major capsid protein vp54
b.121.2.2;Adenovirus hexon
b.121.7.1;Satellite viruses
b.121.1.1;Glycosyl-asparaginase
b.121.1.2;Peptidylglycine alpha-hydroxylating monooxygenase, PHM
b.11.1.1;Crystallins/Ca-binding development proteins
b.11.1.2;Yeast killer toxin
b.11.1.3;Streptomyces metalloproteinase inhibitor, SMPI
b.11.1.4;Killer toxin-like protein SKLP
b.11.1.6;Antifungal protein AFP1
b.11.1.5;Plant antimicrobial protein MIAMP1
b.12.1.1;Lipoxigenase N-terminal domain
b.12.1.2;Colipase-binding domain
b.12.1.3;Alpha-toxin, C-terminal domain
b.14.1.1;Calpain large subunit, middle domain (domain III)
b.132.1.1;Supernatant protein factor (SPF), C-terminal domain
b.123.1.1;Hypothetical protein TM1070
b.94.1.1;Olfactory marker protein
b.15.1.1;HSP20
b.15.1.2;Co-chaperone p23-like
b.15.1.3;GS domain
b.15.1.4;Nuclear movement domain
b.130.1.1;Heat shock protein 70kD (HSP70), peptide-binding domain
b.16.1.1;Ecotin, trypsin inhibitor
b.17.1.1;Phosphatidylethanolamine binding protein
b.17.1.2;Prokaryotic PEBP-like proteins
b.95.1.1;Ganglioside M2 (gm2) activator
b.96.1.1;Nicotinic receptor ligand binding domain-like
b.149.1.1;Beta-galactosidase LacA, domain 3
b.18.1.1;Galactose-binding domain
b.18.1.2;Discoidin domain (FA58C, coagulation factor 5/8 C-terminal domain)
b.18.1.9;APC10-like
b.18.1.3;delta-Endotoxin, C-terminal domain
b.18.1.4;Ephrin receptor ligand binding domain
b.18.1.5;beta-Galactosidase/glucuronidase, N-terminal domain
b.18.1.17;Chondroitin ABC lyase I, N-terminal domain
b.18.1.14;CBM4/9
b.18.1.10;Family 6 carbohydrate binding module, CBM6
b.18.1.11;CBM15
b.18.1.12;Family 17 carbohydrate binding module, CBM17
b.18.1.7;CBM22
b.18.1.18;Family 27 carbohydrate binding module, CBM27
b.18.1.19;Family 29 carbohydrate binding module, CBM29
b.18.1.15;Fucose binding lectin
b.18.1.8;N-terminal domain of xrcc1
b.18.1.21;F-box associated region, FBA
b.18.1.22;Allantoicase repeat
b.18.1.13;PepX C-terminal domain-like
b.18.1.16;PA-IL, galactose-binding lectin 1
b.18.1.20;Proprotein convertase P-domain
b.18.1.23;Family 28 carbohydrate binding module, CBM28
b.18.1.24;Family 30 carbohydrate binding module, CBM30 (PKD repeat)
b.18.1.25;Rhamnogalacturonase B, RhgB, C-terminal domain
b.18.1.26;Hypothetical protein AT3g04780/F7O18 27
b.18.1.27;Beta-galactosidase LacA, domains 4 and 5
b.18.1.28;Family 36 carbohydrate binding module, CBM36
b.18.1.29;Extended PAW domain
b.18.1.30;CBM11
b.18.1.31;beta-mannanase CBM
b.18.1.32;YxiM N-terminal domain-like
b.18.1.33;NPCBM-like
b.19.1.1;Top domain of virus capsid protein
b.19.1.2;Influenza hemagglutinin headpiece
b.19.1.3;Hemagglutinin domain of haemagglutinin-esterase-fusion glycoprotein HEF1
b.115.1.1;Calcium-mediated lectin
b.133.1.1;Dextranase, N-terminal domain
b.134.1.1;Smp-1-like
b.135.1.1;Superantigen (mitogen) Ypm
b.20.1.1;ENV polyprotein, receptor-binding domain
b.147.1.1;BTV NS2-like ssRNA-binding domain
b.170.1.1;WSSV envelope protein-like
b.21.1.1;Adenovirus fiber protein "knob" domain
b.21.1.2;Reovirus attachment protein sigma 1 head domain
b.21.1.3;Lactophage receptor-binding protein head domain
b.22.1.1;TNF-like
b.23.1.1;Spermadhesin, CUB domain
b.23.2.1;Collagen-binding domain
b.23.3.1;Acetamidase/Formamidase-like
b.24.1.1;Hyaluronate lyase-like, C-terminal domain
b.97.1.1;Anemone pore-forming cytolysin
b.97.1.2;Fungal fruit body lectin
b.150.1.1;Putative glucosidase YicI, C-terminal domain
b.151.1.1;CsrA-like
b.25.1.1;Osmotin, thaumatin-like protein
b.26.1.1;SMAD domain
b.26.1.2;FHA domain
b.26.1.3;Interferon regulatory factor 3 (IRF3), transactivation domain
b.26.1.4;EssC N-terminal domain-like
b.27.1.1;Soluble secreted chemokine inhibitor, VCCI
b.28.1.1;Baculovirus p35 protein
b.29.1.1;Legume lectins
b.29.1.13;Lectin leg-like
b.29.1.2;Glycosyl hydrolases family 16
b.29.1.3;Galectin (animal S-lectin)
b.29.1.4;Laminin G-like module
b.29.1.16;Thrombospondin C-terminal domain
b.29.1.5;Pentraxin (pentaxin)
b.29.1.12;Calnexin/calreticulin
b.29.1.14;vp4 sialic acid binding domain
b.29.1.17;Hypothetical protein YesU
b.29.1.18;Alginate lyase
b.29.1.6;Clostridium neurotoxins, the second last domain
b.29.1.7;Exotoxin A, N-terminal domain
b.29.1.8;Vibrio cholerae sialidase, N-terminal and insertion domains
b.29.1.9;Leech intramolecular trans-sialidase, N-terminal domain
b.29.1.15;Trypanosoma sialidase, C-terminal domain
b.29.1.10;Glycosyl hydrolase family 7 catalytic core
b.29.1.19;Glycosyl hydrolases family 32 C-terminal domain
b.29.1.11;Xylanase/endoglucanase 11/12
b.29.1.20;Peptidase A4
b.29.1.21;Alpha-L-arabinofuranosidase B, N-terminal domain
b.29.1.22;SPRY domain
b.29.1.23;Beta-D-xylosidase C-terminal domain-like
b.29.1.24;SO2946-like
b.29.1.25;MAM domain
b.30.5.4;Aldose 1-epimerase (mutarotase)
b.30.5.7;Hypothetical protein HI1317
b.30.5.1;beta-Galactosidase, domain 5
b.30.5.2;Hyaluronate lyase-like, central domain
b.30.5.3;Glycosyltransferase family 36 N-terminal domain
b.30.5.5;Bacterial glucoamylase N-terminal domain-like
b.30.5.8;4-alpha-glucanotransferase, C-terminal domain
b.30.5.6;alpha-mannosidase, C-terminal domain
b.30.5.9;MdoG-like
b.30.5.10;Rhamnogalacturonase B, RhgB, N-terminal domain
b.30.5.11;YicI N-terminal domain-like
b.30.6.1;V-region of surface antigen I/II (SA I/II, PAC)
b.30.2.1;Amine oxidase catalytic domain
b.98.1.1;Leukotriene A4 hydrolase N-terminal domain
b.31.1.1;EV matrix protein
b.116.1.1;Viral chemokine binding protein m3
b.32.1.1;gp9
b.152.1.1;Flagellar hook protein flgE
b.33.1.1;Rieske iron-sulfur protein (ISP)
b.33.1.2;Ring hydroxylating alpha subunit ISP domain
b.33.1.3;NirD-like
b.171.1.1;Trm112p-like
b.172.1.1;YopX-like
b.117.1.1;Obg GTP-binding protein N-terminal domain
b.34.1.1;Biotin repressor (BirA)
b.34.1.2;FeoA-like
b.34.1.3;Transcriptional repressor protein KorB
b.34.2.1;SH3-domain
b.34.11.1;GW domain
b.34.11.2;PhnA-like
b.34.11.3;Spr N-terminal domain-like
b.34.11.4;Ply C-terminal domain-like
b.34.3.1;Myosin S1 fragment, N-terminal domain
b.34.9.1;Tudor domain
b.34.9.2;PWWP domain
b.34.9.3;MBT repeat
b.34.9.4;CPH domain
b.34.13.1;"Histone-like" proteins from archaea
b.34.13.2;Chromo domain
b.34.13.3;Chromo barrel domain
b.34.12.1;BAH domain
b.34.14.1;PAZ domain
b.34.10.1;Cap-Gly domain
b.34.4.1;R67 dihydrofolate reductase
b.34.4.2;Photosystem I accessory protein E (PsaE)
b.34.4.3;Ferredoxin thioredoxin reductase (FTR), alpha (variable) chain
b.34.4.4;Nitrile hydratase beta chain
b.34.5.1;Ribosomal proteins L24p and L21e
b.34.5.2;eIF5a N-terminal domain-like
b.34.5.3;C-terminal domain of ribosomal protein L2
b.34.5.4;N-utilization substance G protein NusG, C-terminal domain
b.34.5.5;SPT5 KOW domain-like
b.34.5.6;Ribosomal protein L19
b.34.5.7;Ribosomal protein L14e
b.34.6.1;CcdB
b.34.6.2;Kid/PemK
b.34.6.3;Rv2302-like
b.34.8.1;Fumarylacetoacetate hydrolase, FAH, N-terminal domain
b.34.7.1;DNA-binding domain of retroviral integrase
b.34.15.1;Hypothetical protein YfhH
b.34.16.1;Kinase-associated protein B-like
b.34.17.1;YccV-like
b.34.18.1;CarD-like
b.34.19.1;Mib/herc2 domain
b.34.20.1;YorP-like
b.34.21.1;Plus3
b.35.1.1;GroES
b.35.1.2;Alcohol dehydrogenase-like, N-terminal domain
b.35.2.1;BglG-like antiterminator proteins
b.36.1.1;PDZ domain
b.36.1.3;Tail specific protease PDZ domain
b.36.1.4;HtrA-like serine proteases
b.36.1.2;Interleukin 16
b.36.1.5;EpsC C-terminal domain-like
b.36.1.6;MTH1368 C-terminal domain-like
b.37.1.1;N-terminal domains of the minor coat protein g3p
b.38.1.1;Sm motif of small nuclear ribonucleoproteins, SNRNP
b.38.1.2;Pleiotropic translational regulator Hfq
b.38.1.3;Mechanosensitive channel protein MscS (YggB), middle domain
b.38.1.4;PF1955-like
b.38.1.5;LSM14 N-terminal domain-like
b.38.1.6;YgdI/YgdR-like
b.38.2.1;YhbC-like, C-terminal domain
b.38.3.1;GatD N-terminal domain-like
b.38.4.1;Dom34/Pelota N-terminal domain-like
b.38.5.1;TrmB C-terminal domain-like
b.136.1.1;Stringent starvation protein B, SspB
b.136.1.2;AGR C 3712p-like
b.137.1.1;RNase P subunit p29-like
b.137.1.2;Rof-like
b.138.1.1;Hydrophobin II, HfbII
b.39.1.1;Ribosomal protein L14
b.40.1.1;Staphylococcal nuclease
b.40.2.1;Bacterial AB5 toxins, B-subunits
b.40.2.2;Superantigen toxins, N-terminal domain
b.40.3.1;Tissue inhibitor of metalloproteinases, TIMP
b.40.3.3;Netrin-like domain (NTR/C345C module)
b.40.3.2;The laminin-binding domain of agrin
b.40.9.1;Heme chaperone CcmE
b.40.8.1;gp4 N-terminal domain-like
b.40.10.1;Hypothetical protein YgiW
b.40.4.1;Anticodon-binding domain
b.40.4.9;RecG "wedge" domain
b.40.4.2;DNA helicase RuvA subunit, N-terminal domain
b.40.4.3;Single strand DNA-binding domain, SSB
b.40.4.4;Myf domain
b.40.4.5;Cold shock DNA-binding domain-like
b.40.4.12;TRAM domain
b.40.4.10;Hypothetical protein MTH1 (MT0001), insert domain
b.40.4.6;DNA ligase/mRNA capping enzyme postcatalytic domain
b.40.4.7;Phage ssDNA-binding proteins
b.40.4.11;DNA replication initiator (cdc21/cdc54) N-terminal domain
b.40.4.8;RNA polymerase subunit RBP8
b.40.4.13;RecO N-terminal domain-like
b.40.4.14;TIP49 domain
b.40.4.15;SSO2064-like
b.40.4.16;RNB domain-like
b.40.5.1;Inorganic pyrophosphatase
b.40.6.1;Molybdate/tungstate binding protein MOP
b.40.6.2;BiMOP, duplicated molybdate-binding domain
b.40.6.3;ABC-transporter additional domain
b.40.7.1;CheW-like
b.40.11.1;TM0957-like
b.40.12.1;NfeD domain-like
b.40.13.1;BC4932-like
b.40.14.1;HupF/HypC-like
b.40.15.1;EutN/CcmL-like
b.40.16.1;HIN-200/IF120x domain
b.41.1.2;MTH1895
b.41.1.1;Photosynthetic reaction centre, H-chain, cytoplasmic domain
b.41.1.3;RIKEN cDNA 2310057j16 protein (KIAA1543)
b.41.1.4;RimM C-terminal domain-like
b.42.1.1;Fibroblast growth factors (FGF)
b.42.1.2;Interleukin-1 (IL-1)
b.42.6.1;MIR domain
b.42.2.1;Ricin B-like
b.42.2.2;Cysteine rich domain
b.42.2.3;GlcNAc-alpha-1,4-Gal-releasing endo-beta-galactosidase, GngC, C-terminal domain
b.42.3.1;Agglutinin
b.42.4.1;Kunitz (STI) inhibitors
b.42.4.2;Clostridium neurotoxins, C-terminal domain
b.42.5.1;Fascin
b.42.5.2;Histidine-rich actin-binding protein (hisactophilin)
b.42.7.1;DNA-binding protein LAG-1 (CSL)
b.42.8.1;AbfB domain
b.43.4.3;Riboflavin synthase
b.43.4.2;Ferredoxin reductase FAD-binding domain-like
b.43.4.1;NADPH-cytochrome p450 reductase FAD-binding domain-like
b.43.5.1;ATP-dependent riboflavin kinase-like
b.43.5.2;CTP-dependent riboflavin kinase-like
b.43.2.1;L-fucose isomerase, C-terminal domain
b.43.2.2;AraA C-terminal domain-like
b.43.3.1;Elongation factors
b.43.3.2;Ribosomal protein L3
b.43.3.3;Ribosomal protein L35ae
b.43.3.4;RimM N-terminal domain-like
b.43.3.5;Gar1-like SnoRNP
b.43.3.6;AlaX-M N-terminal domain-like
b.44.1.1;EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain
b.44.2.1;Aminomethyltransferase beta-barrel domain
b.45.1.1;PNP-oxidase like
b.45.1.2;NADH:FMN oxidoreductase-like
b.45.1.3;UbiD middle domain-like
b.45.1.4;MTH863-like
b.45.2.1;PilZ domain
b.45.2.2;PilZ domain-associated domain
b.45.3.1;YkvR-like
b.106.1.1;Baseplate protein-like
b.106.1.2;gpFII-like
b.106.1.3;XkdM-like
b.139.1.1;Surface presentation of antigens (SPOA)
b.46.1.1;Post formyltransferase domain
b.46.1.2;3-methyladenine DNA glycosylase (AAG, ANPG, MPG)
b.47.1.1;Prokaryotic proteases
b.47.1.2;Eukaryotic proteases
b.47.1.3;Viral proteases
b.47.1.4;Viral cysteine protease of trypsin fold
b.140.1.1;Replicase NSP9
b.48.1.1;mu transposase, C-terminal domain
b.49.1.1;N-terminal domain of alpha and beta subunits of F1 ATP synthase
b.49.2.2;Alanine racemase
b.49.2.3;Eukaryotic ODC-like
b.49.3.1;Aminopeptidase/glucanase lid domain
b.111.1.1;Small protein B (SmpB)
b.50.1.1;Retroviral protease (retropepsin)
b.50.1.2;Pepsin-like
b.50.1.3;LPG0085-like
b.51.1.1;ValRS/IleRS/LeuRS editing domain
b.107.1.1;Urease metallochaperone UreE, N-terminal domain
b.52.1.1;Eng V-like
b.52.1.3;Pollen allergen PHL P 1 N-terminal domain
b.52.1.2;Barwin
b.52.1.4;MLTA-like
b.52.2.1;Pyruvoyl dependent aspartate decarboxylase, ADC
b.52.2.2;Formate dehydrogenase/DMSO reductase, C-terminal domain
b.52.2.3;Cdc48 N-terminal domain-like
b.53.1.1;Ribosomal protein L25-like
b.53.1.2;Gln-tRNA synthetase (GlnRS), C-terminal (anticodon-binding) domain
b.54.1.1;Core binding factor beta, CBF
b.173.1.1;NifT/FixU
b.55.1.1;Pleckstrin-homology domain (PH domain)
b.55.1.2;Phosphotyrosine-binding domain (PTB)
b.55.1.3;Ran-binding domain
b.55.1.4;Enabled/VASP homology 1 domain (EVH1 domain)
b.55.1.7;Dcp1
b.55.1.5;Third domain of FERM
b.55.1.6;PreBEACH PH-like domain
b.55.1.8;GRAM domain
b.55.1.9;TFIIH domain
b.55.1.10;SSRP1-like
b.55.1.11;Necap1 N-terminal domain-like
b.55.1.12;VPS36 N-terminal domain-like
b.55.1.13;BPHL domain
b.55.2.1;PA2021-like
b.56.1.1;Transcription factor IIA (TFIIA), beta-barrel domain
b.157.1.1;Hcp1-like
b.174.1.1;YopT-like
b.57.1.1;Herpes virus serine proteinase, assemblin
b.58.1.1;Pyruvate kinase beta-barrel domain
b.58.1.2;MOSC (MOCO sulphurase C-terminal) domain
b.59.1.1;XRCC4, N-terminal domain
b.124.1.1;HesB-like domain
b.141.1.1;Bacterial fluorinating enzyme, C-terminal domain
b.131.1.3;SPOC domain
b.131.1.1;Ku70 subunit middle domain
b.131.1.2;Ku80 subunit middle domain
b.158.1.1;BH3618-like
b.118.1.1;FAS1 domain
b.60.1.1;Retinol binding protein-like
b.60.1.2;Fatty acid binding protein-like
b.60.1.3;Thrombin inhibitor
b.60.1.4;Hypothetical protein YodA
b.60.1.5;Hypothetical protein YwiB
b.60.1.6;Phenolic acid decarboxylase (PAD)
b.60.1.7;Dinoflagellate luciferase repeat
b.60.1.8;Rv2717c-like
b.60.1.9;All1756-like
b.61.1.1;Avidin/streptavidin
b.61.2.1;Metalloprotease inhibitor
b.61.2.2;Staphostatin
b.61.3.1;D-aminopeptidase, middle and C-terminal domains
b.61.4.1;Quinohemoprotein amine dehydrogenase A chain, domain 3
b.61.5.1;Dipeptidyl peptidase I (cathepsin C), exclusion domain
b.61.6.1;YceI-like
b.61.7.1;Extracellular hemoglobin linker subunit, receptor domain
b.61.8.1;YdhA-like
b.175.1.1;FomD-like
b.159.1.1;Allene oxide cyclase-like
b.159.2.1;SO1590-like
b.176.1.1;AttH-like
b.62.1.1;Cyclophilin (peptidylprolyl isomerase)
b.62.1.2;Outer surface protein, C-terminal domain
b.62.1.3;TM1367-like
b.62.1.4;PH0987 C-terminal domain-like
b.63.1.1;Oncogene products
b.160.1.1;L,D-transpeptidase catalytic domain-like
b.100.1.1;Sortase
b.161.1.1;PTSIIA/GutA-like
b.64.1.1;Mannose 6-phosphate receptor domain
b.65.1.1;Rap30/74 interaction domains
b.66.1.1;Hemopexin-like domain
b.67.1.1;Tachylectin-2
b.67.2.1;alpha-L-arabinanase-like
b.67.2.2;Levansucrase
b.67.2.3;Glycosyl hydrolases family 32 N-terminal domain
b.67.2.4;TM1225-like predicted glycosylases
b.67.2.5;LmjF10.1260-like
b.67.3.1;Apyrase
b.68.1.1;Sialidases (neuraminidases)
b.68.1.2;Endo-alpha-sialidase
b.68.2.1;Soluble quinoprotein glucose dehydrogenase
b.68.3.1;Thermostable phytase (3-phytase)
b.68.4.1;TolB, C-terminal domain
b.68.5.1;YWTD domain
b.68.6.1;SGL-like
b.68.6.2;Serum paraoxonase/arylesterase 1, PON1
b.68.6.3;All0351-like
b.68.7.1;Tricorn protease N-terminal domain
b.68.8.1;Fucose-specific lectin
b.68.9.1;NHL repeat
b.68.10.1;GyrA/ParC C-terminal domain-like
b.68.11.1;Kelch motif
b.69.1.1;Galactose oxidase, central domain
b.69.2.3;YVTN repeat
b.69.2.2;Quinohemoprotein amine dehydrogenase B chain
b.69.2.1;Methylamine dehydrogenase, H-chain
b.69.3.1;Nitrous oxide reductase, N-terminal domain
b.69.4.1;WD40-repeat
b.69.4.2;Cell cycle arrest protein BUB3
b.69.5.1;Regulator of chromosome condensation RCC1
b.69.5.2;beta-lactamase inhibitor protein-II, BLIP-II
b.69.6.1;Clathrin heavy-chain terminal domain
b.69.8.1;Integrin alpha N-terminal domain
b.69.7.1;Prolyl oligopeptidase, N-terminal domain
b.69.7.2;Acylamino-acid-releasing enzyme, N-terminal donain
b.69.9.1;Tricorn protease domain 2
b.69.10.1;3-carboxy-cis,cis-mucoante lactonizing enzyme
b.69.11.1;Putative isomerase YbhE
b.69.12.1;Sema domain
b.69.13.1;Oligoxyloglucan reducing end-specific cellobiohydrolase
b.69.14.1;Nucleoporin domain
b.70.1.1;Quinoprotein alcohol dehydrogenase-like
b.70.2.1;C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase
b.70.3.1;DPP6 N-terminal domain-like
b.71.1.1;alpha-Amylases, C-terminal beta-sheet domain
b.71.1.2;Composite domain of glycosyl hydrolase families 5, 30, 39 and 51
b.71.1.3;Putative alpha-L-fucosidase C-terminal domain
b.71.1.4;Putative glucosidase YicI, domain 3
b.71.1.5;Beta-galactosidase LacA, domain 2
b.72.1.1;WW domain
b.72.2.1;Carbohydrate binding domain
b.72.3.1;Pym (Within the bgcn gene intron protein, WIBG), N-terminal domain
b.73.1.1;Head domain of nucleotide exchange factor GrpE
b.148.1.1;Coronavirus RNA-binding domain
b.101.1.1;Ribonuclease domain of colicin E3
b.143.1.1;NAC domain
b.162.1.1;At5g01610-like
b.74.1.1;Carbonic anhydrase
b.125.1.1;Outer-membrane lipoproteins carrier protein LolA
b.125.1.2;Outer membrane lipoprotein receptor LolB
b.125.1.3;LppX-like
b.177.1.1;YmcC-like
b.178.1.1;PA1994-like
b.75.1.1;Bacteriochlorophyll A protein
b.76.1.1;Outer surface protein
b.76.2.1;Histone H3 K4-specific methyltransferase SET7/9 N-terminal domain
b.77.1.1;Vitelline membrane outer protein-I (VMO-I)
b.77.2.1;delta-Endotoxin (insectocide), middle domain
b.77.3.1;Mannose-binding lectins
b.78.1.1;alpha-D-mannose-specific plant lectins
b.80.7.1;Serralysin-like metalloprotease, C-terminal domain
b.80.1.1;Pectate lyase-like
b.80.1.2;Pectin lyase
b.80.1.3;Galacturonase
b.80.1.4;Chondroitinase B
b.80.1.8;iota-carrageenase
b.80.1.9;Pectate transeliminase
b.80.1.10;Dextranase, catalytic domain
b.80.1.5;Pectin methylesterase
b.80.1.6;P22 tailspike protein
b.80.1.7;Virulence factor P.69 pertactin
b.80.1.11;Filamentous hemagglutinin FhaB, secretion domain
b.80.2.1;Insect cysteine-rich antifreeze protein
b.80.3.1;Cell-division inhibitor MinC, C-terminal domain
b.80.4.1;Alpha subunit of glutamate synthase, C-terminal domain
b.80.5.1;C-terminal domain of adenylylcyclase associated protein
b.80.6.1;Stabilizer of iron transporter SufD
b.80.8.1;Pentapeptide repeats
b.81.1.1;UDP N-acetylglucosamine acyltransferase
b.81.1.2;Tetrahydrodipicolinate-N-succinlytransferase, THDP-succinlytransferase, DapD
b.81.1.3;Galactoside acetyltransferase-like
b.81.1.4;GlmU C-terminal domain-like
b.81.1.5;gamma-carbonic anhydrase-like
b.81.1.6;Serine acetyltransferase
b.81.1.7;YdcK-like
b.81.1.8;PglD-like
b.81.2.1;An insect antifreeze protein
b.81.3.1;Adhesin YadA, collagen-binding domain
b.81.4.1;Guanosine diphospho-D-mannose pyrophosphorylase/mannose-6-phosphate isomerase linker domain
b.82.1.1;dTDP-sugar isomerase
b.82.1.7;Glucose-6-phosphate isomerase, GPI
b.82.1.8;Hypothetical protein TM1112
b.82.1.9;TM1287-like
b.82.1.10;TM1459-like
b.82.1.2;Germin/Seed storage 7S protein
b.82.1.11;YlbA-like
b.82.1.12;Pirin-like
b.82.1.5;Quercetin 2,3-dioxygenase-like
b.82.1.3;Type I phosphomannose isomerase
b.82.1.4;Homogentisate dioxygenase
b.82.1.6;Acireductone dioxygenase
b.82.1.13;KduI-like
b.82.1.14;Ureidoglycolate hydrolase AllA
b.82.1.15;Probable transcriptional regulator VC1968, C-terminal domain
b.82.1.16;YML079-like
b.82.1.17;PA5104-like
b.82.1.18;MJ0764-like
b.82.1.19;Cysteine dioxygenase type I
b.82.1.20;3-hydroxyanthranilic acid dioxygenase-like
b.82.1.21;Acetylacetone-cleaving enzyme-like
b.82.1.22;VPA0057-like
b.82.1.23;Gentisate 1,2-dioxygenase-like
b.82.1.24;EutQ-like
b.82.2.1;Penicillin synthase-like
b.82.2.2;Clavaminate synthase
b.82.2.3;Gab protein (hypothetical protein YgaT)
b.82.2.7;YhcH-like
b.82.2.4;Type II Proline 3-hydroxylase (proline oxidase)
b.82.2.5;TauD/TfdA-like
b.82.2.8;gamma-Butyrobetaine hydroxylase
b.82.2.6;Hypoxia-inducible factor HIF ihhibitor (FIH1)
b.82.2.9;PhyH-like
b.82.2.10;AlkB-like
b.82.2.11;Asparaginyl hydroxylase-like
b.82.2.12;YbiU-like
b.82.2.13;TehB-like
b.82.3.1;CO-sensing protein CooA, N-terminal domain
b.82.3.3;Listeriolysin regulatory protein PrfA, N-terminal domain
b.82.3.2;cAMP-binding domain
b.82.4.1;Regulatory protein AraC
b.82.6.1;Thiamin pyrophosphokinase, substrate-binding domain
b.82.7.1;Calcium ATPase, transduction domain A
b.82.5.1;Trp RNA-binding attenuation protein (TRAP)
b.82.5.2;PA3696/SPS0176-like
b.108.1.1;Middle part of short tail fibre protein gp12
b.108.1.2;Tail-associated lysozyme gp5, C-terminal domain
b.108.1.3;Endo-alpha-sialidase
b.108.1.4;Lactophage receptor-binding protein domain
b.108.1.5;HylP-like
b.83.1.1;Adenovirus
b.83.1.2;Reovirus attachment protein sigma 1
b.144.1.1;Trimeric adhesin
b.109.1.1;Cell wall binding repeat
b.84.1.1;Biotinyl/lipoyl-carrier proteins and domains
b.84.2.1;BC C-terminal domain-like
b.84.2.2;Cytochrome f, small domain
b.84.3.1;Glucose permease-like
b.84.3.2;Peptidoglycan hydrolase LytM
b.84.4.1;Ribosomal L27 protein
b.84.4.2;ECR1 N-terminal domain-like
b.85.1.1;AFP III-like domain
b.85.7.1;Histone lysine methyltransferases
b.85.7.2;Viral histone H3 Lysine 27 Methyltransferase
b.85.7.3;RuBisCo LSMT catalytic domain
b.85.2.1;Head decoration protein D (gpD, major capsid protein D)
b.85.3.1;Urease, beta-subunit
b.85.6.1;MoeA C-terminal domain-like
b.85.4.1;dUTPase-like
b.85.5.1;Tlp20, baculovirus telokin-like protein
b.153.1.2;tRNA-Ile-lysidine synthetase, TilS, C-terminal domain
b.153.1.1;B3/B4 domain of PheRS, PheT
b.119.1.1;C-terminal autoproteolytic domain of nucleoporin nup98
b.163.1.1;Mtd domain-like
b.163.1.2;Lactophage receptor-binding protein N-terminal domain
b.164.1.1;SARS ORF9b-like
b.126.1.1;Adsorption protein p2
b.127.1.1;Baseplate structural protein gp8
b.86.1.1;Hedgehog C-terminal (Hog) autoprocessing domain
b.86.1.2;Intein (protein splicing domain)
b.87.1.1;LexA-related
b.87.1.2;Type 1 signal peptidase
b.110.1.1;Cloacin translocation domain
b.88.1.1;RabGEF Mss4
b.88.1.2;Translationally controlled tumor protein TCTP (histamine-releasing factor)
b.88.1.3;SelR domain
b.88.1.4;Glutathione-dependent formaldehyde-activating enzyme, Gfa
b.89.1.1;Cyanovirin-N
b.120.1.1;Tp47 lipoprotein, N-terminal domain
b.102.1.1;Methuselah ectodomain
b.90.1.1;Head-binding domain of phage P22 tailspike protein
b.91.1.1;E2 regulatory, transactivation domain
b.103.1.1;MoeA N-terminal region -like
b.165.1.1;MOSC N-terminal domain-like
b.166.1.1;MAL13P1.257-like
b.92.1.2;Cytosine deaminase
b.92.1.1;alpha-Subunit of urease
b.92.1.3;Hydantoinase (dihydropyrimidinase)
b.92.1.4;SAH/MTA deaminase-like
b.92.1.7;Isoaspartyl dipeptidase
b.92.1.5;N-acetylglucosamine-6-phosphate deacetylase, NagA
b.92.1.6;D-aminoacylase
b.92.1.8;Adenine deaminase
b.92.1.9;Zn-dependent arginine carboxypeptidase-like
b.92.1.10;Imidazolonepropionase-like
b.92.1.11;DR0824-like
b.93.1.1;Epsilon subunit of F1F0-ATP synthase N-terminal domain
b.113.1.1;N-terminal domain of MutM-like DNA repair proteins
b.128.1.1;Hypothetical protein YojF
b.142.1.1;Type II restriction endonuclease effector domain
b.142.1.2;B3 DNA binding domain
b.129.1.1;Kis/PemI addiction antidote
b.129.1.3;AbrB N-terminal domain-like
b.129.1.2;Hypothetical protein MraZ
b.129.2.1;PG0164-like
b.129.2.2;AF2212-like
b.122.1.1;PUA domain
b.122.1.3;ATP sulfurylase N-terminal domain
b.122.1.2;YggJ N-terminal domain-like
b.122.1.4;Hypothetical protein EF3133
b.122.1.5;Hypothetical protein TTHA0113
b.122.1.6;ProFAR isomerase associated domain
b.122.1.7;yqfB-like
b.122.1.8;Atu2648/PH1033-like
b.122.1.9;Hypothetical RNA methyltransferase domain (HRMD)
b.122.1.10;LON domain-like
b.122.1.11;PrgU-like
b.122.1.12;SRA domain-like
b.122.1.13;YtmB-like
b.145.1.1;AXH domain
b.167.1.1;Usher N-domain
b.168.1.1;HisI-like
b.169.1.1;MFPT repeat
b.104.1.1;P-domain of calnexin/calreticulin
c.1.1.1;Triosephosphate isomerase (TIM)
c.1.2.1;Histidine biosynthesis enzymes
c.1.2.2;D-ribulose-5-phosphate 3-epimerase
c.1.2.3;Decarboxylase
c.1.2.4;Tryptophan biosynthesis enzymes
c.1.2.5;NanE-like
c.1.2.6;PdxS-like
c.1.3.1;Thiamin phosphate synthase
c.1.24.1;Pyridoxine 5'-phosphate synthase
c.1.4.1;FMN-linked oxidoreductases
c.1.5.1;Inosine monophosphate dehydrogenase (IMPDH)
c.1.6.1;Alanine racemase-like, N-terminal domain
c.1.6.2;"Hypothetical" protein ybl036c
c.1.7.1;Aldo-keto reductases (NADP)
c.1.8.1;Amylase, catalytic domain
c.1.8.3;beta-glycanases
c.1.8.11;Putative alpha-L-fucosidase, catalytic domain
c.1.8.4;Family 1 of glycosyl hydrolase
c.1.8.5;Type II chitinase
c.1.8.8;1,4-beta-N-acetylmuraminidase
c.1.8.6;beta-N-acetylhexosaminidase catalytic domain
c.1.8.10;alpha-D-glucuronidase/Hyaluronidase catalytic domain
c.1.8.7;NagZ-like
c.1.8.9;Bee venom hyaluronidase
c.1.8.12;Outer surface protein, N-terminal domain
c.1.8.13;YicI catalytic domain-like
c.1.8.14;Glycosyl hydrolases family 35 catalytic domain
c.1.8.15;TM1410-like
c.1.9.1;Adenosine/AMP deaminase
c.1.9.4;Dihydroorotase
c.1.9.5;Cytosine deaminase catalytic domain
c.1.9.2;alpha-subunit of urease, catalytic domain
c.1.9.6;Hydantoinase (dihydropyrimidinase), catalytic domain
c.1.9.9;SAH/MTA deaminase-like
c.1.9.13;Isoaspartyl dipeptidase, catalytic domain
c.1.9.10;N-acetylglucosamine-6-phosphate deacetylase, NagA, catalytic domain
c.1.9.11;D-aminoacylase, catalytic domain
c.1.9.12;TatD Mg-dependent DNase-like
c.1.9.3;Phosphotriesterase-like
c.1.9.7;Renal dipeptidase
c.1.9.8;Uronate isomerase-like
c.1.9.14;Adenine deaminase-like
c.1.9.15;PP1699/LP2961-like
c.1.9.16;DR0824-like
c.1.9.17;Imidazolonepropionase-like
c.1.9.18;Zn-dependent arginine carboxypeptidase-like
c.1.10.1;Class I aldolase
c.1.10.2;Class II FBP aldolase
c.1.10.3;5-aminolaevulinate dehydratase, ALAD (porphobilinogen synthase)
c.1.10.4;Class I DAHP synthetase
c.1.10.5;HMGL-like
c.1.10.6;NeuB-like
c.1.10.7;GatZ-like
c.1.10.8;Class-II DAHP synthetase
c.1.11.1;Enolase
c.1.11.2;D-glucarate dehydratase-like
c.1.12.1;Pyruvate kinase
c.1.12.2;Pyruvate phosphate dikinase, C-terminal domain
c.1.12.3;Phosphoenolpyruvate carboxylase
c.1.12.7;Phosphoenolpyruvate mutase/Isocitrate lyase-like
c.1.12.5;HpcH/HpaI aldolase
c.1.12.8;Ketopantoate hydroxymethyltransferase PanB
c.1.12.9;Mll9387-like
c.1.13.1;Malate synthase G
c.1.14.1;RuBisCo, large subunit, C-terminal domain
c.1.15.1;Endonuclease IV
c.1.15.4;IolI-like
c.1.15.5;Hypothetical protein YgbM (EC1530)
c.1.15.2;L-rhamnose isomerase
c.1.15.3;Xylose isomerase
c.1.15.6;UxuA-like
c.1.15.7;KguE-like
c.1.16.1;Bacterial luciferase (alkanal monooxygenase)
c.1.16.2;Non-fluorescent flavoprotein (luxF, FP390)
c.1.16.3;F420 dependent oxidoreductases
c.1.16.4;Ssud-like monoxygenases
c.1.17.1;NadC C-terminal domain-like
c.1.17.2;Monomeric nicotinate phosphoribosyltransferase C-terminal domain
c.1.18.1;Mammalian PLC
c.1.18.2;Bacterial PLC
c.1.18.3;Glycerophosphoryl diester phosphodiesterase
c.1.19.1;Methylmalonyl-CoA mutase, N-terminal (CoA-binding) domain
c.1.19.2;Glutamate mutase, large subunit
c.1.19.3;Diol dehydratase, alpha subunit
c.1.19.4;D-lysine 5,6-aminomutase alpha subunit, KamD
c.1.20.1;tRNA-guanine transglycosylase
c.1.21.1;Dihydropteroate synthetase
c.1.21.2;Methyltetrahydrofolate-utiluzing methyltransferases
c.1.22.1;Uroporphyrinogen decarboxylase, UROD
c.1.22.2;Cobalamin-independent methionine synthase
c.1.23.1;Methylenetetrahydrofolate reductase
c.1.23.2;Proline dehydrohenase domain of bifunctional PutA protein
c.1.25.1;Monomethylamine methyltransferase MtmB
c.1.26.1;Homocysteine S-methyltransferase
c.1.27.1;(2r)-phospho-3-sulfolactate synthase ComA
c.1.28.1;Biotin synthase
c.1.28.2;Oxygen-independent coproporphyrinogen III oxidase HemN
c.1.28.3;MoCo biosynthesis proteins
c.1.29.1;GlpP-like
c.1.30.1;CutC-like
c.1.31.1;ThiG-like
c.1.32.1;TM1631-like
c.1.33.1;EAL domain
c.2.1.1;Alcohol dehydrogenase-like, C-terminal domain
c.2.1.2;Tyrosine-dependent oxidoreductases
c.2.1.3;Glyceraldehyde-3-phosphate dehydrogenase-like, N-terminal domain
c.2.1.4;Formate/glycerate dehydrogenases, NAD-domain
c.2.1.11;Siroheme synthase N-terminal domain-like
c.2.1.5;LDH N-terminal domain-like
c.2.1.6;6-phosphogluconate dehydrogenase-like, N-terminal domain
c.2.1.7;Aminoacid dehydrogenase-like, C-terminal domain
c.2.1.9;Potassium channel NAD-binding domain
c.2.1.12;Transcriptional repressor Rex, C-terminal domain
c.2.1.8;CoA-binding domain
c.2.1.13;Ornithine cyclodeaminase-like
c.3.1.1;C-terminal domain of adrenodoxin reductase-like
c.3.1.2;FAD-linked reductases, N-terminal domain
c.3.1.3;GDI-like N domain
c.3.1.4;Succinate dehydrogenase/fumarate reductase flavoprotein N-terminal domain
c.3.1.5;FAD/NAD-linked reductases, N-terminal and central domains
c.3.1.6;Thi4-like
c.3.1.7;GidA-like
c.3.1.8;HI0933 N-terminal domain-like
c.4.1.1;N-terminal domain of adrenodoxin reductase-like
c.4.1.2;D-aminoacid oxidase, N-terminal domain
c.4.1.3;UDP-galactopyranose mutase, N-terminal domain
c.5.1.1;MurCD N-terminal domain
c.6.1.1;Glycosyl hydrolases family 6, cellulases
c.6.3.1;PHP domain
c.6.3.2;RNase P subunit p30
c.6.2.2;4-alpha-glucanotransferase, N-terminal domain
c.6.2.1;alpha-mannosidase
c.6.2.4;AmyC N-terminal domain-like
c.6.2.3;NodB-like polysaccharide deacetylase
c.6.2.5;LamB/YcsF-like
c.6.2.6;PA1517-like
c.6.2.7;Divergent polysaccharide deacetylase
c.6.2.8;YdjC-like
c.7.1.1;PFL-like
c.7.1.2;R1 subunit of ribonucleotide reductase, C-terminal domain
c.7.1.4;B12-dependent (class II) ribonucleotide reductase
c.7.1.3;Class III anaerobic ribonucleotide reductase NRDD subunit
c.7.1.5;SP0239-like
c.8.1.1;Pyruvate phosphate dikinase, central domain
c.8.1.2;N-terminal domain of enzyme I of the PEP:sugar phosphotransferase system
c.8.7.1;RraA-like
c.8.8.1;Putative cyclase
c.8.2.1;LeuD-like
c.8.2.2;IlvD/EDD C-terminal domain-like
c.8.2.3;AF0055-like
c.8.3.1;Carbamoyl phosphate synthetase, small subunit N-terminal domain
c.8.6.1;Swiveling domain of dehydratase reactivase alpha subunit
c.8.4.1;PA domain
c.8.5.1;GroEL-like chaperone, apical domain
c.8.5.2;Group II chaperonin (CCT, TRIC), apical domain
c.8.9.1;FumA C-terminal domain-like
c.8.10.1;LD-carboxypeptidase A C-terminal domain-like
c.9.1.1;Barstar-related
c.9.2.1;Ribosomal protein L32e
c.98.1.1;MurE/MurF N-terminal domain
c.98.2.1;HPr kinase/phoshatase HprK N-terminal domain
c.98.2.2;DRTGG domain
c.10.1.1;28-residue LRR
c.10.1.2;Rna1p (RanGAP1), N-terminal domain
c.10.1.3;Cyclin A/CDK2-associated p19, Skp2
c.10.2.1;Internalin LRR domain
c.10.2.6;Leucine rich effector protein YopM
c.10.2.7;Ngr ectodomain-like
c.10.2.8;Polygalacturonase inhibiting protein PGIP
c.10.2.2;Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
c.10.2.3;mRNA export factor tap
c.10.2.4;U2A'-like
c.10.2.5;L domain
c.10.3.1;Outer arm dynein light chain 1
c.12.1.1;Ribosomal proteins L15p and L18e
c.13.1.1;CRAL/TRIO domain
c.13.2.1;Anti-sigma factor antagonist SpoIIaa
c.13.2.2;Sfri0576-like
c.14.1.1;Clp protease, ClpP subunit
c.14.1.2;Tail specific protease, catalytic domain
c.14.1.3;Crotonase-like
c.14.1.4;Biotin dependent carboxylase carboxyltransferase domain
c.15.1.3;BRCT domain
c.15.1.4;53BP1
c.15.1.1;DNA-repair protein XRCC1
c.15.1.2;DNA ligase
c.15.1.5;DNA topoisomerase II binding protein 1, TopBP1
c.16.1.1;Lumazine synthase
c.18.1.1;Uracil-DNA glycosylase
c.18.1.2;Mug-like
c.18.1.3;Single-strand selective monofunctional uracil-DNA glycosylase SMUG1
c.18.1.4;AF0587 domain-like
c.125.1.1;Creatininase
c.126.1.1;DNA polymerase III psi subunit
c.20.1.1;Initiation factor IF2/eIF5b, domain 3
c.58.1.1;Aminoacid dehydrogenases
c.58.1.2;Tetrahydrofolate dehydrogenase/cyclohydrolase
c.58.1.4;Methylene-tetrahydromethanopterin dehydrogenase
c.58.1.5;Shikimate dehydrogenase-like
c.58.1.3;Malic enzyme N-domain
c.136.1.1;Toprim domain
c.149.1.1;AtpF-like
c.21.1.1;Ribosomal protein L13
c.22.1.1;Ribosomal protein L4
c.142.1.1;Nqo1 FMN-binding domain-like
c.23.1.1;CheY-related
c.23.1.2;Receiver domain of the ethylene receptor
c.23.1.3;Positive regulator of the amidase operon AmiR
c.23.1.4;Ornithine decarboxylase N-terminal "wing" domain
c.23.1.5;N-terminal domain of the circadian clock protein KaiA
c.23.1.6;RcsC linker domain-like
c.23.1.7;AF1403 C-terminal domain-like
c.23.2.1;Toll/Interleukin receptor TIR domain
c.23.3.1;Hypothetical protein MTH538
c.23.4.1;Succinyl-CoA synthetase domains
c.23.5.1;Flavodoxin-related
c.23.5.2;Cytochrome p450 reductase N-terminal domain-like
c.23.5.3;Quinone reductase
c.23.5.5;Hypothetical protein SP1951
c.23.5.6;Hypothetical protein YwqN
c.23.5.4;NADPH-dependent FMN reductase
c.23.5.7;Flavoprotein NrdI
c.23.5.8;WrbA-like
c.23.6.1;Cobalamin (vitamin B12)-binding domain
c.23.8.1;N5-CAIR mutase (phosphoribosylaminoimidazole carboxylase, PurE)
c.23.10.1;Esterase
c.23.10.2;Esterase domain of haemagglutinin-esterase-fusion glycoprotein HEF1
c.23.10.3;Acetylhydrolase
c.23.10.4;Rhamnogalacturonan acetylesterase
c.23.10.5;TAP-like
c.23.10.6;Hypothetical protein alr1529
c.23.10.7;Putative acetylxylan esterase-like
c.23.10.8;YxiM C-terminal domain-like
c.23.10.9;BT2961-like
c.23.11.1;Beta-D-glucan exohydrolase, C-terminal domain
c.23.12.1;Formate/glycerate dehydrogenases, substrate-binding domain
c.23.12.2;L-alanine dehydrogenase-like
c.23.12.3;S-adenosylhomocystein hydrolase
c.23.13.1;Type II 3-dehydroquinate dehydratase
c.23.14.1;N-deoxyribosyltransferase
c.23.14.2;Hypothetical protein PA1492
c.23.14.3;ADP ribosyl cyclase-like
c.23.15.1;Ribosomal protein S2
c.23.17.1;Precorrin-8X methylmutase CbiC/CobH
c.23.16.1;Class I glutamine amidotransferases (GAT)
c.23.16.5;A4 beta-galactosidase middle domain
c.23.16.2;DJ-1/PfpI
c.23.16.3;Catalase, C-terminal domain
c.23.16.4;Aspartyl dipeptidase PepE
c.23.16.6;ThuA-like
c.23.16.7;LD-carboxypeptidase A N-terminal domain-like
c.23.16.8;HTS-like
c.23.16.9;STM3548-like
c.24.1.1;Carbamoyl phosphate synthetase, large subunit allosteric, C-terminal domain
c.24.1.2;Methylglyoxal synthase, MgsA
c.24.1.3;Inosicase
c.25.1.1;Reductases
c.25.1.2;Aromatic dioxygenase reductase-like
c.25.1.3;Dihydroorotate dehydrogenase B, PyrK subunit
c.25.1.4;NADPH-cytochrome p450 reductase-like
c.25.1.5;Flavohemoglobin, C-terminal domain
c.26.1.1;Class I aminoacyl-tRNA synthetases (RS), catalytic domain
c.26.1.2;Cytidylyltransferase
c.26.1.3;Adenylyltransferase
c.26.1.4;Pantothenate synthetase (Pantoate-beta-alanine ligase, PanC)
c.26.1.5;ATP sulfurylase catalytic domain
c.26.2.1;N-type ATP pyrophosphatases
c.26.2.5;PP-loop ATPase
c.26.2.2;PAPS reductase-like
c.26.2.3;ETFP subunits
c.26.2.4;Universal stress protein-like
c.26.2.6;ThiI-like
c.26.3.1;UDP-glucose/GDP-mannose dehydrogenase C-terminal domain
c.27.1.1;Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain
c.28.1.1;Cryptochrome/photolyase, N-terminal domain
c.114.1.1;DsrEF-like
c.114.1.2;DsrH-like
c.120.1.1;PIN domain
c.120.1.2;5' to 3' exonuclease catalytic domain
c.121.1.1;Ribose/Galactose isomerase RpiB/AlsB
c.150.1.1;ChaN-like
c.150.1.2;PMT domain-like
c.150.1.3;EreA-like
c.116.1.3;YbeA-like
c.116.1.4;tRNA(m1G37)-methyltransferase TrmD
c.116.1.1;SpoU-like RNA 2'-O ribose methyltransferase
c.116.1.2;Hypothetical protein MTH1 (MT0001), dimerisation domain
c.116.1.5;YggJ C-terminal domain-like
c.116.1.6;EMG1/NEP1-like
c.116.1.7;AF1056-like
c.116.1.8;AF0751-like
c.30.1.1;BC N-terminal domain-like
c.30.1.2;D-Alanine ligase N-terminal domain
c.30.1.6;Lysine biosynthesis enzyme LysX, N-terminal domain
c.30.1.3;Prokaryotic glutathione synthetase, N-terminal domain
c.30.1.4;Eukaryotic glutathione synthetase, substrate-binding domain
c.30.1.5;Synapsin domain
c.30.1.7;Glutathionylspermidine synthase substrate-binding domain-like
c.30.1.8;PurP N-terminal domain-like
c.31.1.1;Deoxyhypusine synthase, DHS
c.31.1.2;C-terminal domain of the electron transfer flavoprotein alpha subunit
c.31.1.3;Pyruvate oxidase and decarboxylase, middle domain
c.31.1.4;Transhydrogenase domain III (dIII)
c.31.1.5;Sir2 family of transcriptional regulators
c.31.1.6;ACDE2-like
c.32.1.1;Tubulin, GTPase domain
c.33.1.3;Isochorismatase-like hydrolases
c.99.1.1;Dipeptide transport protein
c.34.1.1;Homo-oligomeric flavin-containing Cys decarboxylases, HFCD
c.108.1.5;Probable phosphatase YrbI
c.108.1.1;HAD-related
c.108.1.6;beta-Phosphoglucomutase-like
c.108.1.2;YihX-like
c.108.1.3;Phosphonoacetaldehyde hydrolase-like
c.108.1.4;Phosphoserine phosphatase
c.108.1.8;5'(3')-deoxyribonucleotidase (dNT-2)
c.108.1.11;Homoserine kinase ThrH
c.108.1.12;Class B acid phosphatase, AphA
c.108.1.13;Hypothetical protein MW1667 (SA1546)
c.108.1.9;phosphatase domain of polynucleotide kinase
c.108.1.10;Predicted hydrolases Cof
c.108.1.14;NagD-like
c.108.1.7;Meta-cation ATPase, catalytic domain P
c.108.1.15;Trehalose-phosphatase
c.108.1.16;NLI interacting factor-like phosphatase
c.108.1.17;Magnesium-dependent phosphatase-1, Mdp1
c.108.1.18;Hypothetical protein VC0232
c.108.1.19;Histidinol phosphatase-like
c.108.1.20;MtnX-like
c.108.1.21;Pyrimidine 5'-nucleotidase (UMPH-1)
c.108.1.22;Enolase-phosphatase E1
c.108.1.23;5' nucleotidase-like
c.108.1.24;AF1437-like
c.108.1.25;BT0820-like
c.124.1.1;NagB-like
c.124.1.4;D-ribose-5-phosphate isomerase (RpiA), catalytic domain
c.124.1.3;CoA transferase beta subunit-like
c.124.1.2;CoA transferase alpha subunit-like
c.124.1.5;IF2B-like
c.124.1.6;Methenyltetrahydrofolate synthetase
c.124.1.7;YkgG-like
c.124.1.8;SorC sugar-binding domain-like
c.115.1.1;Hypothetical protein MTH777 (MT0777)
c.100.1.1;Thiamin pyrophosphokinase, catalytic domain
c.101.1.1;Undecaprenyl diphosphate synthase
c.127.1.1;F420-dependent methylenetetrahydromethanopterin dehydrogenase (MTD)
c.36.1.5;Pyruvate oxidase and decarboxylase Pyr module
c.36.1.6;TK-like Pyr module
c.36.1.7;Branched-chain alpha-keto acid dehydrogenase Pyr module
c.36.1.8;PFOR Pyr module
c.36.1.9;Pyruvate oxidase and decarboxylase PP module
c.36.1.10;TK-like PP module
c.36.1.11;Branched-chain alpha-keto acid dehydrogenase PP module
c.36.1.12;PFOR PP module
c.37.1.1;Nucleotide and nucleoside kinases
c.37.1.2;Shikimate kinase (AroK)
c.37.1.3;Chloramphenicol phosphotransferase
c.37.1.17;Gluconate kinase
c.37.1.21;Plasmid maintenance system epsilon/zeta, toxin zeta subunit
c.37.1.4;Adenosine-5'phosphosulfate kinase (APS kinase)
c.37.1.15;ATP sulfurylase C-terminal domain
c.37.1.5;PAPS sulfotransferase
c.37.1.6;Phosphoribulokinase/pantothenate kinase
c.37.1.7;6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, kinase domain
c.37.1.8;G proteins
c.37.1.9;Motor proteins
c.37.1.10;Nitrogenase iron protein-like
c.37.1.11;RecA protein-like (ATPase-domain)
c.37.1.22;Bacterial cell division inhibitor SulA
c.37.1.12;ABC transporter ATPase domain-like
c.37.1.19;Tandem AAA-ATPase domain
c.37.1.20;Extended AAA-ATPase domain
c.37.1.14;RNA helicase
c.37.1.16;Helicase-like "domain" of reverse gyrase
c.37.1.23;DNA helicase UvsW
c.37.1.18;YjeE-like
c.37.1.24;Type II thymidine kinase
c.37.1.25;Atu3015-like
c.38.1.1;PTS IIb component
c.128.1.1;DNA polymerase III chi subunit
c.39.1.1;Nicotinate mononucleotide:5,6-dimethylbenzimidazole phosphoribosyltransferase (CobT)
c.143.1.1;CofD-like
c.129.1.1;MoCo carrier protein-like
c.129.1.2;YpsA-like
c.40.1.1;Methylesterase CheB, C-terminal domain
c.41.1.1;Subtilases
c.41.1.2;Serine-carboxyl proteinase, SCP
c.138.1.1;Indigoidine synthase A-like
c.42.1.1;Arginase-like amidino hydrolases
c.42.1.2;Histone deacetylase, HDAC
c.130.1.1;Alpha-2,3/8-sialyltransferase CstII
c.102.1.1;Cell-division inhibitor MinC, N-terminal domain
c.110.1.1;DTD-like
c.43.1.1;CAT-like
c.43.1.3;Choline/Carnitine O-acyltransferase
c.43.1.2;NRPS condensation domain (amide synthase)
c.44.1.1;Low-molecular-weight phosphotyrosine protein phosphatases
c.44.2.1;PTS system, Lactose/Cellobiose specific IIB subunit
c.44.2.2;PTS system, Fructose specific IIB subunit-like
c.45.1.1;Dual specificity phosphatase-like
c.45.1.2;Higher-molecular-weight phosphotyrosine protein phosphatases
c.45.1.3;Myotubularin-like phosphatases
c.45.1.4;Myo-inositol hexaphosphate phosphohydrolase (phytase) PhyA
c.45.1.5;Mycobacterial PtpB-like
c.46.1.1;Cell cycle control phosphatase, catalytic domain
c.46.1.3;Single-domain sulfurtransferase
c.46.1.2;Multidomain sulfurtransferase (rhodanese)
c.46.1.4;Ubiquitin carboxyl-terminal hydrolase 8, USP8
c.47.1.1;Thioltransferase
c.47.1.2;PDI-like
c.47.1.3;Calsequestrin
c.47.1.13;DsbA-like
c.47.1.5;Glutathione S-transferase (GST), N-terminal domain
c.47.1.6;Phosducin
c.47.1.7;ERP29 N domain-like
c.47.1.8;spliceosomal protein U5-15Kd
c.47.1.14;SH3BGR (SH3-binding, glutamic acid-rich protein-like)
c.47.1.15;KaiB-like
c.47.1.9;DsbC/DsbG C-terminal domain-like
c.47.1.10;Glutathione peroxidase-like
c.47.1.11;Thioredoxin-like 2Fe-2S ferredoxin
c.47.1.12;ArsC-like
c.47.1.16;Txnl5-like
c.47.1.17;YuzD-like
c.47.1.18;YKR049C-like
c.47.1.19;Atu2684-like
c.47.1.20;HyaE-like
c.47.1.21;NQO2-like
c.47.1.22;Mitochondrial ribosomal protein L51/S25/CI-B8 domain
c.47.1.23;Selenoprotein W-related
c.47.1.24;UAS domain
c.47.2.1;RNA 3'-terminal phosphate cyclase, RPTC, insert domain
c.131.1.1;Peptidyl-tRNA hydrolase II
c.48.1.1;Transketolase C-terminal domain-like
c.48.1.2;Branched-chain alpha-keto acid dehydrogenase beta-subunit, C-terminal-domain
c.48.1.3;Pyruvate-ferredoxin oxidoreductase, PFOR, domain II
c.49.1.1;Pyruvate kinase, C-terminal domain
c.49.1.2;MTH1675-like
c.49.2.1;ATP synthase (F1-ATPase), gamma subunit
c.51.1.1;Anticodon-binding domain of Class II aaRS
c.51.1.2;Brix domain
c.51.2.1;TolB, N-terminal domain
c.51.3.1;Diol dehydratase, beta subunit
c.51.3.2;Dehydratase-reactivating factor beta subunit
c.51.4.1;ITPase (Ham1)
c.51.4.2;Maf-like
c.51.4.3;YjjX-like
c.51.5.1;CinA-like
c.51.6.1;NLBH-like
c.51.6.2;XCC0632-like
c.103.1.1;MTH938-like
c.52.1.1;Restriction endonuclease EcoRI
c.52.1.2;Restriction endonuclease EcoRV
c.52.1.3;Restriction endonuclease BamHI
c.52.1.4;Restriction endonuclease BglI
c.52.1.5;Restriction endonuclease BglII
c.52.1.21;Restriction endonuclease BstyI
c.52.1.6;Restriction endonuclease PvuII
c.52.1.7;Cfr10I/Bse634I
c.52.1.8;Restriction endonuclease MunI
c.52.1.9;Restriction endonuclease NaeI
c.52.1.10;Restriction endonuclease NgoIV
c.52.1.11;Restriction endonuclease BsobI
c.52.1.19;Restriction endonuclease HincII
c.52.1.12;Restriction endonuclease FokI, C-terminal (catalytic) domain
c.52.1.22;Type II restriction endonuclease catalytic domain
c.52.1.13;lambda exonuclease
c.52.1.14;DNA mismatch repair protein MutH from
c.52.1.15;Very short patch repair (VSR) endonuclease
c.52.1.16;TnsA endonuclease, N-terminal domain
c.52.1.17;Endonuclease I (Holliday junction resolvase)
c.52.1.18;Hjc-like
c.52.1.20;XPF/Rad1/Mus81 nuclease
c.52.1.23;Restriction endonuclease MspI
c.52.1.24;Exodeoxyribonuclease V beta chain (RecB), C-terminal domain
c.52.1.25;Exodeoxyribonuclease V beta chain (RecC), C-terminal domain
c.52.1.26;Hypothetical protein VC1899
c.52.1.27;Hypothetical protein TT1808 (TTHA1514)
c.52.1.28;RecU-like
c.52.1.29;Restriction endonuclease EcoO109IR
c.52.1.30;MRR-like
c.52.1.31;PA4535-like
c.52.1.32;XisH-like
c.52.1.33;YaeQ-like
c.52.2.1;tRNA-intron endonuclease catalytic domain-like
c.52.3.1;Eukaryotic RPB5 N-terminal domain
c.52.4.1;TBP-interacting protein-like
c.53.1.1;gamma,delta resolvase, catalytic domain
c.53.2.1;beta-carbonic anhydrase, cab
c.54.1.1;EIIA-man component-like
c.54.1.2;DhaM-like
c.55.1.1;Actin/HSP70
c.55.1.5;BadF/BadG/BcrA/BcrD-like
c.55.1.2;Acetokinase-like
c.55.1.6;ATPase domain of dehydratase reactivase alpha subunit
c.55.1.3;Hexokinase
c.55.1.4;Glycerol kinase
c.55.1.7;Glucokinase
c.55.1.8;Ppx/GppA phosphatase
c.55.1.9;YeaZ-like
c.55.1.10;ROK
c.55.1.11;Cyto-EpsL domain
c.55.1.12;Ta0583-like
c.55.1.13;CoaX-like
c.55.1.14;Fumble-like
c.55.2.1;Creatinase/prolidase N-terminal domain
c.55.3.1;Ribonuclease H
c.55.3.2;Retroviral integrase, catalytic domain
c.55.3.3;mu transposase, core domain
c.55.3.4;Transposase inhibitor (Tn5 transposase)
c.55.3.5;DnaQ-like 3'-5' exonuclease
c.55.3.6;RuvC resolvase
c.55.3.7;Mitochondrial resolvase ydc2 catalytic domain
c.55.3.8;Putative Holliday junction resolvase RuvX
c.55.3.9;CAF1-like ribonuclease
c.55.3.10;PIWI domain
c.55.3.11;TM1739-like
c.55.3.12;Hermes transposase-like
c.55.3.13;Tex RuvX-like domain-like
c.55.3.14;Prp8 beta-finger domain-like
c.55.4.1;Ribosomal protein L18 and S11
c.55.4.2;ERF1/Dom34 middle domain-like
c.55.5.1;MTH1175-like
c.55.5.2;Nitrogenase accessory factor
c.55.6.1;DNA repair protein MutS, domain II
c.55.7.1;Methylated DNA-protein cysteine methyltransferase domain
c.56.1.1;Hydrogenase maturating endopeptidase HybD
c.56.1.2;Germination protease
c.56.2.1;Purine and uridine phosphorylases
c.56.3.1;Peptidyl-tRNA hydrolase-like
c.56.4.1;Pyrrolidone carboxyl peptidase (pyroglutamate aminopeptidase)
c.56.5.1;Pancreatic carboxypeptidases
c.56.5.2;Carboxypeptidase T
c.56.5.3;Leucine aminopeptidase, C-terminal domain
c.56.5.4;Bacterial dinuclear zinc exopeptidases
c.56.5.5;FolH catalytic domain-like
c.56.5.6;N-acetylmuramoyl-L-alanine amidase-like
c.56.5.7;AstE/AspA-like
c.56.5.8;Glutaminyl-peptide cyclotransferase-like
c.56.5.9;FGase-like
c.56.6.1;LigB-like
c.56.7.1;AF0625-like
c.56.8.1;Cgl1923-like
c.57.1.1;MogA-like
c.57.1.2;MoeA central domain-like
c.151.1.1;CobE/GbiG C-terminal domain-like
c.152.1.1;CbiG N-terminal domain-like
c.132.1.1;Bacterial fluorinating enzyme, N-terminal domain
c.17.1.1;Caspase catalytic domain
c.17.1.2;Gingipain R (RgpB), N-terminal domain
c.50.1.1;Leucine aminopeptidase (Aminopeptidase A), N-terminal domain
c.50.1.2;Macro domain
c.59.1.1;MurCDEF C-terminal domain
c.59.1.2;Folylpolyglutamate synthetase, C-terminal domain
c.60.1.1;Cofactor-dependent phosphoglycerate mutase
c.60.1.2;Histidine acid phosphatase
c.60.1.4;6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, phosphatase domain
c.61.1.1;Phosphoribosyltransferases (PRTases)
c.61.1.2;Phosphoribosylpyrophosphate synthetase-like
c.62.1.1;Integrin A (or I) domain
c.62.1.2;Trunk domain of Sec23/24
c.62.1.3;Ku70 subunit N-terminal domain
c.62.1.4;Ku80 subunit N-terminal domain
c.62.1.5;RoRNP C-terminal domain-like
c.64.1.1;Pyruvate-ferredoxin oxidoreductase, PFOR, domain III
c.133.1.1;RbsD-like
c.19.1.1;FabD-like
c.19.1.2;Lysophospholipase
c.19.1.3;Patatin
c.122.1.1;L-sulfolactate dehydrogenase-like
c.65.1.1;Formyltransferase
c.66.1.1;COMT-like
c.66.1.12;Plant O-methyltransferase, C-terminal domain
c.66.1.2;RNA methyltransferase FtsJ
c.66.1.3;Fibrillarin homologue
c.66.1.33;rRNA methyltransferase RlmA
c.66.1.29;rRNA methyltransferase AviRa
c.66.1.24;rRNA adenine dimethylase-like
c.66.1.25;mRNA cap methylase
c.66.1.34;mRNA cap (Guanine N-7) methyltransferase
c.66.1.4;Hypothetical protein MJ0882
c.66.1.14;Hypothetical protein HI0319 (YecO)
c.66.1.5;Glycine N-methyltransferase
c.66.1.15;Arylamine N-methyltransferase
c.66.1.19;Histamine methyltransferase
c.66.1.21;Hypothetical Protein YjhP
c.66.1.35;Salicylic acid carboxyl methyltransferase (SAMT)
c.66.1.36;Thiopurine S-methyltransferase
c.66.1.37;Leucine carboxy methyltransferase Ppm1
c.66.1.22;Precorrin-6Y methyltransferase (CbiT)
c.66.1.23;MraW-like putative methyltransferases
c.66.1.30;N5-glutamine methyltransferase, HemK
c.66.1.31;Catalytic, N-terminal domain of histone methyltransferase Dot1l
c.66.1.16;Guanidinoacetate methyltransferase
c.66.1.6;Arginine methyltransferase
c.66.1.7;Protein-L-isoaspartyl O-methyltransferase
c.66.1.20;Glucose-inhibited division protein B (GidB)
c.66.1.13;tRNA(1-methyladenosine) methyltransferase-like
c.66.1.38;NOL1/NOP2/sun
c.66.1.39;Ribosomal protein L11 methyltransferase PrmA
c.66.1.40;(Uracil-5-)-methyltransferase
c.66.1.8;Chemotaxis receptor methyltransferase CheR, C-terminal domain
c.66.1.26;C5 cytosine-specific DNA methylase, DCM
c.66.1.27;DNA methylase TaqI, N-terminal domain
c.66.1.28;N6 adenine-specific DNA methylase, DAM
c.66.1.11;Type II DNA methylase
c.66.1.17;Spermidine synthase
c.66.1.18;Mycolic acid cyclopropane synthase
c.66.1.32;Ta1320-like
c.66.1.41;UbiE/COQ5-like
c.66.1.42;AD-003 protein-like
c.66.1.43;CAC2371-like
c.66.1.44;TehB-like
c.66.1.45;N-6 DNA Methylase-like
c.66.1.46;YhhF-like
c.66.1.47;Met-10+ protein-like
c.66.1.48;Nsp15 N-terminal domain-like
c.66.1.49;BC2162-like
c.66.1.50;CmcI-like
c.66.1.51;hypothetical RNA methyltransferase
c.66.1.52;RPA4359-like
c.66.1.53;TrmB-like
c.66.1.54;Methyltransferase 10 domain
c.66.1.55;YhiQ-like
c.66.1.56;FkbM-like
c.66.1.57;ML2640-like
c.66.1.58;TRM1-like
c.66.1.59;LPG1296-like
c.134.1.1;LmbE-like
c.67.1.1;AAT-like
c.67.1.2;Beta-eliminating lyases
c.67.1.6;Pyridoxal-dependent decarboxylase
c.67.1.3;Cystathionine synthase-like
c.67.1.4;GABA-aminotransferase-like
c.67.1.5;Ornithine decarboxylase major domain
c.67.1.7;Glycine dehydrogenase subunits (GDC-P)
c.67.1.8;SelA-like
c.67.1.9;SepSecS-like
c.67.2.1;PhnH-like
c.67.3.1;Dhaf3308-like
c.68.1.1;Spore coat polysaccharide biosynthesis protein SpsA
c.68.1.2;beta 1,4 galactosyltransferase (b4GalT1)
c.68.1.4;Galactosyltransferase LgtC
c.68.1.14;Glycogenin
c.68.1.9;alpha-1,3-galactosyltransferase-like
c.68.1.5;UDP-glucose pyrophosphorylase
c.68.1.6;glucose-1-phosphate thymidylyltransferase
c.68.1.7;1,3-glucuronyltransferase
c.68.1.10;N-acetylglucosaminyltransferase I
c.68.1.15;Exostosin
c.68.1.8;Molybdenum cofactor biosynthesis protein MobA
c.68.1.13;Cytidylytransferase
c.68.1.16;Glycolipid 2-alpha-mannosyltransferase
c.68.1.17;Polypeptide N-acetylgalactosaminyltransferase 1, N-terminal domain
c.68.1.18;MGS-like
c.68.1.19;TTHA0179-like
c.68.1.20;mannose-1-phosphate guanylyl transferase
c.68.1.21;MM2497-like
c.68.1.22;Glycosylating toxin catalytic domain-like
c.144.1.1;RibA-like
c.111.1.1;Molybdenum cofactor biosynthesis protein MoeB
c.111.1.2;Ubiquitin activating enzymes (UBA)
c.69.1.1;Acetylcholinesterase-like
c.69.1.2;Carboxylesterase
c.69.1.3;Mycobacterial antigens
c.69.1.27;Hypothetical protein TT1662
c.69.1.21;PepX catalytic domain-like
c.69.1.4;Prolyl oligopeptidase, C-terminal domain
c.69.1.24;DPP6 catalytic domain-like
c.69.1.5;Serine carboxypeptidase-like
c.69.1.6;Gastric lipase
c.69.1.7;Proline iminopeptidase-like
c.69.1.25;Acetyl xylan esterase-like
c.69.1.8;Haloalkane dehalogenase
c.69.1.9;Dienelactone hydrolase
c.69.1.10;Carbon-carbon bond hydrolase
c.69.1.26;Biotin biosynthesis protein BioH
c.69.1.28;Aclacinomycin methylesterase RdmC
c.69.1.29;Carboxylesterase/lipase
c.69.1.11;Epoxide hydrolase
c.69.1.12;Haloperoxidase
c.69.1.13;Thioesterases
c.69.1.14;Carboxylesterase/thioesterase 1
c.69.1.23;Ccg1/TafII250-interacting factor B (Cib)
c.69.1.15;A novel bacterial esterase
c.69.1.16;Lipase
c.69.1.17;Fungal lipases
c.69.1.18;Bacterial lipase
c.69.1.19;Pancreatic lipase, N-terminal domain
c.69.1.20;Hydroxynitrile lyase-like
c.69.1.22;Thioesterase domain of polypeptide, polyketide and fatty acid synthases
c.69.1.30;Cutinase-like
c.69.1.31;YdeN-like
c.69.1.32;Putative serine hydrolase Ydr428c
c.69.1.33;Acylamino-acid-releasing enzyme, C-terminal donain
c.69.1.34;Hypothetical esterase YJL068C
c.69.1.35;Hypothetical protein VC1974
c.69.1.36;Atu1826-like
c.69.1.37;PHB depolymerase-like
c.69.1.38;IroE-like
c.69.1.39;TTHA1544-like
c.69.1.40;O-acetyltransferase
c.69.1.41;2,6-dihydropseudooxynicotine hydrolase-like
c.70.1.1;Nucleoside hydrolase
c.71.1.1;Dihydrofolate reductases
c.71.1.2;RibD C-terminal domain-like
c.72.1.2;Thiamin biosynthesis kinases
c.72.1.4;YjeF C-terminal domain-like
c.72.1.5;PfkB-like kinase
c.72.1.1;Ribokinase-like
c.72.1.3;ADP-specific Phosphofructokinase/Glucokinase
c.72.2.1;MurCDEF
c.72.2.2;Folylpolyglutamate synthetase
c.72.3.1;CoaB-like
c.104.1.1;YjeF N-terminal domain-like
c.73.1.1;Carbamate kinase
c.73.1.2;N-acetyl-l-glutamate kinase
c.73.1.3;PyrH-like
c.105.1.1;2,3-Bisphosphoglycerate-independent phosphoglycerate mutase, substrate-binding domain
c.76.1.3;2,3-Bisphosphoglycerate-independent phosphoglycerate mutase, catalytic domain
c.76.1.1;Alkaline phosphatase
c.76.1.2;Arylsulfatase
c.76.1.4;Phosphonoacetate hydrolase
c.76.1.5;DeoB catalytic domain-like
c.140.1.1;Hypothetical protein TT1679
c.140.1.2;Aminoglycoside 3-N-acetyltransferase-like
c.112.1.1;Glycerol-3-phosphate (1)-acyltransferase
c.74.1.1;AraD-like aldolase/epimerase
c.74.1.2;Phosphomethylpyrimidine kinase C-terminal domain-like
c.106.1.1;SurE-like
c.153.1.1;YerB-like
c.154.1.1;CdCA1 repeat-like
c.77.1.1;Dimeric isocitrate & isopropylmalate dehydrogenases
c.77.1.3;PdxA-like
c.77.1.4;PlsX-like
c.77.1.5;Phosphotransacetylase
c.77.1.2;Monomeric isocitrate dehydrogenase
c.117.1.1;Amidase signature (AS) enzymes
c.78.1.1;Aspartate/ornithine carbamoyltransferase
c.78.2.1;Aspartate/glutamate racemase
c.79.1.1;Tryptophan synthase beta subunit-like PLP-dependent enzymes
c.80.1.3;mono-SIS domain
c.80.1.1;double-SIS domain
c.80.1.2;Phosphoglucose isomerase, PGI
c.81.1.1;Formate dehydrogenase/DMSO reductase, domains 1-3
c.82.1.1;ALDH-like
c.82.1.2;L-histidinol dehydrogenase HisD
c.145.1.1;NadA-like
c.83.1.1;Aconitase iron-sulfur domain
c.84.1.1;Phosphoglucomutase, first 3 domains
c.85.1.1;L-fucose isomerase, N-terminal and second domains
c.85.1.2;AraA N-terminal and middle domain-like
c.146.1.1;YgbK-like
c.86.1.1;Phosphoglycerate kinase
c.87.1.1;beta-Glucosyltransferase (DNA-modifying)
c.87.1.2;Peptidoglycan biosynthesis glycosyltransferase MurG
c.87.1.3;UDP-N-acetylglucosamine 2-epimerase
c.87.1.5;Gtf glycosyltransferase
c.87.1.7;ADP-heptose LPS heptosyltransferase II
c.87.1.6;Trehalose-6-phosphate synthase, OtsA
c.87.1.4;Oligosaccharide phosphorylase
c.87.1.8;Glycosyl transferases group 1
c.87.1.9;Sialyltransferase-like
c.87.1.10;UDPGT-like
c.87.1.11;FucT-like
c.88.1.1;Glutaminase/Asparaginase
c.89.1.1;Phosphofructokinase
c.90.1.1;Tetrapyrrole methylase
c.118.1.1;GckA/TtuD-like
c.119.1.1;DegV-like
c.119.1.2;DAK1
c.107.1.1;Manganese-dependent inorganic pyrophosphatase (family II)
c.107.1.2;Exonuclease RecJ
c.141.1.1;Glycerate kinase I
c.91.1.1;PEP carboxykinase C-terminal domain
c.91.1.2;HPr kinase HprK C-terminal domain
c.109.1.1;PEP carboxykinase N-terminal domain
c.92.1.1;Ferrochelatase
c.92.1.2;Cobalt chelatase CbiK
c.92.1.3;CbiX-like
c.92.2.1;Periplasmic ferric siderophore binding protein FhuD
c.92.2.2;TroA-like
c.92.2.3;Nitrogenase iron-molybdenum protein
c.92.2.4;TM0189-like
c.92.3.1;PrpR receptor domain-like
c.113.1.1;HemD-like
c.147.1.1;CAC2185-like
c.93.1.1;L-arabinose binding protein-like
c.94.1.1;Phosphate binding protein-like
c.94.1.2;Transferrin
c.94.1.3;PG0945 N-terminal domain-like
c.95.1.1;Thiolase-related
c.95.1.2;Chalcone synthase-like
c.135.1.1;NIF3 (NGG1p interacting factor 3)-like
c.96.1.1;Fe-only hydrogenase
c.148.1.1;ComB-like
c.123.1.1;CoA-transferase family III (CaiB/BaiF)
c.97.1.1;Cytidine deaminase
c.97.1.2;Deoxycytidylate deaminase-like
c.97.1.3;Hypothetical protein TM1506
c.97.1.4;AICAR transformylase domain of bifunctional purine biosynthesis enzyme ATIC
c.97.1.5;FdhD/NarQ
c.97.3.1;JAB1/MPN domain
d.1.1.2;Bacterial ribonucleases
d.1.1.4;Fungal ribonucleases
d.1.1.3;Ribotoxin
d.2.1.1;Family 19 glycosidase
d.2.1.2;C-type lysozyme
d.2.1.3;Phage lysozyme
d.2.1.4;Lambda lysozyme
d.2.1.5;G-type lysozyme
d.2.1.6;Bacterial muramidase, catalytic domain
d.2.1.7;Chitosanase
d.2.1.8;RPF-like
d.2.1.9;NMB1012-like
d.2.1.10;PBP transglycosylase domain-like
d.2.1.11;PA2222-like
d.3.1.1;Papain-like
d.3.1.10;Avirulence protein Avrpph3
d.3.1.2;FMDV leader protease
d.3.1.3;Calpain large subunit, catalytic domain (domain II)
d.3.1.4;Transglutaminase core
d.3.1.5;Arylamine N-acetyltransferase
d.3.1.6;Ubiquitin carboxyl-terminal hydrolase UCH-L
d.3.1.9;Ubiquitin carboxyl-terminal hydrolase, UCH
d.3.1.7;Adenain-like
d.3.1.8;Microbial transglutaminase
d.3.1.11;Ubiquitin thiolesterase protein OTUB2 (Otubain-2)
d.3.1.12;IgG-specific endopeptidase IdeS (Sib38)
d.3.1.13;Lpg0564-like
d.3.1.14;Phytochelatin synthase
d.3.1.15;CHAP domain
d.3.1.16;NlpC/P60
d.3.1.17;PMT C-terminal domain like
d.3.1.18;MOA C-terminal domain-like
d.3.1.19;Atu2299-like
d.3.1.20;M48USP-like
d.3.1.21;YiiX-like
d.3.1.22;Autophagin-like
d.4.1.6;Endonuclease I
d.4.1.1;HNH-motif
d.4.1.2;DNA/RNA non-specific endonuclease
d.4.1.3;Intron-encoded homing endonucleases
d.4.1.5;Recombination endonuclease VII, N-terminal domain
d.4.1.7;Caspase-activated DNase, CAD (DffB, DFF40)
d.5.1.1;Ribonuclease A-like
d.294.1.1;Eukaryotic EndoU ribonuclease
d.294.1.2;Nsp15 C-terminal domain-like
d.6.1.1;Prion-like
d.7.1.1;LysM domain
d.186.1.1;Head-to-tail joining protein W, gpW
d.186.2.1;XkdW-like
d.266.1.1;Hypothetical protein MTH677
d.288.1.1;GTF2I-like repeat
d.8.1.1;Urease, gamma-subunit
d.9.1.1;Interleukin 8-like chemokines
d.9.2.1;PhtA domain-like
d.10.1.1;DNA-binding domain from tn916 integrase
d.10.1.4;lambda integrase N-terminal domain
d.10.1.2;GCC-box binding domain
d.10.1.3;Methyl-CpG-binding domain, MBD
d.11.1.1;Penicillin-binding protein 2x (pbp-2x), c-terminal domain
d.230.2.1;Dodecin-like
d.230.3.1;Amyloid beta a4 protein copper binding domain (domain 2)
d.230.1.1;N-terminal, heterodimerisation domain of RBP7 (RpoE)
d.230.4.1;D-lysine 5,6-aminomutase beta subunit KamE, N-terminal domain
d.230.5.1;YbjQ-like
d.230.6.1;YdgH-like
d.12.1.1;L23p
d.12.1.2;L15e
d.12.1.3;Ribosomal protein S24e
d.241.2.1;Trigger factor ribosome-binding domain
d.241.1.1;Translation initiation factor 2 beta, aIF2beta, N-terminal domain
d.295.1.1;TFB5-like
d.242.1.1;Obg GTP-binding protein C-terminal domain
d.13.1.1;HIT (HINT, histidine triad) family of protein kinase-interacting proteins
d.13.1.2;Hexose-1-phosphate uridylyltransferase
d.13.1.3;mRNA decapping enzyme DcpS C-terminal domain
d.13.1.4;CDH-like
d.13.2.1;Rotavirus NSP2 fragment, C-terminal domain
d.198.1.1;Type III secretory system chaperone
d.198.1.2;Tll0839-like
d.198.2.1;Arp2/3 complex subunits
d.198.3.1;YjbR-like
d.198.4.1;YdhG-like
d.198.5.1;YgaC-like
d.198.5.2;TfoX N-terminal domain-like
d.285.1.1;DNA-binding domain of intron-encoded endonucleases
d.199.1.1;DNA-binding C-terminal domain of the transcription factor MotA
d.296.1.1;YktB-like
d.296.1.2;PF0168-like
d.232.1.1;Mago nashi protein
d.297.1.1;WGR domain
d.342.1.1;PH1570-like
d.14.1.1;Translational machinery components
d.14.1.2;RNase P protein
d.14.1.3;DNA gyrase/MutL, second domain
d.14.1.8;Hsp90 middle domain
d.14.1.4;Ribonuclease PH domain 1-like
d.14.1.5;GHMP Kinase, N-terminal domain
d.14.1.6;Early switch protein XOL-1, N-terminal domain
d.14.1.7;UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase LpxC
d.14.1.9;Imidazole glycerol phosphate dehydratase
d.14.1.10;ATP-dependent protease Lon (La), catalytic domain
d.14.1.11;YigZ N-terminal domain-like
d.14.1.12;Formaldehyde-activating enzyme, FAE
d.15.1.1;Ubiquitin-related
d.15.1.2;UBX domain
d.15.1.3;GABARAP-like
d.15.1.4;First domain of FERM
d.15.1.5;Ras-binding domain, RBD
d.15.1.6;BM-002-like
d.15.1.7;APG12-like
d.15.1.8;DIX domain
d.15.2.1;CAD domain
d.15.2.2;PB1 domain
d.15.3.1;MoaD
d.15.3.2;ThiS
d.15.3.3;C9orf74 homolog
d.15.3.4;HI0395-like
d.15.10.1;TGS domain
d.15.10.2;G domain-linked domain
d.15.4.1;2Fe-2S ferredoxin-related
d.15.4.2;2Fe-2S ferredoxin domains from multidomain proteins
d.15.5.1;Staphylokinase/streptokinase
d.15.11.1;Doublecortin (DC)
d.15.6.1;Superantigen toxins, C-terminal domain
d.15.7.1;Immunoglobulin-binding domains
d.15.8.1;Translation initiation factor IF3, N-terminal domain
d.15.9.1;Glutamine synthetase, N-terminal domain
d.15.12.1;TmoB-like
d.15.13.1;Nqo1 middle domain-like
d.15.14.1;NSP3A-like
d.343.1.1;MM3350-like
d.289.1.1;WWE domain
d.16.1.1;GMC oxidoreductases
d.16.1.2;PHBH-like
d.16.1.3;D-aminoacid oxidase-like
d.16.1.7;UDP-galactopyranose mutase
d.16.1.5;L-aminoacid/polyamine oxidase
d.16.1.6;GDI-like
d.16.1.8;Electron transfer flavoprotein-ubiquinone oxidoreductase-like
d.17.1.1;Monellin
d.17.1.2;Cystatins
d.17.1.3;Cathelicidin motif
d.17.1.4;Staphopain B, prodomain
d.17.1.5;Latexin-like
d.17.1.6;PepSY-like
d.17.2.1;Amine oxidase N-terminal region
d.17.3.1;DsbC/DsbG N-terminal domain-like
d.17.4.1;Scytalone dehydratase
d.17.4.2;NTF2-like
d.17.4.7;Association domain of calcium/calmodulin-dependent protein kinase type II alpha subunit, CAMK2A
d.17.4.8;Limonene-1,2-epoxide hydrolase-like
d.17.4.9;SnoaL-like polyketide cyclase
d.17.4.10;PhzA/PhzB-like
d.17.4.3;Ketosteroid isomerase-like
d.17.4.4;Ring hydroxylating beta subunit
d.17.4.5;Penicillin binding protein 2a (PBP2A), N-terminal domain
d.17.4.6;Orange carotenoid protein, C-terminal domain
d.17.4.11;Hypothetical protein egc068 from a soil-derived mobile gene cassette
d.17.4.12;PA1314-like
d.17.4.13;TIM44-like
d.17.4.14;Sbal0622-like
d.17.4.15;CHU142-like
d.17.4.16;SO0125-like
d.17.4.17;SAV4671-like
d.17.4.18;BxeB1374-like
d.17.4.19;Atu0744-like
d.17.4.20;Rpa4348-like
d.17.4.21;Ava4193-like
d.17.4.22;YybH-like
d.17.4.23;PFL3262-like
d.17.4.24;Exig0174-like
d.17.4.25;Rv3472-like
d.17.4.26;VirB8-like
d.17.4.27;ECA1476-like
d.17.4.28;BaiE/LinA-like
d.17.4.29;Atu0742-like
d.17.4.30;SEC-C associated NTF2-like domain
d.17.5.1;Uracil-DNA glycosylase inhibitor protein
d.17.7.1;Putative dsDNA mimic
d.17.6.1;Archaeosine tRNA-guanine transglycosylase, C2 domain
d.17.6.2;Hypothetical protein Ta1423, N-terminal domain
d.17.6.3;Nip7p homolog, N-terminal domain
d.17.6.4;Hypothetical protein APE0525, N-terminal domain
d.17.6.5;AF0587 pre C-terminal domain-like
d.221.1.1;Nuclease A inhibitor (NuiA)
d.243.1.1;Colicin D nuclease domain
d.243.1.2;Colicin E5 nuclease domain
d.298.1.1;YoeB/Txe-like
d.298.1.2;RelE-like
d.267.1.1;Hypothetical protein SAV1430
d.299.1.1;Ns1 effector domain-like
d.222.1.1;YbaB-like
d.300.1.1;Spc25-like
d.300.1.2;Spc24-like
d.301.1.1;Ribosomal protein L35p
d.244.1.1;Cell division protein ZapA-like
d.18.1.1;Transcriptional coactivator PC4 C-terminal domain
d.18.1.2;Plant transcriptional regulator PBF-2
d.18.1.3;PMN2A0962/syc2379c-like
d.18.1.4;Guide RNA binding protein gBP
d.187.1.1;Photosystem I subunit PsaD
d.344.1.1;YqbF N-terminal domain-like
d.344.1.2;PSF2 N-terminal domain-like
d.344.1.3;SLD5 C-terminal domain-like
d.344.1.4;PSF3 N-terminal domain-like
d.19.1.1;MHC antigen-recognition domain
d.20.1.1;UBC-related
d.20.1.2;UEV domain
d.20.1.3;RWD domain
d.20.1.4;UFC1-like
d.217.1.1;SAND domain
d.217.1.2;SMAD4-binding domain of oncoprotein Ski
d.345.1.1;USP8 interacting domain
d.302.1.1;Coronavirus NSP8-like
d.268.1.1;ParB-like nuclease domain
d.268.1.2;Hypothetical protein PF0380
d.268.1.3;Atu1540-like
d.268.1.4;Sulfiredoxin-like
d.269.1.1;Gamma-glutamyl cyclotransferase-like
d.303.1.1;BB1717-like
d.346.1.1;SARS Nsp1-like
d.347.1.1;Acetoacetate decarboxylase-like
d.290.1.1;Alpha-acetolactate decarboxylase-like
d.290.1.2;PTD012-like
d.290.1.3;AF0104-like
d.245.1.1;NSFL1 (p97 ATPase) cofactor p47, SEP domain
d.304.1.1;TTHA1013-like
d.304.1.2;TTHA0281-like
d.348.1.1;YegP-like
d.21.1.1;Diaminopimelate epimerase
d.21.1.2;PhzC/PhzF-like
d.21.1.3;Proline racemase
d.21.1.4;PA0793-like
d.22.1.1;Fluorescent proteins
d.22.1.2;Domain G2 of nidogen-1
d.23.1.1;Transcriptional factor tubby, C-terminal domain
d.23.1.2;At5g01750-like
d.24.1.1;Pilin
d.24.1.2;TcpA-like pilin
d.24.1.3;Pseudopilin
d.24.1.4;YadA C-terminal domain-like
d.24.1.5;EpsJ-like
d.24.1.6;GspK pilin-like domain
d.24.1.7;GSPII I/J protein-like
d.25.1.1;Mitochondrial glycoprotein MAM33-like
d.305.1.1;NAP-like
d.223.1.2;Polo-box duplicated region
d.223.1.1;Swapped Polo-box domain
d.246.1.1;mRNA decapping enzyme DcpS N-terminal domain
d.233.1.1;Inhibitor of vertebrate lysozyme, Ivy
d.26.1.1;FKBP immunophilin/proline isomerase
d.26.1.2;GreA transcript cleavage factor, C-terminal domain
d.26.1.3;3-mercaptopyruvate sulfurtransferase, C-terminal domain
d.26.2.1;Colicin E3 immunity protein
d.26.3.1;Chitinase insertion domain
d.27.1.1;Ribosomal protein S16
d.28.1.1;Ribosomal protein S19
d.306.1.1;YefM-like
d.29.1.1;Ribosomal protein L31e
d.30.1.1;Allophycocyanin linker chain (domain)
d.31.1.1;Cdc48 domain 2-like
d.32.1.1;Glyoxalase I (lactoylglutathione lyase)
d.32.1.2;Antibiotic resistance proteins
d.32.1.4;Methylmalonyl-CoA epimerase
d.32.1.5;Hypothetical protein YecM (EC4020)
d.32.1.3;Extradiol dioxygenases
d.32.1.6;Hypothetical protein BC1747
d.32.1.7;3-demethylubiquinone-9 3-methyltransferase
d.32.1.8;Hypothetical protein YycE
d.32.1.9;Hypothetical protein At5g48480
d.32.1.10;BC1024-like
d.247.1.1;Chromosomal protein MC1
d.349.1.1;CPE0013-like
d.211.1.1;Ankyrin repeat
d.211.2.1;Plakin repeat
d.234.1.1;Proguanylin
d.33.1.1;Bacterial protein-export protein SecB
d.33.1.2;SP1558-like
d.229.1.1;MesJ substrate recognition domain-like
d.235.1.1;Hypothetical protein Yhr087W
d.235.1.2;Hypothetical protein AF0491, N-terminal domain
d.213.1.1;VSV matrix protein
d.34.1.1;DNA-binding domain of Mlu1-box binding protein MBP1
d.35.1.1;Heme-binding protein A (HasA)
d.36.1.1;Chalcone isomerase
d.248.1.1;Coproporphyrinogen III oxidase
d.249.1.1;Hypothetical protein Ta1206
d.37.1.1;CBS-domain pair
d.38.1.1;4HBT-like
d.38.1.2;beta-Hydroxydecanol thiol ester dehydrase
d.38.1.3;Acyl-CoA thioesterase
d.38.1.4;MaoC-like
d.38.1.5;PaaI/YdiI-like
d.38.1.6;FabZ-like
d.38.1.7;TTHA0967-like
d.38.1.8;Acyl-ACP thioesterase-like
d.39.1.1;DLC
d.40.1.1;CI-2 family of serine protease inhibitors
d.200.1.1;Integrin beta tail domain
d.350.1.1;YcgL-like
d.41.1.1;CO dehydrogenase molybdoprotein N-domain-like
d.41.2.1;NadC N-terminal domain-like
d.41.2.2;Monomeric nicotinate phosphoribosyltransferase N-terminal domain-like
d.41.3.1;Pyrimidine nucleoside phosphorylase C-terminal domain
d.41.4.1;Ribosomal protein L10e
d.41.4.2;Ribosomal protein L16p
d.41.5.1;Molybdopterin synthase subunit MoaE
d.42.1.1;BTB/POZ domain
d.42.1.2;Tetramerization domain of potassium channels
d.43.1.1;Elongation factor Ts (EF-Ts), dimerisation domain
d.43.2.1;Band 7/SPFH domain
d.44.1.1;Fe,Mn superoxide dismutase (SOD), C-terminal domain
d.45.1.1;Ribosomal protein L7/12, C-terminal domain
d.45.1.2;Adaptor protein ClpS (YljA)
d.214.1.1;Hypothetical protein MTH1880
d.47.1.1;Ribosomal L11/L12e N-terminal domain
d.48.1.1;RecA protein, C-terminal domain
d.48.2.1;Anti-lipopolysaccharide factor
d.49.1.1;Signal recognition particle alu RNA binding heterodimer, SRP9/14
d.50.1.1;Double-stranded RNA-binding domain (dsRBD)
d.50.1.3;The homologous-pairing domain of Rad52 recombinase
d.50.1.2;Ribosomal S5 protein, N-terminal domain
d.50.2.1;Porphobilinogen deaminase (hydroxymethylbilane synthase), C-terminal domain
d.50.3.1;PI-Pfui intein middle domain
d.50.3.2;YcfA-like
d.50.3.3;YkfF-like
d.50.4.1;Peptidyl-tRNA hydrolase domain
d.50.5.1;Rv2632c-like
d.270.1.1;2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain
d.351.1.1;NMB0488-like
d.201.1.1;SRP19
d.224.1.1;SufE-like
d.224.1.2;NifU/IscU domain
d.224.1.3;SP1160 C-terminal domain-like
d.352.1.1;FlaG-like
d.353.1.1;AMPKBI-like
d.236.1.1;DNA-binding protein Tfx
d.51.1.1;Eukaryotic type KH-domain (KH-domain type I)
d.52.1.1;Alpha-lytic protease prodomain
d.52.2.1;GMP synthetase C-terminal dimerisation domain
d.52.3.1;Prokaryotic type KH domain (KH-domain type II)
d.52.5.1;Probable GTPase Der, C-terminal domain
d.52.7.1;Ribosome-binding factor A, RbfA
d.52.4.1;YhbC-like, N-terminal domain
d.52.6.1;BolA-like
d.52.8.1;NifU C-terminal domain-like
d.52.8.2;PaaD-like
d.52.9.1;Cation efflux protein cytoplasmic domain-like
d.52.10.1;GSPII protein E N-terminal domain-like
d.218.1.5;Catalytic subunit of bi-partite nucleotidyltransferase
d.218.1.1;Kanamycin nucleotidyltransferase (KNTase), N-terminal domain
d.218.1.3;Poly(A) polymerase, PAP, N-terminal domain
d.218.1.6;2'-5'-oligoadenylate synthetase 1, OAS1, N-terminal domain
d.218.1.7;Archaeal tRNA CCA-adding enzyme catalytic domain
d.218.1.2;DNA polymerase beta-like
d.218.1.4;Poly A polymerase head domain-like
d.218.1.8;RelA/SpoT domain
d.218.1.9;GlnE-like domain
d.218.1.10;RNA editing terminal uridyl transferase 2, RET2, catalytic domain
d.218.1.11;TM1012-like
d.218.1.12;Iojap/YbeB-like
d.218.1.13;AadK N-terminal domain-like
d.218.1.14;GrpB-like
d.307.1.1;Nqo5-like
d.53.1.1;Ribosomal protein S3 C-terminal domain
d.202.1.1;Transcription factor NusA, N-terminal domain
d.54.1.1;Enolase N-terminal domain-like
d.55.1.1;Ribosomal protein L22
d.188.1.1;Prokaryotic ribosomal protein L17
d.56.1.1;GroEL-like chaperone, intermediate domain
d.56.1.2;Group II chaperonin (CCT, TRIC), intermediate domain
d.189.1.1;PX domain
d.354.1.1;Shew3726-like
d.203.1.1;DsrC, the gamma subunit of dissimilatory sulfite reductase
d.57.1.1;DNA damage-inducible protein DinI
d.271.1.1;HSP90 C-terminal domain
d.58.1.1;Short-chain ferredoxins
d.58.1.2;7-Fe ferredoxin
d.58.1.3;Archaeal ferredoxins
d.58.1.4;Single 4Fe-4S cluster ferredoxin
d.58.1.5;Ferredoxin domains from multidomain proteins
d.58.1.6;ETF-QO domain-like
d.58.2.1;Aspartate carbamoyltransferase, Regulatory-chain, N-terminal domain
d.58.3.1;Pancreatic carboxypeptidase, activation domain
d.58.3.2;Subtilase propeptides/inhibitors
d.58.3.3;Prohormone convertase 1 pro-domain
d.58.4.3;Actinorhodin biosynthesis monooxygenase ActVa-Orf6
d.58.4.4;Plant stress-induced protein
d.58.4.5;PG130-like
d.58.4.6;Hypothetical protein YjcS
d.58.4.7;YciI-like
d.58.4.1;Muconalactone isomerase, MLI
d.58.4.2;Lrp/AsnC-like transcriptional regulator C-terminal domain
d.58.4.8;Polyketide synthesis cyclase
d.58.4.9;DGPF domain (Pfam 04946)
d.58.4.10;Chlorite dismutase-like
d.58.4.11;PA3566-like
d.58.4.12;Hypothetical protein YdhR
d.58.4.13;NIPSNAP
d.58.4.14;Dyp-type peroxidase-like
d.58.4.15;EthD-like
d.58.4.16;Atu0297-like
d.58.4.17;SOR-like
d.58.4.18;YbaA-like
d.58.4.19;MmlI-like
d.58.4.20;Marine metagenome family DABB2
d.58.4.21;YiiL-like
d.58.4.22;Marine metagenome family DABB1
d.58.4.23;Marine metagenome family DABB3
d.58.5.1;Prokaryotic signal transducing protein
d.58.5.2;Divalent ion tolerance proteins CutA (CutA1)
d.58.5.4;DUF190/COG1993
d.58.5.3;ATP phosphoribosyltransferase (ATP-PRTase, HisG), regulatory C-terminal domain
d.58.5.5;RPA1041-like
d.58.41.1;SEA domain
d.58.6.1;Nucleoside diphosphate kinase, NDK
d.58.7.1;Canonical RBD
d.58.7.2;Non-canonical RBD domain
d.58.7.3;Splicing factor U2AF subunits
d.58.7.4;Smg-4/UPF3
d.58.7.5;GUCT domain
d.58.8.1;Viral DNA-binding domain
d.58.9.1;Ribulose 1,5-bisphosphate carboxylase-oxygenase
d.58.10.1;Acylphosphatase-like
d.58.10.2;BLUF domain
d.58.11.1;EF-G/eEF-2 domains III and V
d.58.11.2;YigZ C-terminal domain-like
d.58.11.3;Hypothetical protein AF0491, C-terminal domain
d.58.12.1;eEF-1beta-like
d.58.46.1;eEF1-gamma domain
d.58.13.1;Anticodon-binding domain of PheRS
d.58.14.1;Ribosomal protein S6
d.58.15.1;Ribosomal protein S10
d.58.42.1;N-utilization substance G protein NusG, N-terminal domain
d.58.16.1;Poly(A) polymerase, PAP, C-terminal domain
d.58.16.2;Archaeal tRNA CCA-adding enzyme
d.58.17.1;HMA, heavy metal-associated domain
d.58.38.1;Urease metallochaperone UreE, C-terminal domain
d.58.18.1;Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain
d.58.18.2;Allosteric threonine deaminase C-terminal domain
d.58.18.3;Phenylalanine metabolism regulatory domain
d.58.18.4;Nickel responsive regulator NikR, C-terminal domain
d.58.18.5;Glycine cleavage system transcriptional repressor
d.58.18.6;IlvH-like
d.58.18.7;SP0238-like
d.58.18.8;Atu0741-like
d.58.18.9;VC0802-like
d.58.18.10;Aspartokinase allosteric domain-like
d.58.18.11;BT0572-like
d.58.18.12;AF1403 N-terminal domain-like
d.58.18.13;NIL domain-like
d.58.18.14;TM1266-like
d.58.19.1;Bacterial exopeptidase dimerisation domain
d.58.20.1;NAD-binding domain of HMG-CoA reductase
d.58.21.1;Molybdenum cofactor biosynthesis protein C, MoaC
d.58.22.1;TRADD, N-terminal domain
d.58.23.1;Probable ACP-binding domain of malonyl-CoA ACP transacylase
d.58.24.1;CheY-binding domain of CheA
d.58.40.1;D-ribose-5-phosphate isomerase (RpiA), lid domain
d.58.25.1;Killer toxin KP6 alpha-subunit
d.58.47.1;Hypothetical protein VC0424
d.58.50.1;Hypothetical protein TT1725
d.58.43.1;Mechanosensitive channel protein MscS (YggB), C-terminal domain
d.58.26.7;Galactokinase
d.58.26.1;Homoserine kinase
d.58.26.3;Mevalonate kinase
d.58.26.4;Phosphomevalonate kinase (PMK)
d.58.26.2;Mevalonate 5-diphosphate decarboxylase
d.58.26.5;4-(cytidine 5'-diphospho)-2C-methyl-D-erythritol kinase IspE
d.58.26.6;Early switch protein XOL-1
d.58.27.1;Translational regulator protein regA
d.58.28.1;Peptide methionine sulfoxide reductase
d.58.29.1;Adenylyl and guanylyl cyclase catalytic domain
d.58.29.2;GGDEF domain
d.58.30.1;6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, HPPK
d.58.39.1;Glutamyl tRNA-reductase catalytic, N-terminal domain
d.58.48.1;MTH1187-like
d.58.48.2;Putative thiamin/HMP-binding protein YkoF
d.58.31.1;Methyl-coenzyme M reductase gamma chain
d.58.31.2;Methyl-coenzyme M reductase alpha and beta chain N-terminal domain
d.58.32.1;Vanillyl-alcohol oxidase-like
d.58.32.2;D-lactate dehydrogenase
d.58.32.3;Cholesterol oxidase
d.58.32.4;Cytokinin dehydrogenase 1
d.58.33.1;Formylmethanofuran:tetrahydromethanopterin formyltransferase
d.58.34.1;Formiminotransferase domain of formiminotransferase-cyclodeaminase.
d.58.36.1;Duplicated SiR/NiR-like domains 1 and 3
d.58.36.2;DsrA/DsrB N-terminal-domain-like
d.58.44.1;Multidrug efflux transporter AcrB pore domain; PN1, PN2, PC1 and PC2 subdomains
d.58.49.1;YajQ-like
d.58.51.1;eIF-2-alpha, C-terminal domain
d.58.52.1;Sporulation related repeat
d.58.53.1;CRISPR-associated protein
d.58.54.1;YbeD-like
d.58.54.2;HP0495-like
d.58.55.1;DOPA dioxygenase-like
d.58.56.1;CcmK-like
d.58.57.1;Transposase IS200-like
d.58.58.1;TTP0101/SSO1404-like
d.58.59.1;Rpp14/Pop5-like
d.58.60.1;FepE-like
d.58.61.1;MTH889-like
d.58.62.1;Ribosomal protein L10-like
d.284.1.1;PurS subunit of FGAM synthetase
d.284.1.2;FGAM synthase PurL, PurS-like domain
d.355.1.1;RplX-like
d.272.1.1;Dystroglycan, domain 2
d.265.1.1;Pseudouridine synthase I TruA
d.265.1.2;Pseudouridine synthase II TruB
d.265.1.3;Pseudouridine synthase RsuA/RluD
d.265.1.4;tRNA pseudouridine synthase TruD
d.356.1.1;SP0830-like
d.250.1.1;Aminomethyltransferase folate-binding domain
d.250.1.2;TrmE formyl-THF-binding domain
d.308.1.1;THUMP domain
d.308.1.2;PAE0736-like
d.308.1.3;Minimal THUMP
d.309.1.1;AMMECR1-like
d.357.1.1;NosL-like
d.357.1.2;MerB-like
d.291.1.1;YehU-like
d.251.1.1;Hypothetical protein YwqG
d.310.1.1;VC0467-like
d.240.1.1;Lesion bypass DNA polymerase (Y-family), little finger domain
d.311.1.1;ImmE5-like
d.59.1.1;Ribosomal protein L30p/L7e
d.190.1.1;Chorismate lyase
d.190.1.2;UTRA domain
d.190.1.3;AF1396-like
d.358.1.1;YdfO-like
d.312.1.1;TM1622-like
d.359.1.1;BH3703-like
d.60.1.3;Gyrase inhibitory protein GyrI (SbmC, YeeB)
d.60.1.1;Multidrug-binding domain of transcription activator BmrR
d.60.1.2;Rob transcription factor, C-terminal domain
d.60.1.4;SOUL heme-binding protein
d.252.1.1;CheC-like
d.61.1.1;tRNA splicing product Appr>p cyclic nucleotide phosphodiesterase
d.61.1.2;2'-5' RNA ligase LigT
d.61.1.3;2',3'-cyclic nucleotide 3'-phosphodiesterase, catalytic domain
d.61.1.4;Atu0111-like
d.62.1.1;Pepsin inhibitor-3
d.63.1.1;mRNA triphosphatase CET1
d.63.1.2;CYTH domain
d.313.1.1;Prenyltransferase-like
d.64.1.1;eIF1-like
d.64.2.1;TM1457-like
d.65.1.1;Muramoyl-pentapeptide carboxypeptidase
d.65.1.3;MepA-like
d.65.1.4;VanX-like
d.65.1.2;Hedgehog (development protein), N-terminal signaling domain
d.65.1.5;VanY-like
d.66.1.2;Ribosomal protein S4
d.66.1.3;Heat shock protein 15 kD
d.66.1.4;Tyrosyl-tRNA synthetase (TyrRS), C-terminal domain
d.66.1.6;YbcJ-like
d.66.1.5;Pseudouridine synthase RsuA N-terminal domain
d.67.1.1;Threonyl-tRNA synthetase (ThrRS), second 'additional' domain
d.67.1.2;AlaX-like
d.67.2.1;Arginyl-tRNA synthetase (ArgRS), N-terminal 'additional' domain
d.67.3.1;Ribosome recycling factor, RRF
d.67.4.1;General secretion pathway protein M, EpsM
d.185.1.2;Autoinducer-2 production protein LuxS
d.185.1.1;MPP-like
d.68.1.1;Translation initiation factor IF3, C-terminal domain
d.68.4.1;YhbY-like
d.68.3.3;SirA-like
d.68.6.1;DNA-binding protein AlbA
d.68.6.2;Hypothetical protein At2g34160
d.68.5.1;C-terminal domain of ProRS
d.68.7.1;R3H domain
d.68.2.1;RNA 3'-terminal phosphate cyclase, RPTC
d.68.2.2;Enolpyruvate transferase, EPT
d.68.8.1;Smr domain
d.314.1.1;PUG domain
d.360.1.1;PG1857-like
d.361.1.1;PB2 C-terminal domain-like
d.204.1.1;Ribosome binding protein Y (YfiA homologue)
d.212.1.1;TolA
d.212.1.2;TonB
d.70.1.1;Virally encoded KP4 toxin
d.70.1.2;SMK toxin
d.71.1.1;Cell division protein MinE topological specificity domain
d.253.1.1;Hypothetical protein YoaG
d.362.1.1;BLRF2-like
d.254.1.1;Arterivirus nucleocapsid protein
d.254.1.2;Coronavirus nucleocapsid protein
d.72.1.1;Cyanase C-terminal domain
d.225.1.1;Multidrug efflux transporter AcrB TolC docking domain; DN and DC subdomains
d.73.1.1;RuBisCO, small subunit
d.74.1.1;PCD-like
d.74.2.1;C-terminal domain of arginine repressor
d.74.3.2;RBP11/RpoL
d.74.3.1;RNA polymerase alpha subunit dimerisation domain
d.74.4.1;GAD domain
d.74.4.2;PH0730 C-terminal domain-like
d.74.5.1;PH0987 N-terminal domain-like
d.315.1.1;TRCF domain
d.363.1.1;NMB0513-like
d.364.1.1;PA1123-like
d.263.1.1;Hypothetical protein Yml108w
d.75.1.1;tRNA-intron endonuclease N-terminal domain-like
d.75.2.1;DNA repair protein MutS, domain I
d.76.1.1;GYF domain
d.76.2.1;BRK domain-like
d.205.1.1;GTP cyclohydrolase I feedback regulatory protein, GFRP
d.77.1.1;Ribosomal protein L5
d.77.1.2;SSO1042-like
d.78.1.1;RPB5
d.79.1.1;YjgF/L-PSP
d.79.1.2;Chorismate mutase
d.79.5.1;IpsF-like
d.79.2.1;Tubulin, C-terminal domain
d.79.3.1;L30e/L7ae ribosomal proteins
d.79.3.3;RNA 2'-O ribose methyltransferase substrate binding domain
d.79.3.2;ERF1/Dom34 C-terminal domain-like
d.79.4.1;PurM N-terminal domain-like
d.79.6.1;Holliday junction resolvase RusA
d.79.7.1;OmpA-like
d.79.8.1;YueI-like
d.79.9.1;BB2672-like
d.273.1.1;YjbQ-like
d.80.1.1;4-oxalocrotonate tautomerase-like
d.80.1.2;5-carboxymethyl-2-hydroxymuconate isomerase (CHMI)
d.80.1.3;MIF-related
d.80.1.4;Hypothetical protein HI1388.1
d.80.1.5;VC0714-like
d.80.1.6;MSAD-like
d.81.1.1;GAPDH-like
d.81.1.2;Homoserine dehydrogenase-like
d.81.1.3;Dihydrodipicolinate reductase-like
d.81.1.4;Biliverdin reductase
d.81.1.5;Glucose 6-phosphate dehydrogenase-like
d.81.2.1;Serine dehydratase beta chain-like
d.81.2.2;SerA intervening domain-like
d.81.3.1;FwdE-like
d.81.4.1;V-type ATPase subunit E
d.365.1.1;Ava3019-like
d.274.1.1;Hypothetical protein PF0899
d.183.1.1;Major capsid protein gp5
d.316.1.1;MK0786-like
d.317.1.1;YkuJ-like
d.82.1.1;Copper amine oxidase, domain N
d.82.2.1;Frataxin-like
d.82.2.2;Nqo15-like
d.82.3.1;Hypothetical protein c14orf129, hspc210
d.82.4.1;GAS2 domain
d.82.5.1;GK1464-like
d.83.2.1;Activator of Hsp90 ATPase, Aha1
d.83.1.1;Bactericidal permeability-increasing protein, BPI
d.366.1.1;SpoVG-like
d.84.1.1;Subtilisin inhibitor
d.85.1.1;RNA bacteriophage capsid protein
d.86.1.1;Translation initiation factor eIF4e
d.86.1.2;BLES03-like
d.87.1.1;FAD/NAD-linked reductases, dimerisation (C-terminal) domain
d.87.2.1;CO dehydrogenase flavoprotein C-terminal domain-like
d.88.1.1;SRF-like
d.89.1.1;The origin DNA-binding domain of SV40 T-antigen
d.89.1.4;DNA-binding domain of REP protein
d.89.1.2;Replication initiation protein E1
d.89.1.3;Replication protein Rep, nuclease domain
d.89.1.5;Relaxase domain
d.318.1.1;SARS receptor-binding domain-like
d.275.1.1;Hut operon positive regulatory protein HutP
d.276.1.1;Hypothetical protein yfbM
d.319.1.1;TTHA1528-like
d.320.1.1;YojJ-like
d.321.1.1;STIV B116-like
d.277.1.1;Bacillus phage protein
d.90.1.1;NADH oxidase/flavin reductase
d.90.1.2;Putative nitroreductase TM1586
d.91.1.1;N-terminal domain of eukaryotic peptide chain release factor subunit 1, ERF1
d.367.1.1;EscU C-terminal domain-like
d.92.1.1;Zinc protease
d.92.1.12;Fungal zinc peptidase
d.92.1.2;Thermolysin-like
d.92.1.13;Leukotriene A4 hydrolase catalytic domain
d.92.1.4;Neutral endopeptidase (neprilysin)
d.92.1.5;Neurolysin-like
d.92.1.14;Anthrax toxin lethal factor, N- and C-terminal domains
d.92.1.3;Leishmanolysin
d.92.1.6;Serralysin-like metalloprotease, catalytic (N-terminal) domain
d.92.1.7;Clostridium neurotoxins, catalytic domain
d.92.1.8;Astacin
d.92.1.9;Reprolysin-like
d.92.1.10;TNF-alpha converting enzyme, TACE, catalytic domain
d.92.1.11;Matrix metalloproteases, catalytic domain
d.92.1.15;Predicted metal-dependent hydrolase
d.92.1.16;Caur0242-like
d.92.1.17;TTHA0227-like
d.92.2.1;beta-N-acetylhexosaminidase domain
d.92.2.2;alpha-D-glucuronidase, N-terminal domain
d.92.2.3;Hyaluronidase N-terminal domain-like
d.93.1.1;SH2 domain
d.94.1.1;HPr-like
d.94.2.1;Putative transcriptional regulator TM1602, C-terminal domain
d.286.1.1;TrkA C-terminal domain-like
d.237.1.1;Hypothetical protein YjiA, C-terminal domain
d.206.1.1;YggU-like
d.95.1.1;Glucose permease domain IIB
d.95.2.1;Group I mobile intron endonuclease
d.95.2.2;Intein endonuclease
d.96.1.1;GTP cyclohydrolase I
d.96.1.2;6-pyruvoyl tetrahydropterin synthase
d.96.1.3;DHN aldolase/epimerase
d.96.1.4;Urate oxidase (uricase)
d.96.2.1;ApbE-like
d.96.2.2;DVU1097-like
d.97.1.1;Cell cycle regulatory proteins
d.368.1.1;Yonk-like
d.98.1.1;beta-lactamase-inhibitor protein, BLIP
d.98.2.1;BT0923-like
d.99.1.1;Ribosomal protein L9 C-domain
d.100.1.1;Ribosomal protein L9 N-domain
d.100.1.2;N-terminal domain of RNase HI
d.100.2.1;MbtH-like
d.255.1.1;Tombusvirus P19 core protein, VP19
d.101.1.1;Ribonuclease PH domain 2-like
d.102.1.1;Regulatory factor Nef
d.103.1.1;CytB endotoxin-like
d.104.1.1;Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain
d.104.1.2;Biotin holoenzyme synthetase
d.104.1.3;LplA-like
d.104.1.4;PH0223-like
d.105.1.1;Clathrin adaptor appendage, alpha and beta chain-specific domain
d.105.1.2;Coatomer appendage domain
d.106.1.1;Sterol carrier protein, SCP
d.106.1.2;Micothiol-dependent maleylpyruvate isomerase C-terminal domain-like
d.106.1.3;Alkylsulfatase C-terminal domain-like
d.106.1.4;EF1021 C-terminal domain-like
d.256.1.1;Ta1353-like
d.107.1.1;Ran-binding protein mog1p
d.107.1.2;PsbP-like
d.107.1.3;PA0094-like
d.107.1.4;DIP2269-like
d.369.1.1;SMI1/KNR4-like
d.108.1.1;N-acetyl transferase, NAT
d.108.1.2;N-myristoyl transferase, NMT
d.108.1.3;Autoinducer synthetase
d.108.1.4;FemXAB nonribosomal peptidyltransferases
d.108.1.5;Hypothetical protein cg14615-pa
d.108.1.6;LFTR-like
d.108.1.7;Ornithine decarboxylase antizyme-like
d.108.1.8;AstA-like
d.108.1.9;Aq 1966-like
d.108.1.10;EF1021-like
d.109.1.1;Gelsolin-like
d.109.1.2;Cofilin-like
d.109.2.1;C-terminal, gelsolin-like domain of Sec23/24
d.109.3.1;FLJ32549 C-terminal domain-like
d.322.1.1;Janus/Ocnus
d.322.1.2;PPK middle domain-like
d.110.1.1;Profilin (actin-binding protein)
d.110.2.1;GAF domain
d.110.2.2;IclR ligand-binding domain-like
d.110.2.3;HrcA C-terminal domain-like
d.110.2.4;Phytochrome-specific domain
d.110.3.1;PYP-like
d.110.3.2;Heme-binding PAS domain
d.110.3.6;Flavin-binding PAS domain
d.110.3.5;N-terminal PAS domain of Pas kinase
d.110.3.7;Hypoxia-inducible factor Hif2a, C-terminal domain
d.110.3.8;PAS domain of steroid receptor coactivator 1A, NCo-A1
d.110.3.9;BphP N-terminal domain-like
d.110.5.1;Pheromone-binding domain of LuxR-like quorum-sensing transcription factors
d.110.6.1;Sensory domain of two-component sensor kinase
d.110.6.2;YkuI C-terminal domain-like
d.110.6.3;LuxQ-periplasmic domain-like
d.110.4.1;Synatpobrevin N-terminal domain
d.110.4.3;Sedlin (SEDL)
d.110.4.2;Clathrin coat assembly domain
d.110.4.4;SRP alpha N-terminal domain-like
d.110.7.1;Roadblock/LC7 domain
d.110.8.1;YagB/YeeU/YfjZ-like
d.110.9.1;GlcG-like
d.110.10.1;YNR034W-A-like
d.278.1.1;H-NOX domain
d.278.1.2;TRAPP components
d.278.1.3;MJ1460-like
d.323.1.1;Lambda phage gpU-like
d.323.1.2;STM4215-like
d.111.1.1;PR-1-like
d.112.1.1;IIA domain of mannitol-specific and ntr phosphotransferase EII
d.112.1.2;Anion transport protein, cytoplasmic domain
d.113.1.1;MutT-like
d.113.1.3;MutY C-terminal domain-like
d.113.1.4;NADH pyrophosphatase
d.113.1.2;IPP isomerase-like
d.113.1.5;GDP-mannose mannosyl hydrolase NudD
d.113.1.6;BT0354 N-terminal domain-like
d.113.1.7;mRNA decapping enzyme-like
d.114.1.1;5'-nucleotidase (syn. UDP-sugar hydrolase), C-terminal domain
d.115.1.1;YrdC-like
d.115.1.2;3,4-dihydroxy-2-butanone 4-phosphate synthase, DHBP synthase, RibB
d.226.1.1;GIY-YIG endonuclease
d.116.1.1;YbaK/ProRS associated domain
d.117.1.1;Thymidylate synthase/dCMP hydroxymethylase
d.207.1.1;Thymidylate synthase-complementing protein Thy1
d.118.1.1;N-acetylmuramoyl-L-alanine amidase-like
d.120.1.1;Cytochrome b5
d.120.1.2;Steroid-binding domain
d.370.1.1;BTG domain-like
d.324.1.1;DUSP, domain in ubiquitin-specific proteases
d.121.1.1;Vaccinia DNA topoisomerase I, 9 kDa N-terminal fragment
d.122.1.1;Heat shock protein 90, HSP90, N-terminal domain
d.122.1.2;DNA gyrase/MutL, N-terminal domain
d.122.1.3;Histidine kinase
d.122.1.4;alpha-ketoacid dehydrogenase kinase, C-terminal domain
d.371.1.1;YehR-like
d.123.1.1;Sporulation response regulatory protein Spo0B
d.124.1.1;Ribonuclease Rh-like
d.192.1.1;YlxR-like
d.279.1.1;YggX-like
d.325.1.1;Ribosomal protein L28
d.325.1.2;Ribosomal protein L31p
d.372.1.1;YqaI-like
d.125.1.1;Ornithine decarboxylase C-terminal domain
d.126.1.1;Ribosome anti-association factor eIF6 (aIF6)
d.126.1.2;Amidinotransferase
d.126.1.3;Dimethylarginine dimethylaminohydrolase DDAH
d.126.1.4;Arginine deiminase
d.126.1.5;Peptidylarginine deiminase Pad4, catalytic C-terminal domain
d.126.1.6;Porphyromonas-type peptidylarginine deiminase
d.126.1.7;Succinylarginine dihydrolase-like
d.127.1.1;Creatinase/aminopeptidase
d.373.1.1;gpW/gp25-like
d.128.1.1;Glutamine synthetase catalytic domain
d.128.1.2;Guanido kinase catalytic domain
d.128.1.3;Glutamate-cysteine ligase family 2 (GCS2)
d.128.1.4;Glutamate-cysteine ligase
d.128.1.5;GatB/GatE catalytic domain-like
d.129.1.1;TATA-box binding protein (TBP), C-terminal domain
d.129.1.2;DNA repair glycosylase, N-terminal domain
d.129.5.1;MoaD-related protein, C-terminal domain
d.129.6.1;Kinase associated domain 1, KA1
d.129.6.2;Ssp2 C-terminal domain-like
d.129.7.1;TT1751-like
d.129.4.1;Cell-division protein ZipA, C-terminal domain
d.129.2.1;Phosphoglucomutase, C-terminal domain
d.129.3.1;Pathogenesis-related protein 10 (PR10)-like
d.129.3.2;STAR domain
d.129.3.4;Phoshatidylinositol transfer protein, PITP
d.129.3.3;Ring hydroxylating alpha subunit catalytic domain
d.129.3.5;AHSA1 domain
d.129.3.6;oligoketide cyclase/dehydrase-like
d.129.3.7;PA1206-like
d.129.3.8;Atu1531-like
d.129.3.9;Smu440-like
d.129.3.10;CoxG-like
d.129.8.1;Rbstp2229 protein
d.129.9.1;RalF, C-terminal domain
d.129.10.1;YwmB-like
d.129.11.1;YugN-like
d.326.1.1;XisI-like
d.130.1.1;S-adenosylmethionine synthetase
d.131.1.1;DNA polymerase III, beta subunit
d.131.1.2;DNA polymerase processivity factor
d.257.1.1;Hypothetical protein TM0160
d.374.1.1;TTHC002-like
d.133.1.1;Molybdenum cofactor-binding domain
d.375.1.1;NE1680-like
d.134.1.1;Nitrite and sulphite reductase 4Fe-4S domain-like
d.327.1.1;DeoB insert domain-like
d.135.1.1;The spindle assembly checkpoint protein mad2
d.136.1.1;Nuclease
d.136.1.2;Phospholipase D
d.136.1.3;Tyrosyl-DNA phosphodiesterase TDP1
d.136.1.4;Polyphosphate kinase C-terminal domain
d.136.1.5;TrmB middle domain-like
d.328.1.1;CorA soluble domain-like
d.137.1.1;Monooxygenase (hydroxylase) regulatory protein
d.139.1.1;PurM C-terminal domain-like
d.329.1.1;PF0523-like
d.258.1.1;Chorismate synthase, AroC
d.193.1.1;Hsp33 domain
d.208.1.1;MTH1598-like
d.197.1.1;Protein-L-isoaspartyl O-methyltransferase, C-terminal domain
d.227.1.1;Ohr/OsmC resistance proteins
d.227.1.2;YhfA-like
d.259.1.1;Hypothetical protein HI1480
d.330.1.1;ERH-like
d.140.1.1;Ribosomal protein S8
d.141.1.1;Ribosomal protein L6
d.331.1.1;NE0471 N-terminal domain-like
d.376.1.1;Lp2179-like
d.332.1.1;RGC domain
d.215.1.1;Smc hinge domain
d.292.1.1;DNA mismatch repair protein MutL
d.142.1.1;ATP-binding domain of peptide synthetases
d.142.1.7;Lysine biosynthesis enzyme LysX ATP-binding domain
d.142.1.2;BC ATP-binding domain-like
d.142.1.3;Synapsin C-terminal domain
d.142.1.4;Succinyl-CoA synthetase, beta-chain, N-terminal domain
d.142.1.5;Pyruvate phosphate dikinase, N-terminal domain
d.142.1.6;Eukaryotic glutathione synthetase ATP-binding domain
d.142.1.8;Glutathionylspermidine synthase ATP-binding domain-like
d.142.1.9;PurP ATP-binding domain-like
d.142.2.1;ATP-dependent DNA ligase catalytic domain
d.142.2.2;Adenylation domain of NAD+-dependent DNA ligase
d.142.2.3;mRNA capping enzyme
d.142.2.4;RNA ligase
d.143.1.1;SAICAR synthase
d.143.1.2;Phosphatidylinositol phosphate kinase IIbeta, PIPK IIbeta
d.143.1.3;Inositol polyphosphate kinase (IPK)
d.144.1.7;Protein kinases, catalytic subunit
d.144.1.3;Actin-fragmin kinase, catalytic domain
d.144.1.5;MHCK/EF2 kinase
d.144.1.4;Phoshoinositide 3-kinase (PI3K), catalytic domain
d.144.1.8;Choline kinase
d.144.1.6;APH phosphotransferases
d.144.1.9;RIO1-like kinases
d.145.1.1;FAD-linked oxidases, N-terminal domain
d.145.1.2;Uridine diphospho-N-Acetylenolpyruvylglucosamine reductase (MurB), N-terminal domain
d.145.1.3;CO dehydrogenase flavoprotein N-terminal domain-like
d.145.1.4;CorC/HlyC domain-like
d.146.1.1;Uridine diphospho-N-Acetylenolpyruvylglucosamine reductase, MurB, C-terminal domain
d.147.1.1;Methenyltetrahydromethanopterin cyclohydrolase
d.264.1.1;PriA-like
d.264.1.2;Bifunctional DNA primase/polymerase N-terminal domain
d.264.1.3;HP0184-like
d.148.1.1;Hect, E3 ligase catalytic domain
d.149.1.1;Nitrile hydratase alpha chain
d.150.1.2;Holo-(acyl carrier protein) synthase ACPS
d.150.1.1;4'-Phosphopantetheinyl transferase SFP
d.151.1.1;DNase I-like
d.151.1.2;Inositol polyphosphate 5-phosphatase (IPP5)
d.151.1.3;Sphingomyelin phosphodiesterase-like
d.152.1.1;Aldehyde ferredoxin oxidoreductase, N-terminal domain
d.153.1.1;Class II glutamine amidotransferases
d.153.1.2;Penicillin acylase, catalytic domain
d.153.1.3;Penicillin V acylase
d.153.1.4;Proteasome subunits
d.153.1.5;(Glycosyl)asparaginase
d.153.1.6;Gamma-glutamyltranspeptidase-like
d.153.1.7;SPO2555-like
d.153.2.1;Archaeal IMP cyclohydrolase PurO
d.154.1.1;DmpA-like
d.154.1.2;ArgJ-like
d.155.1.2;Arginine decarboxylase
d.155.1.1;Histidine decarboxylase
d.156.1.1;S-adenosylmethionine decarboxylase
d.156.1.2;Bacterial S-adenosylmethionine decarboxylase
d.157.1.1;Zn metallo-beta-lactamase
d.157.1.4;Hypothetical protein TM0207
d.157.1.2;Glyoxalase II (hydroxyacylglutathione hydrolase)
d.157.1.3;ROO N-terminal domain-like
d.157.1.5;Methyl parathion hydrolase
d.157.1.6;Coenzyme PQQ synthesis protein B, PqqB
d.157.1.7;RNase Z-like
d.157.1.8;Pce catalytic domain-like
d.157.1.9;YhfI-like
d.157.1.10;beta-CASP RNA-metabolising hydrolases
d.157.1.11;TM0894-like
d.157.1.12;Ava3068-like
d.157.1.13;Alkylsulfatase-like
d.157.1.14;PqsE-like
d.219.1.1;PP2C-like
d.159.1.1;Purple acid phosphatase-like
d.159.1.4;DNA double-strand break repair nuclease
d.159.1.2;5'-nucleotidase (syn. UDP-sugar hydrolase), N-terminal domain
d.159.1.3;Protein serine/threonine phosphatase
d.159.1.5;Phosphoesterase-related
d.159.1.6;TT1561-like
d.159.1.7;YfcE-like
d.159.1.8;Hypothetical protein aq 1666
d.159.1.9;DR1281-like
d.159.1.10;TTHA0625-like
d.159.1.11;GpdQ-like
d.159.1.12;ADPRibase-Mn-like
d.160.1.1;Nitrilase
d.160.1.2;Carbamilase
d.194.1.1;Type 1 cytotoxic necrotizing factor, catalytic domain
d.194.1.2;YfiH-like
d.194.1.3;CheD-like
d.161.1.1;ADC synthase
d.280.1.1;Sulfolobus fructose-1,6-bisphosphatase-like
d.162.1.1;Lactate & malate dehydrogenases, C-terminal domain
d.162.1.2;AglA-like glucosidase
d.163.1.1;Lambda integrase-like, catalytic core
d.163.1.2;Eukaryotic DNA topoisomerase I, catalytic core
d.228.1.1;Replication modulator SeqA, C-terminal DNA-binding domain
d.164.1.1;SMAD MH1 domain
d.195.1.1;YopH tyrosine phosphatase N-terminal domain
d.216.1.1;Rotavirus NSP2 fragment, N-terminal domain
d.377.1.1;Rv2827c C-terminal domain-like
d.378.1.1;Phosphoprotein oligomerization domain-like
d.379.1.1;Taf5 N-terminal domain-like
d.380.1.1;Jann2411-like
d.381.1.1;ATP12-like
d.165.1.1;Plant cytotoxins
d.165.1.2;Shiga toxin, A-chain
d.166.1.1;ADP-ribosylating toxins
d.166.1.3;Ecto-ART
d.166.1.2;Poly(ADP-ribose) polymerase, C-terminal domain
d.166.1.4;AvrPphF ORF2, a type III effector
d.166.1.5;Tpt1/KptA
d.166.1.6;BC2332-like
d.166.1.7;CC0527-like
d.167.1.1;Peptide deformylase
d.209.1.1;LCCL domain
d.168.1.1;Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain
d.169.1.1;C-type lectin domain
d.169.1.2;Aerolysin/Pertussis toxin (APT) domain
d.169.1.3;Invasin/intimin cell-adhesion fragment, C-terminal domain
d.169.1.4;Link domain
d.169.1.5;Endostatin
d.169.1.6;Noncollagenous (NC1) domain of collagen IV
d.169.1.7;Sulfatase-modifying factor-like
d.169.1.8;Mtd variable domain
d.281.1.1;Hemolytic lectin CEL-III, C-terminal domain
d.170.1.1;Scavenger receptor cysteine-rich (SRCR) domain
d.170.1.2;Hepsin, N-terminal domain
d.170.2.1;A heparin-binding domain
d.171.1.1;Fibrinogen C-terminal domain-like
d.172.1.1;gp120 core
d.173.1.1;Methionine synthase SAM-binding domain
d.173.1.2;Hypothetical protein TM0269
d.333.1.1;UbiD C-terminal domain-like
d.238.1.1;Hypothetical protein TM0875
d.220.1.1;Metal cation-transporting ATPase, ATP-binding domain N
d.260.1.1;Suppressor of Fused, N-terminal domain
d.174.1.1;Nitric oxide (NO) synthase oxygenase domain
d.175.1.1;Penicillin binding protein dimerisation domain
d.176.1.1;Oxidoreductase molybdopterin-binding domain
d.177.1.1;FAH
d.178.1.1;Aromatic aminoacid monoxygenases, catalytic and oligomerization domains
d.179.1.1;Substrate-binding domain of HMG-CoA reductase
d.210.1.1;Argininosuccinate synthetase, C-terminal domain
d.261.1.1;Hypothetical protein PH1602
d.334.1.1;lvD/EDD N-terminal domain-like
d.287.1.1;TaqI C-terminal domain-like
d.287.1.2;Type I restriction modification DNA specificity domain
d.239.1.1;GCM domain
d.180.1.1;Conserved core of transcriptional regulatory protein vp16
d.181.1.1;Insert subdomain of RNA polymerase alpha subunit
d.182.1.1;Baseplate structural protein gp11
d.231.1.1;Receptor-binding domain of short tail fibre protein gp12
d.196.1.1;Outer capsid protein sigma 3
d.293.1.1;Phosphoprotein M1, C-terminal domain
d.335.1.1;L,D-transpeptidase pre-catalytic domain-like
d.336.1.1;YbiA-like
d.262.1.1;NinB
d.337.1.1;AF2331-like
d.282.1.1;SSo0622-like
d.283.1.1;Putative modulator of DNA gyrase, PmbA/TldD
d.382.1.1;PSTPO5379-like
d.383.1.1;PG1388-like
d.338.1.1;Oxysterol-binding protein
d.339.1.1;ORC1-binding domain
d.340.1.1;CofE-like
d.341.1.1;Peptidoglycan deacetylase N-terminal noncatalytic region
d.184.1.1;Phycoerythrin 545 alpha-subunits
d.184.1.2;Virulence effector SptP domain
d.184.1.3;Ubiquinol-cytochrome c reductase 8 kDa protein
e.1.1.1;Serpins
e.59.1.1;FdhE-like
e.64.1.1;FlhC-like
e.2.1.1;Replication terminator protein (Tus)
e.65.1.1;VPA0735-like
e.44.1.1;2-methylcitrate dehydratase PrpD
e.45.1.1;Antivirulence factor
e.66.1.1;Api92-like
e.67.1.1;PH0156-like
e.68.1.1;YacF-like
e.46.1.1;Virulence-associated V antigen
e.5.1.1;Heme-dependent catalases
e.5.1.2;Allene oxide synthase
e.6.1.1;Medium chain acyl-CoA dehydrogenase, NM (N-terminal and middle) domains
e.6.1.2;acyl-CoA oxidase N-terminal domains
e.7.1.1;Inositol monophosphatase/fructose-1,6-bisphosphatase-like
e.7.1.2;GlpX-like bacterial fructose-1,6-bisphosphatase
e.8.1.1;DNA polymerase I
e.8.1.7;Lesion bypass DNA polymerase (Y-family), catalytic domain
e.8.1.2;Reverse transcriptase
e.8.1.3;T7 RNA polymerase
e.8.1.4;RNA-dependent RNA-polymerase
e.8.1.6;dsRNA phage RNA-dependent RNA-polymerase
e.29.1.1;RNA-polymerase beta
e.29.1.2;RNA-polymerase beta-prime
e.69.1.1;Poxvirus poly(A) polymerase catalytic subunit-like
e.41.1.1;Adenylylcyclase toxin (the edema factor)
e.10.1.1;Prokaryotic type I DNA topoisomerase
e.11.1.1;Type II DNA topoisomerase
e.12.1.1;DNA topoisomerase IV, alpha subunit
e.13.1.1;DNA primase DnaG catalytic core
e.13.1.2;Primase fragment of primase-helicase protein
e.49.1.1;Recombination protein RecR
e.15.1.1;Eukaryotic DNA topoisomerase I, N-terminal DNA-binding fragment
e.17.1.1;D-aminoacid aminotransferase-like PLP-dependent enzymes
e.18.1.1;Nickel-iron hydrogenase, large subunit
e.18.1.2;Nqo4-like
e.19.1.1;Nickel-iron hydrogenase, small subunit
e.19.1.2;Nq06-like
e.22.1.1;Dehydroquinate synthase, DHQS
e.22.1.2;Iron-containing alcohol dehydrogenase
e.37.1.1;Siroheme synthase middle domains-like
e.23.1.1;Acetyl-CoA synthetase-like
e.24.1.1;Ribosomal protein L1
e.38.1.1;Release factor
e.56.1.1;YaeB-like
e.70.1.1;MalF N-terminal region-like
e.39.1.1;YebC-like
e.40.1.1;Cullin homology domain
e.25.1.1;Sec1/munc18-like (SM) proteins
e.26.1.2;Carbon monoxide dehydrogenase
e.26.1.1;Hybrid cluster protein (prismane protein)
e.26.1.3;Acetyl-CoA synthase
e.43.1.1;Capz alpha-1 subunit
e.43.1.2;Capz beta-1 subunit
e.3.1.1;beta-Lactamase/D-ala carboxypeptidase
e.3.1.2;Glutaminase
e.3.1.3;Dac-like
e.27.1.1;Upper collar protein gp10 (connector protein)
e.71.1.1;AF1531-like
e.32.1.1;Phase 1 flagellin
e.47.1.1;39 kda initiator binding protein, IBP39, C-terminal domains
e.50.1.1;AF1104-like
e.72.1.1;Cas DxTHG
e.51.1.1;Urocanase
e.52.1.1;NAD kinase-like
e.52.1.2;Diacylglycerol kinase-like
e.53.1.1;QueA-like
e.54.1.1;CbiD-like
e.55.1.1;Rap/Ran-GAP
e.57.1.1;Vacuolar ATP synthase subunit C
e.60.1.1;Thermophilic metalloprotease (M29)
e.61.1.1;ImpE-like
e.73.1.1;CV3147-like
e.62.1.1;HemS/ChuS-like
e.62.1.2;ChuX-like
e.74.1.1;HI0933 insert domain-like
e.34.1.1;NSP3 homodimer
e.63.1.1;DP dimerization segment
e.63.1.2;E2F dimerization segment
e.35.1.1;Membrane penetration protein mu1
e.75.1.1;Flu NP-like
e.76.1.1;Glycoprotein B-like
e.76.1.2;Spike glycoprotein-like
e.28.1.1;Orbivirus core
e.28.1.2;Phytoreovirus core
e.42.1.1;L-A virus major coat protein
e.48.1.1;Major capsid protein VP5
e.58.1.1;Viral ssDNA binding protein
f.1.1.1;Colicin
f.1.2.1;Diphtheria toxin, middle domain
f.1.3.1;delta-Endotoxin (insectocide), N-terminal domain
f.1.4.1;Bcl-2 inhibitors of programmed cell death
f.1.5.1;Exotoxin A, middle domain
f.13.1.1;Bacteriorhodopsin-like
f.13.1.2;Rhodopsin-like
f.23.10.1;Photosystem II reaction centre subunit H, transmembrane region
f.23.1.1;Mitochondrial cytochrome c oxidase subunit IV
f.23.2.1;Mitochondrial cytochrome c oxidase subunit VIa
f.23.3.1;Mitochondrial cytochrome c oxidase subunit VIc
f.23.4.1;Mitochondrial cytochrome c oxidase subunit VIIa
f.23.5.1;Mitochondrial cytochrome c oxidase subunit VIIb
f.23.6.1;Mitochondrial cytochrome c oxidase subunit VIIc (aka VIIIa)
f.23.7.1;Mitochondrial cytochrome c oxidase subunit VIIIb (aka IX)
f.23.8.1;Bacterial aa3 type cytochrome c oxidase subunit IV
f.23.9.1;Bacterial ba3 type cytochrome c oxidase subunit IIa
f.23.21.1;F1F0 ATP synthase subunit B, membrane domain
f.23.11.1;Cytochrome c1 subunit of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase), transmembrane anchor
f.23.12.1;ISP transmembrane anchor
f.23.13.1;Ubiquinone-binding protein QP-C of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.23.14.1;Subunit X (non-heme 7 kDa protein) of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.23.15.1;Subunit XI (6.4 kDa protein) of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.23.16.1;Subunit III of photosystem I reaction centre, PsaF
f.23.17.1;Subunit VIII of photosystem I reaction centre, PsaI
f.23.18.1;Subunit IX of photosystem I reaction centre, PsaJ
f.23.19.1;Subunit XII of photosystem I reaction centre, PsaM
f.23.20.1;Subunit PsaX of photosystem I reaction centre
f.23.22.1;Iron-sulfur subunit of formate dehydrogenase N, transmembrane anchor
f.23.23.1;Cytochrome f subunit of the cytochrome b6f complex, transmembrane anchor
f.23.24.1;PetL subunit of the cytochrome b6f complex
f.23.25.1;PetM subunit of the cytochrome b6f complex
f.23.26.1;PetG subunit of the cytochrome b6f complex
f.23.27.1;PetN subunit of the cytochrome b6f complex
f.23.28.1;Preprotein translocase SecE subunit
f.23.29.1;Sec-beta subunit
f.23.30.1;Oligosaccharyltransferase subunit ost4p
f.23.31.1;PsbL-like
f.23.32.1;PsbJ-like
f.23.33.1;PsbH-like
f.23.34.1;PsbT-like
f.23.35.1;PsbM-like
f.23.36.1;PsbK-like
f.23.37.1;PsbI-like
f.23.38.1;Cytochrome b559 subunits
f.26.1.1;Bacterial photosystem II reaction centre, L and M subunits
f.24.1.1;Cytochrome c oxidase subunit I-like
f.25.1.1;Cytochrome c oxidase subunit III-like
f.17.2.1;Cytochrome c oxidase subunit II-like, transmembrane region
f.17.1.1;F1F0 ATP synthase subunit C
f.17.3.1;Magnesium transport protein CorA, transmembrane region
f.17.4.1;Htr2 transmembrane domain-like
f.17.5.1;PsbZ-like
f.18.1.1;F1F0 ATP synthase subunit A
f.52.1.1;ATP synthase B chain-like
f.53.1.1;ATP synthase D chain-like
f.19.1.1;Aquaporin-like
f.44.1.1;Ammonium transporter
f.38.1.1;Glycerol-3-phosphate transporter
f.38.1.2;LacY-like proton/sugar symporter
f.54.1.1;SNF-like
f.49.1.1;Proton glutamate symport protein
f.20.1.1;Clc chloride channel
f.14.1.1;Voltage-gated potassium channels
f.15.1.1;Small-conductance potassium channel
f.16.1.1;Gated mechanosensitive channel
f.36.1.1;Neurotransmitter-gated ion-channel transmembrane pore
f.34.1.1;Mechanosensitive channel protein MscS (YggB), transmembrane region
f.39.1.1;Multidrug resistance efflux transporter EmrE
f.40.1.1;V-type ATP synthase subunit C
f.41.1.1;Preprotein translocase SecY subunit
f.29.1.1;Photosystem I subunits PsaA/PsaB
f.30.1.1;Photosystem I reaction center subunit X, PsaK
f.31.1.1;Photosystem I reaction center subunit XI, PsaL
f.22.1.1;ABC transporter involved in vitamin B12 uptake, BtuC
f.37.1.1;ABC transporter transmembrane region
f.35.1.1;Multidrug efflux transporter AcrB transmembrane domain
f.32.1.1;a domain/subunit of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.21.1.2;Cytochrome b of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.21.1.1;Formate dehydrogenase N, cytochrome (gamma) subunit
f.21.3.1;Respiratory nitrate reductase 1 gamma chain
f.21.2.1;Fumarate reductase respiratory complex cytochrome b subunit, FrdC
f.21.2.2;Succinate dehydrogenase/Fumarate reductase transmembrane subunits (SdhC/FrdC and SdhD/FrdD)
f.27.1.1;14 kDa protein of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.28.1.1;Non-heme 11 kDa protein of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
f.45.1.1;Mitochondrial ATP synthase coupling factor 6
f.33.1.1;Calcium ATPase, transmembrane domain M
f.3.1.1;Light-harvesting complex subunits
f.55.1.1;Photosystem II antenna protein-like
f.42.1.1;Mitochondrial carrier
f.43.1.1;Chlorophyll a-b binding protein
f.56.1.1;MAPEG domain
f.57.1.1;MgtE membrane domain-like
f.58.1.1;MetI-like
f.51.1.1;Rhomboid-like
f.59.1.1;Cation efflux protein transmembrane domain-like
f.50.1.1;Connexin43
f.4.1.1;Outer membrane protein
f.4.1.2;Outer membrane enzyme PagP
f.4.1.3;GNA1870 immunodominant domain-like
f.4.1.4;PsbO-like
f.4.4.1;Outer membrane protease OMPT
f.4.4.2;Outer membrane adhesin/invasin OpcA
f.4.5.1;Autotransporter
f.4.2.1;Outer membrane phospholipase A (OMPLA)
f.4.3.1;Porin
f.4.3.2;Maltoporin-like
f.4.3.3;Ligand-gated protein channel
f.4.3.4;Outer membrane protein transport protein
f.4.6.1;Tsx-like channel
f.5.1.1;Outer membrane efflux proteins (OEP)
f.46.1.1;HlyD-like secretion proteins
f.6.1.1;Leukocidin (pore-forming toxin)
f.6.1.2;Porin MspA
f.7.1.1;Lipovitellin-phosvitin complex; beta-sheet shell regions
f.8.1.1;(Pro)aerolysin, pore-forming lobe
f.8.1.2;ETX/MTX2
f.9.1.1;Perfringolysin
f.10.1.1;Viral glycoprotein, central and dimerisation domains
f.47.1.1;VP4 membrane interaction domain
f.12.1.1;Head and neck region of the ectodomain of NDV fusion glycoprotein
f.48.1.1;OmpH-like
f.11.1.1;Anthrax protective antigen
g.1.1.1;Insulin-like
g.3.1.1;Hevein-like agglutinin (lectin) domain
g.3.1.2;Antimicrobial peptide 2, AC-AMP2
g.3.2.1;Plant inhibitors of proteinases and amylases
g.3.3.1;Kalata B1
g.3.3.2;Cycloviolacin
g.3.3.3;Circulin A
g.3.3.4;Palicourein
g.3.4.1;Gurmarin, a sweet taste-suppressing polypeptide
g.3.4.2;Antifungal peptide
g.3.5.1;Agouti-related protein
g.3.6.1;Conotoxin
g.3.6.2;Spider toxins
g.3.6.3;Insect toxins
g.3.6.4;Albumin 1
g.3.6.5;Vhv1.1, polydnaviral gene product
g.3.7.1;Long-chain scorpion toxins
g.3.7.2;Short-chain scorpion toxins
g.3.7.3;Defensin MGD-1
g.3.7.4;Insect defensins
g.3.7.5;Plant defensins
g.3.8.1;Cellulose-binding domain
g.3.9.1;Growth factor receptor domain
g.3.10.1;Colipase-like
g.3.11.1;EGF-type module
g.3.11.6;Integrin beta EGF-like domains
g.3.11.5;EGF-like domain of nidogen-1
g.3.11.2;Laminin-type module
g.3.11.3;Follistatin (FS) module N-terminal domain, FS-N
g.3.11.4;Merozoite surface protein 1 (MSP-1)
g.3.11.7;Cripto EGF-like domain-like
g.3.12.1;Bromelain inhibitor VI (cysteine protease inhibitor)
g.3.13.1;Bowman-Birk inhibitor, BBI
g.3.14.1;Elafin-like
g.3.15.1;Huristasin-like
g.3.15.2;Hirudin-like
g.3.16.1;Granulin repeat
g.3.17.1;Satiety factor CART (cocaine and amphetamine regulated transcript)
g.3.18.1;DPY module
g.3.19.1;Bubble protein
g.4.1.1;PMP inhibitors
g.5.1.1;Midkine, a heparin-binding growth factor, N-terminal domain
g.5.1.2;Midkine, a heparin-binding growth factor, C-terminal domain
g.60.1.1;TSP-1 type 1 repeat
g.6.1.1;Amb V allergen
g.7.1.1;Snake venom toxins
g.7.1.2;Dendroaspin
g.7.1.3;Extracellular domain of cell surface receptors
g.8.1.1;Small Kunitz-type inhibitors & BPTI-like toxins
g.8.1.2;Soft tick anticoagulant proteins
g.8.1.3;Tick tryptase inhibitor-like
g.9.1.1;Defensin
g.9.1.2;Myotoxin
g.9.1.3;Tick carboxypeptidase inhibitor-like
g.10.1.1;Hairpin loop containing domain
g.10.1.2;Anti-platelet protein
g.10.1.3;Pan module (APPLE domain)
g.11.1.1;Neurotoxin III (ATX III)
g.12.1.1;LDL receptor-like module
g.13.1.1;Crambin-like
g.14.1.1;Kringle modules
g.14.1.2;Fibronectin type II module
g.68.1.1;Ovomucoid domain III-like
g.68.1.2;Serine proteinase inhibitor lekti
g.69.1.1;Plant proteinase inhibitors
g.16.1.1;Trefoil
g.16.2.1;Plexin repeat
g.16.3.1;Variant surface glycoprotein MITAT 1.2, VSG 221, C-terminal domain
g.70.1.1;Necrosis inducing protein 1, NIP1
g.17.1.1;Platelet-derived growth factor-like
g.17.1.2;Transforming growth factor (TGF)-beta
g.17.1.7;Noggin
g.17.1.3;Neurotrophin
g.17.1.4;Gonadodropin/Follitropin
g.17.1.6;Interleukin 17F, IL-17F
g.17.1.5;Coagulogen
g.18.1.1;Complement control module/SCR domain
g.19.1.1;Sea anemone toxin k
g.19.1.2;Crisp domain
g.20.1.1;Blood coagulation inhibitor (disintegrin)
g.21.1.1;Methylamine dehydrogenase, L chain
g.22.1.1;ATI-like
g.22.1.2;BSTI
g.23.1.1;TB module/8-cys domain
g.24.1.1;TNF receptor-like
g.24.1.2;BAFF receptor-like
g.25.1.1;Heparin-binding domain from vascular endothelial growth factor
g.26.1.1;Antifungal protein (AGAFP)
g.27.1.1;Fibronectin type I module
g.27.1.2;VWC domain
g.28.1.1;Thyroglobulin type-1 domain
g.29.1.1;Type X cellulose binding domain, CBDX
g.55.1.1;Cellulose docking domain, dockering
g.30.1.1;Carboxypeptidase inhibitor
g.31.1.1;Tachycitin
g.31.1.2;Antifungal peptide scarabaecin
g.58.1.1;Pheromone ER-23
g.63.1.1;Mollusk pheromone
g.61.1.1;Apical membrane antigen 1
g.64.1.1;Somatomedin B domain
g.65.1.1;Notch domain
g.71.1.1;Mini-collagen I, C-terminal domain
g.76.1.1;Hormone receptor domain
g.77.1.1;Resistin
g.78.1.1;YAP1 redox domain
g.2.1.1;Heat-stable enterotoxin B
g.2.2.1;Neurotoxin B-IV
g.2.3.1;Pollen allergen ole e 6
g.2.4.1;VhTI-like
g.83.1.1;Tim10/DDP
g.84.1.1;Vanabin-like
g.32.1.1;GLA-domain
g.33.1.1;Cholecystokinin A receptor, N-domain
g.34.1.1;HIV-1 VPU cytoplasmic domain
g.35.1.1;HIPIP (high potential iron protein)
g.36.1.1;Ferredoxin thioredoxin reductase (FTR), catalytic beta chain
g.37.1.1;Classic zinc finger, C2H2
g.37.1.3;Plant C2H2 finger (QALGGH zinc finger)
g.37.1.2;C2HC finger
g.37.1.4;HkH motif-containing C2H2 finger
g.37.1.7;CHHC finger
g.37.1.5;variant C2H2 finger
g.37.1.6;BED zinc finger
g.38.1.1;Zn2/Cys6 DNA-binding domain
g.39.1.1;Erythroid transcription factor GATA-1
g.39.1.2;Nuclear receptor
g.39.1.10;Transcription factor grauzone Cg33133-Pa, zinc finger associated domain
g.39.1.3;LIM domain
g.39.1.4;LASP-1
g.39.1.5;DNA repair factor XPA DNA- and RPA-binding domain, N-terminal subdomain
g.39.1.6;Ribosomal protein L24e
g.39.1.9;Hypothetical zinc finger protein YacG
g.39.1.7;Ribosomal protein S14
g.39.1.8;C-terminal, Zn-finger domain of MutM-like DNA repair proteins
g.39.1.11;ClpX chaperone zinc binding domain
g.39.1.12;PARP-type zinc finger
g.39.1.13;Prokaryotic DksA/TraR C4-type zinc finger
g.39.1.14;Type II thymidine kinase zinc finger
g.39.1.15;A20-like zinc finger
g.39.1.16;THAP domain
g.39.1.17;TRASH domain
g.39.1.18;FwdE C-terminal domain-like
g.72.1.1;SBT domain
g.40.1.1;Retrovirus zinc finger-like domains
g.41.1.1;Methionyl-tRNA synthetase (MetRS), Zn-domain
g.41.2.1;Microbial and mitochondrial ADK, insert "zinc finger" domain
g.41.14.1;NADH pyrophosphatase intervening domain
g.41.3.1;Transcriptional factor domain
g.41.3.2;DNA primase zinc finger
g.41.3.3;Prokaryotic DNA topoisomerase I, a C-terminal fragment
g.41.3.4;Putative zinc binding domain
g.41.3.5;PhnA zinc-binding domain
g.41.4.1;Casein kinase II beta subunit
g.41.5.1;Rubredoxin
g.41.5.2;Desulforedoxin
g.41.5.3;Cytochrome c oxidase Subunit F
g.41.10.1;Zn-finger domain of Sec23/24
g.41.11.1;Ran binding protein zinc finger-like
g.41.13.1;Hypothetical protein Ta0289 C-terminal domain
g.41.6.1;Hypothetical protein MTH1184
g.41.7.1;Aspartate carbamoyltransferase, Regulatory-chain, C-terminal domain
g.41.8.1;Ribosomal protein L37ae
g.41.8.2;Ribosomal protein L37e
g.41.8.3;Ribosomal protein L44e
g.41.8.4;Ribosomal protein S27e
g.41.8.5;Ribosomal protein L32p
g.41.8.6;Ribosomal protein L33p
g.41.8.7;Ribosomal protein L40e
g.41.8.8;Ribosomal protein S27a
g.41.9.2;RBP12 subunit of RNA polymerase II
g.41.9.3;RpoE2-like
g.41.15.1;NOB1 zinc finger-like
g.41.16.1;Nucleolar RNA-binding protein Nop10-like
g.41.17.1;CSL zinc finger
g.41.18.1;YfgJ-like
g.42.1.1;Ribosomal protein L36
g.59.1.1;Zinc-binding domain of translation initiation factor 2 beta
g.79.1.1;WRKY DNA-binding domain
g.43.1.1;B-box zinc-binding domain
g.44.1.1;RING finger domain, C3HC4
g.44.1.2;U-box
g.44.1.3;Variant RING domain
g.44.1.4;IBR domain
g.44.1.5;Zf-UBP
g.44.1.6;ZZ domain
g.45.1.1;Pyk2-associated protein beta ARF-GAP domain
g.45.1.2;RecO C-terminal domain-like
g.46.1.1;Metallothionein
g.47.1.1;Zinc domain conserved in yeast copper-regulated transcription factors
g.48.1.1;Ada DNA repair protein, N-terminal domain (N-Ada 10)
g.49.1.1;Protein kinase cysteine-rich domain (cys2, phorbol-binding domain)
g.49.1.2;TFIIH p44 subunit cysteine-rich domain
g.49.1.3;C1-like domain
g.80.1.1;AN1-like Zinc finger
g.85.1.1;MYND zinc finger
g.85.1.2;HIT zinc finger
g.89.1.1;CHY zinc finger
g.50.1.1;FYVE, a phosphatidylinositol-3-phosphate binding domain
g.50.1.2;PHD domain
g.50.1.3;variant PHD-like domain
g.51.1.1;Zn-binding domains of ADDBP
g.52.1.1;Inhibitor of apoptosis (IAP) repeat
g.66.1.1;CCCH zinc finger
g.90.1.1;E6 C-terminal domain-like
g.91.1.1;E7 C-terminal domain-like
g.67.1.1;Zinc finger domain of DNA polymerase-alpha
g.53.1.1;TAZ domain
g.92.1.1;T-antigen specific domain-like
g.62.1.1;Cysteine-rich DNA binding domain, (DM domain)
g.86.1.1;Coronavirus NSP10-like
g.93.1.1;Zinc hairpin stack
g.54.1.1;DnaJ/Hsp40 cysteine-rich domain
g.81.1.1;HSP33 redox switch-like
g.73.1.1;CCHHC domain
g.74.1.1;Sec-C motif
g.87.1.1;Viral leader polypeptide zinc finger
g.75.1.1;TSP type-3 repeat
g.82.1.1;Expressed protein At2g23090/F21P24.15
g.88.1.1;TSP9-like
h.1.1.1;Triple coiled coil domain of C-type lectins
h.1.2.1;Trimerization domain of TRAF
h.1.3.1;Leucine zipper domain
h.1.4.1;Inovirus (filamentous phage) major coat protein
h.1.5.1;Tropomyosin
h.1.6.1;Chicken cartilage matrix protein
h.1.7.1;Assembly domain of cartilage oligomeric matrix protein
h.1.8.1;Fibrinogen coiled-coil and central regions
h.1.9.1;Coiled-coil domain of nucleotide exchange factor GrpE
h.1.10.1;Coiled-coil dimerization domain from cortexillin I
h.1.11.1;XRCC4, C-terminal oligomerization domain
h.1.20.1;Intermediate filament protein, coiled coil region
h.1.12.1;Delta-sleep-inducing peptide immunoreactive peptide
h.1.13.1;NSP4 oligomerization domain
h.1.13.2;NSP3 C-terminal domain, NS34
h.1.14.1;Multimerization domain of the phosphoprotein from sendai virus
h.1.15.1;SNARE fusion complex
h.1.16.1;Outer membrane lipoprotein
h.1.17.1;Fibritin
h.1.18.1;N-terminal coiled coil domain from apc
h.1.19.1;Tetrabrachion
h.1.21.1;Eea1 homodimerisation domain
h.1.22.1;Mitotic arrest deficient-like 1, Mad1
h.1.23.1;Dimerization motif of sir4
h.1.24.1;Head morphogenesis protein gp7
h.1.25.1;Troponin T
h.1.25.2;Troponin I
h.1.26.1;Myosin rod fragments
h.1.27.1;RhoA-binding domain
h.1.27.2;Rabaptin-5
h.1.28.1;Geminin coiled-coil domain
h.1.29.1;Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain
h.1.30.1;MPN010-like
h.1.31.1;Eferin C-derminal domain-like
h.1.32.1;Heterotrimerisation domain of extracellular hemoglobin linker subunits
h.1.33.1;Sec2 N-terminal region
h.1.34.1;RILP dimerisation region
h.2.1.1;Tetramerization domain of the Mnt repressor
h.3.1.1;Influenza hemagglutinin (stalk)
h.3.2.1;Virus ectodomain
h.3.3.1;Coronavirus S2 glycoprotein
h.4.1.1;Variant surface glycoprotein (N-terminal domain)
h.4.2.1;Clostridium neurotoxins, "coiled-coil" domain
h.4.3.1;Colicin Ia, N-terminal domain
h.4.9.1;Colicin E3 receptor domain
h.4.4.1;Hemolysin E (HlyE, ClyA, SheA)
h.4.4.2;HBL-like
h.4.5.1;Methyl-accepting chemotaxis protein (MCP) signaling domain
h.4.6.1;Oligomerization domain of hepatitis delta antigen
h.4.8.1;F1 ATPase inhibitor, IF1, C-terminal domain
h.4.11.1;Chemotaxis phosphatase CheZ
h.4.12.1;Rad50 coiled-coil Zn hook
h.4.10.1;C-terminal domain of PLC-beta
h.4.13.1;Tumor suppressor gene product Apc
h.4.15.1;Proline/betaine transporter ProP, C-terminal cytoplasmic domain
h.4.16.1;Fzo-like conserved region
h.4.17.1;Occludin/ELL domain
h.4.18.1;Gam-like
h.4.19.1;PspA lactotransferrin-binding region
h.5.1.1;Apolipoprotein A-I
h.6.1.1;Apolipoprotein A-II
h.7.1.1;Synuclein
i.1.1.1;Ribosome complexes
i.1.1.2;Large subunit
i.1.1.3;Small subunit
i.25.1.1;Collagen fibre
i.26.1.1;Fatty acid syntase
i.2.1.1;Helicase
i.3.1.1;ATP synthase
i.18.1.1;Membrane ion ATPase
i.13.1.1;Multidrug resistance ABC transporter
i.4.1.1;Electron transport chains
i.5.1.1;Photosystems
i.6.1.1;Viruses and virus-receptor complexes
i.7.1.1;Reovirus components
i.17.1.1;Virus envelope proteins
i.14.1.1;Bacteriophage HK97 procapsid (prohead II)
i.19.1.1;Bacteriophage T4 3D cryo-EM reconstruction
i.8.1.1;RNA polymerase
i.9.1.1;Blood clotting
i.10.1.1;Microtubule complexes
i.15.1.1;Muscle protein complexes
i.20.1.1;Ep-cadherin
i.21.1.1;Transferrin receptor-transferrin complex
i.22.1.1;Signal recognition particle (SRP) complex
i.16.1.1;GroE chaperon
i.23.1.1;clathrin assemblies
i.24.1.1;anthrax toxin protective antigen-receptor complex
i.11.1.1;Computational models partly based on experimental data
i.12.1.1;Proteins of incorrect, partial and unknown sequence
j.1.1.1;Gramicidin
j.1.1.2;Peptaibol
j.2.1.1;Actagardine
j.2.1.2;Mersacidin
j.2.1.3;Nisin
j.106.1.1;Leucocin-like bacteriocin
j.3.1.2;Insect defense peptide thanatin
j.3.1.3;Androctonin
j.3.1.6;Gomesin
j.3.1.7;Tachyplesin I
j.3.1.4;theta defensin-like
j.3.1.5;Lactoferricin B (lfcinb)
j.3.1.8;Hepcidin
j.3.1.9;Cyclic trypsin inhibitor STFI-1
j.4.1.1;Magainin
j.4.1.3;Moricin
j.4.1.4;Tachykinin peptides
j.4.1.5;Cytotoxic linear peptide IsCT
j.4.1.6;Distinctin
j.5.1.1;Microcin J25
j.5.1.2;Subtilosin A
j.6.1.1;Peptide hormones
j.102.1.1;Angiotensin
j.7.1.1;delta-Toxin
j.7.2.1;Antimicrobial peptide HP(2-20)
j.7.3.1;Anticancer peptides
j.8.1.1;PSP1-like
j.9.1.1;30S ribosomal protein THX
j.9.2.1;HIV-1 REV fragments
j.9.3.1;RSG-1.2 peptide
j.9.4.1;TAT peptides
j.9.5.1;Box B RNA-binding N peptide
j.9.6.1;HTLV-1 peptide
j.9.7.1;Ilarvirus coat protein N-terminal fragment
j.10.1.1;DNA-binding domains of HMG-I(Y)
j.11.1.1;VPR protein fragments
j.12.1.1;Inactivation gate of potassium and sodium channels
j.13.1.1;Coagulation factor VIII, membrane-binding peptide
j.14.1.1;Phosphocholine cytidylyltransferase membrane-binding peptides
j.15.1.1;Parathyroid hormone fragments (residues between 1 and 39)
j.16.1.1;Corticotropin releasing hormone
j.17.1.1;Liposaccharide-binding protein CAP18 (residues 106-137)
j.18.1.1;Polymorphic antigen SPAM-H1 (residues 90-127)
j.19.1.1;Mellitin-like toxins
j.19.1.2;Poneratoxin (Pac-Tx)
j.20.1.1;Tertiapin
j.21.1.1;Antifreeze polypeptide HPLC-6
j.22.1.1;Troponin I fragments
j.23.1.1;Pilin fragments
j.24.1.1;RP71935
j.25.1.1;Atrial natriuretic peptide
j.26.1.1;Compstatin
j.27.1.1;Membrane-bound antimicrobial peptides
j.28.1.1;Endothelin-like
j.29.1.1;Heat-stable enterotoxin (HSE)
j.30.1.1;mu-conotoxin
j.30.1.2;alpha-conotoxin
j.30.1.3;Alpha-a-conotoxin
j.30.1.4;psi-conotoxin
j.30.1.5;Conotoxin tiA
j.30.1.6;Conotoxin mrIB
j.30.1.7;Delta-conotoxin
j.31.1.1;Conantokin G (conatoxin G)
j.31.1.2;Conantokin-T
j.32.1.1;Contryphan-R
j.33.1.1;Immunodominant region of protein G of BRSV
j.33.2.1;Potassium channel toxins
j.107.1.1;Penaeidin-3a
j.34.1.1;Bradykinin
j.35.1.1;Transmembrane helical fragments
j.36.1.1;Ferredoxin chloroplastic transit peptide
j.36.2.1;Vacuolar targeting peptide from NA-PROPI (residues 29-54)
j.36.3.1;Microcin leader peptide
j.36.4.1;ATP synthase beta chain, mitochondrial prepeptide
j.37.1.1;Phospholamban fragments
j.79.1.1;Influenza hemagglutinin fragments
j.38.1.1;Fragments of bowman-birk inhibitor
j.39.1.1;Fragments of apolipoproteins
j.40.1.1;Transactivation protein TAT
j.41.1.1;Proline pipe
j.42.1.1;Amyloid peptides
j.43.1.1;Gelsolin fragment (residues 150-169)
j.44.1.1;Acetylcholine receptor fragment (residues alpha 67-76)
j.45.1.1;Thrombomodulin EGF domain fragment (residues 409-426)
j.78.1.1;C-terminal fragment of thermolysin
j.47.1.1;Capsid protein major homology region peptide analog
j.48.1.1;CD4 and CD8 receptor regions
j.108.1.1;Proto-oncogene tyrosine-protein kinase lck CD4/CD8 interacting region
j.49.1.1;Heparin binding site of non collagenous domain I (nc1) of collagen facit xiv
j.50.1.1;GroES fragments
j.51.1.1;cAMP and cGMP phosphodiesterase (PDE) fragments
j.52.1.1;HIV-1 Nef protein fragments
j.53.1.1;HIV-1 envelope gp120 protein fragments
j.85.1.1;HIV-1 gp41 fragments
j.54.1.1;Hepatitis C virus N-terminal capsid protein fragment 2-45
j.55.1.1;P27(KIP1) fragment 22-106
j.56.1.1;Transducin alpha-1 subunit rhodopsin binding domain (res. 340-350)
j.103.1.1;Transducin gamma-t1 subunit rhodopsin bound fragment (res. 60-71)
j.57.1.1;alpha-lactalbumin peptide model
j.58.1.1;Coat protein-binding domain of bacteriophage P22 scaffolding protein
j.59.1.1;Immunoreceptor tyrosine kinase activation motif, ITAM
j.60.1.1;Integrin fragments
j.61.1.1;Human glutathione reductase (HGR) inhibitor
j.62.1.1;Small subunit C-terminal inhibitory peptide of ribonucleotide reductase
j.63.1.1;Histone H3 C-terminal fragment 130-135
j.64.1.1;Smad-binding domain of Sara
j.96.1.1;Transactivation domain
j.112.1.1;Nuclear receptor coactivator Src-1
j.104.1.1;TBP-binding domain of the transcription factor IIIb Brf1 subunit
j.97.1.1;BRCA2 BRC4 repeat
j.65.1.1;Peptide derived from p-21 activated kinase
j.66.1.1;pak1 autoregulatory domain
j.67.1.1;Translocated intimin receptor (tir) intimin-binding domain
j.68.1.1;Fragments of the L-type calcium channel alpha subunit Cav.1 (dihydropyridine receptor)
j.69.1.1;Tumor suppressor p53 fragments
j.70.1.1;FxFG nucleoporin repeats
j.71.1.1;beta-Catenine bound non-globular protein regions
j.72.1.1;Synaptobrevin-II fragments
j.73.1.1;VMIP-II fragment
j.74.1.1;Papillomavirus e6-interacting peptide of e6ap
j.75.1.1;Isolated insulin B-chain
j.76.1.1;N-terminal hairpin of ubiquitin (residues 1-17)
j.77.1.1;alpha-helical hairpin of p8mtcp1
j.80.1.1;Syndecan-4 cytoplasmic domain
j.86.1.1;Actin-binding peptides
j.81.1.1;Pituitary adenylate cyclase activating polypeptide, pacap21
j.87.1.1;Rack1 interaction site of the CAMP-specific phosphodiesterase pde4d5.
j.88.1.1;Prepeptide of 5-ALAS
j.82.1.1;Cholecystokinin receptor fragments
j.89.1.1;the cytoplasmic N-terminus of the bk beta-subunit kcnmb2
j.83.1.1;Trypsin inhibitor SFTIf-1
j.90.1.1;Prion protein fragments
j.91.1.1;Tumor suppressor protein p19-ARF fragment
j.92.1.1;Antennapedia homeodomain fragments
j.93.1.1;Sheep myeloid antimicrobial peptide SMAP29 based peptides
j.94.1.1;alpha-2a adrenergic receptor pepride t3-i2
j.95.1.1;Catestatin fragment from chromogranin A
j.98.1.1;Bhpbr3, the Baff-binding loop of br3 embedded in a beta-hairpin peptide
j.99.1.1;N-terminal fragment of gastric H/K-ATPase
j.100.1.1;Barstar fragment
j.101.1.1;Cannabinoid receptor 1 (CB1) fragment
j.84.1.1;Ribosomal protein L10
j.105.1.1;Ubiquitin interacting motif (UIM)
j.109.1.1;Metal-binding peptide from MerP
j.110.1.1;Marinostatin, MstI
j.111.1.1;Cross-reactive peptides from 60S acidic ribosomal protein p2
j.113.1.1;NTR, cyclotide processing element
j.114.1.1;HMG-box transcription factor 1 fragments
j.115.1.1;MAD protein fragments
j.116.1.1;Fragments of TNF receptors
j.117.1.1;Ezrin-radixin-moesin binding phosphoprotein 50 (ebp50) fragments
j.118.1.1;Ribosomal protein L34p
j.122.1.1;Ribosomal protein S21p
j.119.1.1;Retinoblastoma-associated protein RB1 fragments
j.120.1.1;Genome linked protein vpg
j.121.1.1;Programmed cell death protein 5 fragments
k.41.1.1;alpha+beta folds
k.42.1.1;Function-directed selections
k.1.1.1;Hybrid and chimeric proteins
k.2.1.1;Amphiphilic (amphipathic) alpha helix
k.3.1.1;Collagen-like peptides
k.4.1.1;Coiled serine
k.40.1.1;Designed trimeric coiled-coil
k.6.1.1;Designed heterodimeric coiled-coil
k.7.1.1;Thermostable heterotrimeric coiled coil
k.8.1.1;Designed four-helix bundle protein
k.9.1.1;Designed single chain three-helix bundle
k.10.1.1;Peptide f (amphiphilic octadecapeptide)
k.11.1.1;Retro-GCN4 leucine zipper
k.31.1.1;Glytm1bzip
k.12.1.1;Zinc finger design
k.13.1.1;Protein A Ig(Fc)-binding domain mimics
k.14.1.1;Zinc finger based beta-beta-alpha motif
k.15.1.1;helix-turn-helix motif
k.16.1.1;alpha2d
k.17.1.1;Right-handed coiled coil
k.38.1.1;TPR domain-based design
k.18.1.1;Erythropoietin (EPO) mimetic peptides
k.19.1.1;IL-1 receptor type 1 antagonist peptide AF10847
k.20.1.1;Octreotide (Sandostatine), a somatostatine analogue
k.21.1.1;Calmodulin
k.22.1.1;WW domain-based designs
k.37.1.1;Artificial ankyrin repeat proteins
k.43.1.1;Carboxypeptidase A prodomain-based design
k.45.1.1;Ubiquitin
k.46.1.1;Cro lambda fold design
k.23.1.1;Potassium channel toxin hstx1
k.23.1.2;Mini-protein reproducing the core of the CD4 surface
k.26.1.1;TH (toxin hand)-motif beta-sheet mini-protein designs
k.24.1.1;Inhibitor of mammalian ribonucleotide reductase
k.27.1.1;Integrin-binding RGD peptide
k.28.1.1;Peptide antagonists of IGF-1
k.29.1.1;beta-hairpin design
k.32.1.1;Trp-cage miniprotein
k.30.1.1;Hairpin peptide
k.30.1.2;Zeta peptides
k.33.1.1;IFN mimetic syr6
k.34.1.1;TAZ (CH) Zn-binding domain based design
k.35.1.1;Beta-sheet designs
k.36.1.1;PW2, a tryptophan-rich anticocidial peptide
k.44.1.1;Designed EF-hand type cation-binding loop
k.39.1.1;Metalloporphyrin-binding designed peptides
